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Figure 2.1  Survivorship (mean + SD) of copepods (Acartia tonsa): (A) fed 
combinations of Karenia brevis (0, 34, 63, 81, 93, 100% of diet) and 
Rhodomonas lens for five days or a starvation control (abbreviated 
Starv.) (n = 5; starting with 30 copepods per replicate) and (B) fed R. 
lens with or without the addition of extracellular extracts of K. brevis 
for five days (n = 4; starting with 8-11 copepods per replicate). Letters 
indicate significant grouping of treatments (ANOVA and Tukey-
Kramer test) at p < 0.05. 17 
 
Figure 2.2   Ingestion of experimental diets by copepods (Acartia tonsa) (mean + 
SD, n = 5). Total daily ingestion rates expressed as phytoplankton 
biovolume, for copepods fed combinations of Karenia brevis and 
Rhodomonas lens each day for five days. Letters indicate significant 
grouping of treatments (ANOVA and Tukey-Kramer test) at p < 0.05. 19  
 
Figure 2.3  Feeding discrimination by copepods (A. tonsa). The percent of 
Karenia brevis ingested (
___
) as a function of the diet offered and the 
expected proportion of phytoplankters ingested (---) if copepods 
showed no feeding preferences. Asterisks (*) indicate data that 
significantly differed from non-discriminatory behavior (1-sample 2-
tailed t test) at p < 0.013 (determined by a sequential Bonferroni 
adjustment for multiple comparisons). 19 
 
Figure 2.4   Egg production rates for the copepod Acartia tonsa (A) fed 
combinations of Karenia brevis and Rhodomonas lens, measured on 
Day 5 (mean + SD, n = 5) and (B) as a proportion of K. brevis in the 
diet. Letters indicate significant grouping of treatments (ANOVA and 
Tukey-Kramer test) at p < 0.05. The solid line in (B) represents linear 
regression of all data (r
2 
= 0.57, p < 0.0001), with the shaded area 
representing 95% confidence intervals for this regression. The dashed 
line connects mean egg production of copepods fed 0% K. brevis to 
mean egg production of copepods fed 100% K. brevis. 21 
 
Figure 2.5   Egg production rates on Day 5 for the copepod Acartia tonsa as a 
function of Rhodomonas lens ingestion rates. The solid line represents 
linear regression of data from copepods fed 100% R. lens (R. lens 
only, ■) (r
2
 = 0.24). The dashed line represents linear regression of 
data from mixed diet treatments (R. lens and K. brevis, ○) (r
2
 = 0.55) 




Figure 2.6   Egg hatching success for the copepod Acartia tonsa fed combinations 
of Karenia brevis and Rhodomonas lens, measured from eggs laid on 
Day 4 (mean + SD, n = 5). Letters indicate significant grouping of 
treatments (ANOVA and Tukey-Kramer test) at p < 0.05. The total 
number of eggs used to determine hatching success is shown within 
the bars. 23 
 
Figure 4.1 Effects of extracellular extracts of (A) K. brevis bloom or (B) cultures 
on the growth of 5 competing phytoplankton species (Experiment 1). 
Changes in cell concentration were assessed by in vivo fluorescence 
after 48 h for all species except the slow-growing A. cf. sanguinea 
whose final concentration was measured after 96 h. Error bars in this 
and subsequent figures indicate one standard deviation. Significance is 
marked with an asterisk (*) (p < 0.05; n = 5-10). 59 
 
Figure 4.2   Effects of K. brevis allelopathy on competitor photosynthetic 
efficiency (Experiment 2). (A) During exponential growth stage, 
competitor species were treated with extracellular extracts of either K. 
brevis bloom or non-bloom sample. (B) Competitor species were 
treated with an allelopathic extracellular extract of cultured K. brevis 
or a solvent control at three different competitor growth stages (lag, 
exponential growth (log), or stationary (stat) phases). Insets show 
growth curve of competitors, where number of days is on the x axis, 
and fluorescence (µg Chl a L
-1
) is on the y axis.  Arrows indicate the 
place in the growth curve where competitors were harvested for this 
experiment. Significance is marked with an asterisk (*) (p < 0.017, t-
test; p < 0.05, Wilcoxon sign-rank test; n = 5).   61 
 
Figure 4.3  Allelopathic effect of cultured K. brevis extracellular extract on the 
esterase activity of five competing phytoplankton species measured 
with fluorescein diacetate (FDA) (Experiment 3).  For all five species, 
contrasts between treatments and controls yielded p > 0.10 (n = 7).  63 
 
Figure 4.4  Allelopathic effect of cultured K. brevis extracellular extract on the 
membrane permeability of five competing phytoplankton species using 
SYTOX green to assess damaged (permeable) cells (Experiment 4). 
(A) Cells with damaged membranes for all species tested (p < 0.05; n 
= 7-8). (B) Akashiwo cf. sanguinea and (C) Prorocentrum minimum. 
Motile (swimming) cells with damaged membranes (p < 0.017; n = 8). 
Significant difference between treatments and controls is marked with 
an asterisk (*). 64 
 
Figure 4.5  Test of siderophore activity for cultured K. brevis extracellular extracts 
(Experiment 5).  The presence of iron binding compounds in K. brevis 
extracellular extracts was tested at natural (1X) and ten times natural 
(10X) concentration using a chrome azurol S (CAS) shuttle solution 
x 
(Schwyn and Neilands 1987). Data depict the proportion of 
siderophore-bound iron relative to the appropriate media control. 
Contrasts between allelopathic and non-allelopathic extract treatments 
yielded p > 0.40 at both concentrations (n = 3). 66 
 
Figure 5.1 Effects of extracellular extracts of Karenia brevis blooms and non-
bloom controls on the growth of Skeletonema costatum (Experiment 
1). Each bar represents the average maximum growth of S. costatum 
treated with extract of an independent field sample and measured after 
14-18 d. Black lines indicate the grand mean of each treatment. Error 
bars indicate standard error. The grand mean is significantly different 
between treatments (p < 0.001; n = 10-11), and the effect of sample 
within treatments is significant (p < 0.001; n = 3-10). 87 
 
Figure 5.2 Effects of live Skeletonema costatum cells on the allelopathic effects 
of Karenia brevis bloom extracts (Experiment 2). Paired samples are 
connected by a line. Error bars indicate standard error. The mean is 
significantly different between treatments (p < 0.001; n = 5 bloom 
samples; n = 3-10 allelopathy assays per sample). 89 
 
Figure 5.3 A) The effects of extracellular extracts of Karenia brevis cultures 
exposed to seawater or competitor culture, on the growth of nine 
competitor species. Each bar represents the maximum cell density of a 
phytoplankton species normalized to growth of the same species 
exposed to a seawater control. B) Six independent tests of the growth 
of Skeletonema costatum exposed to the same treatments as A. 
Asterisks (*) indicate a significant allelopathic effect relative to 
seawater control and plus signs (+) indicate a significant difference 
between treatments for a given species (n = 5-8). 91 
 
Figure 6.1 HPLC fractionation of Karenia brevis extracellular extracts. (A) C-18 
reversed-phase HPLC chromatogram of K. brevis extracellular extracts 
in a gradient of aqueous methanol, with absorbance measured at 215 
and 254 nm. Vertical lines indicate fractions collected. (B) Growth of 
the diatom Asterionellopsis glacialis exposed to HPLC fractions 
normalized to a solvent control. “ALL” represents a treatment 
containing recombined HPLC fractions. Bars above the reference line 
indicate increased A. glacialis growth relative to solvent controls, 
while bars below the reference line indicate suppressed A. glacialis 
growth relative to solvent controls. Asterisks indicate A. glacialis 
growth significantly different from solvent controls (p < 0.05; n = 10 
for all).  115 
 
Figure 6.2 Growth of A. glacialis exposed to Karenia brevis extracellular extracts 
fractionated by three methods. (A) HP20ss fractionation. Fractions 
represent substances eluted from the column with water (“WATER”), 
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with methanol/acetone (“ORGANIC”), and recombined fractions 
(“ALL”). (B) Strong anion exchange chromatography. Fractions 
represent those that were not negatively charged (“SAX1”), to those 
that were charged (“SAX2”, “SAX3”), and a recombined fraction 
(“ALL”). For panels (A) and (B) asterisks represent treatments 
significantly different from controls (n = 7; p < 0.05) (C) Dialysis 
membrane separation. A. glacialis was exposed K. brevis materials 
greater than 1000 Daltons (>1000), less than 1000 Daltons (< 1000), 
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treatments significantly different from one another (n = 7; p < 0.05). 118 
 
Figure 6.3 Effects of fractions from size exclusion column on growth of A. 
glacialis, normalized to solvent controls. (A) Initial separation (n = 5). 
(B) The relative concentrations of molecular weight standards in each 
fraction (in panel C). The solid line represents the relative abundance 
of cyclodextrin (1135 Da), the dashed line napthol blue black (570 
Da), and the dotted line rhodamine (433 Da). (C) Further separation of 
fraction 8 (n = 7). The inset shows effects of combined fractions 8’2-4 
and 8’5-7 on the growth of A. glacialis after eight months storage at -
20 °C  (n = 7). For all panels, asterisks indicate significant differences 
relative to controls (p < 0.05). 120 
 
Figure 6.4 Spectroscopic analysis of combined size exclusion fraction 8’2-4. 
High resolution electrospray positive ion mass spectrum (A) before, 
and (B) after decompostion. 
1
H NMR spectrum (C) before, and (D) 
after decomposition. 122 
 
Figure 6.5 Spectroscopic analysis of combined size exclusion fraction 8’5-7. 
High resolution electrospray positive ion mass spectrum (A) before, 
and (B) after decompostion. 
1
H NMR spectrum (C) before, and (D) 








 The species composition of planktonic communities is determined not only by 
abiotic factors, such as nutrient availability, temperature, and water column stratification 
– but also by biotic interactions between hosts and parasites, predators and prey, and 
among competitors. Blooms of the red tide dinoflagellate, Karenia brevis, can 
dramatically alter the planktonic community, reaching densities of millions of cells per 
liter and occurring nearly monospecifically. However, K. brevis has a relatively low 
nutrient affinity and growth rate, suggesting that abiotic factors alone cannot explain its 
dominance of the community. I investigated whether K. brevis uses chemical compounds 
to defend against grazing or to inhibit the growth of competitors. Because K. brevis is 
known to produce brevetoxins, polyketide compounds which act as potent neurotoxins in 
mammals, I also investigated whether brevetoxins played a role in competition or 
predator resistance.  
Experiments revealed that copepods fed diets rich in Karenia brevis experienced 
lowered survival and fecundity, however, nutritional inadequacy, rather than toxicity, 
seems to have been responsible for the decrease in grazer fitness. Compounds exuded 
from natural samples of K. brevis blooms did, however, inhibit the growth of four of five 
model competitors. Compounds exuded from K. brevis cultures were similarly 
allelopathic to competitors. Exposure to these allelopathic compounds resulted in lowered 
photosynthetic efficiency of all competitors, and decreased cell membrane integrity of 
three competitors. The allelopathic potency of K. brevis blooms was variable between 
collections and years, but allelopathy did not correlate with bloom density or 
xiii 
concentration of brevetoxins.  However, the variability of allelopathy could partially be 
explained by the presence of specific competitors. The diatom Skeletonema costatum 
reduced the growth-inhibiting effects of K. brevis bloom exudates, suggesting that S. 
costatum has a mechanism for undermining K. brevis allelopathy. Allelopathic 
compounds exuded by K. brevis that inhibited the growth of the diatom Asterionellopsis 
glacialis were partially characterized. K. brevis produced multiple, polar, organic 
compounds that inhibited A. glacialis growth. Two partially characterized allelopathic 
compounds were found to have molecular weights in the range of 500-1000 Da and to 
possess aromatic functional groups but no negative charge. Exuded brevetoxins, on the 
other hand, had no effect on A.glacialis growth.  
Taken together, these results indicate that K. brevis is not chemically defended 
against grazing, but does produce yet-unidentified allelopathic compounds that inhibit the 
growth of competing phytoplankton. Brevetoxins had no discernable effect on 
competitors or grazers, underscoring the important difference between toxicity to 
mammals and the ecological roles of natural products. Blooms of K. brevis may be 
facilitated by the exudation of potent allelopathic compounds, but the specific 








 In marine systems, chemical cues mediate interactions between conspecifics, 
interspecific competitors, among hosts and their parasites or pathogens, and between 
predators and their prey. For example, chemical signaling allows some copepods to find 
and recognize conspecific mates (Yen et al. 1998; Ting et al. 2000). Compounds 
produced by sponges prevent overgrowth by competitors (Engel and Pawlik 2000; 
Kubanek et al. 2002), and compounds on the surface of macroalgae prevent fouling 
(Dworjanyn et al. 2006; Nylund et al. 2006) and infection by pathogens (Kubanek et al. 
2003). Some dinoflagellates can detect chemical cues from parasites, and consequently 
avoid parasitism (Toth et al. 2004). Many seaweeds and benthic invertebrates produce 
compounds that defend against consumers (reviewed in Hay 1996; Pohnert 2004; Paul et 
al. 2006). For example, the brown seaweed Dictyota menstraulis is chemically defended 
against mobile herbivores (Duffy and Hay 1994). Chemically-mediated interactions 
among benthic marine organisms are better characterized than interactions between 
pelagic marine organisms (McClintock and Baker 2001), but chemically-mediated 
planktonic interactions have the potential for ecosystem-wide effects, spanning multiple 
trophic levels and thousands of miles (Hay and Kubanek 2002). 
 Because grazers regulate the standing crop of phytoplankton during much of the 
year and can consume up to 60% of the primary production daily (Valiela 1995), 
selection on phytoplankton to evolve defenses against grazers should be high. However, 
demonstrating ecologically relevant chemical defenses from single-celled phytoplankton 
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is a major challenge for researchers (Pohnert et al. 2007). Upon cell lysis, some diatoms 
have been shown to produce volatile aldehydes which have deleterious effects on grazer 
reproduction (Pohnert 2000; Ianora et al. 2004a). However, the implications of these 
findings are still debated; because individual diatoms are killed by grazer attacks, the 
defense is only advantageous to surviving diatom clones and their descendents (Pohnert 
2005). When damaged, the coccolithophore Emiliania huxleyi, 
dimethylsulfoniopropionate is enzymatically cleaved to produce dimethylsulfate (DMS) 
and acrylic acid, compounds that were initially believed to inhibit grazing by Oxyrrhis 
marina (Wolfe et al. 1997). Further investigation, however, indicated that neither 
enzymatic product inhibited O. marina grazing (Strom et al. 2003). Perhaps the most 
convincing example of a phytoplankton chemical defense against grazers comes from the 
dinoflagellates Alexandrium spp., which produce paralytic shellfish toxins (PSTs), a 
group of at least 21 neurotoxic compounds that block mammalian sodium channels 
(Llewellyn 2006). Recent studies have also indicated that PSTs reduce fitness in bivalves 
(Bricelj et al. 2005) and copepods (Colin and Dam 2002a; Colin and Dam 2002b). 
Additionally, the presence of copepods was shown to induce PST production in 
Alexandrium minutum, resulting in selectively reduced copepod grazing on cells with 
high PST concentrations (Selander et al. 2006). 
Phytoplankton have also been shown to kill or inhibit the growth of competitors 
through the production and exudation of allelopathic compounds (Legrand et al. 2003). 
For example, compounds exuded by the dinoflagellates Alexandrium spp. cause reduced 
growth, impaired motility, and cell lysis of competitor monocultures and natural 
competitor assemblages (Tillmann and John 2002; Fistarol et al. 2004b; Tillmann et al. 
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2007). Planktonic allelopathy can have community-wide effects: allelopathic compounds 
produced by phytoplankton may alter the species composition of phytoplankton 
assemblages (Fistarol et al. 2003), influence phytoplankton succession (Keating 1977), 
and facilitate the spread of invasive species (Figueredo et al. 2007). Allelopathy has also 
been hypothesized to facilitate the formation of harmful algal blooms (reviewed in 
Legrand et al. 2003). While some bloom-forming species produce potent neurotoxins 
which can kill fish, birds, and marine mammals (Landsberg 2002), these toxins have 
rarely been linked to allelopathy (Sugg and Van Dolah 1999; Tillmann and John 2002; 
Fistarol et al. 2004b; Lundholm et al. 2005). 
Blooms of the red tide dinoflagellate, Karenia brevis, occur seasonally in the Gulf 
of Mexico, sometimes reaching densities of millions of cells per liter (Steidinger et al. 
1998). K. brevis produces brevetoxins, a group of polyketide neurotoxins that accumulate 
in shellfish and cause neurotoxic shellfish poisoning in humans (Baden 1989). 
Brevetoxins also cause massive fish kills (Landsberg 2002). While fish are known to 
accumulate brevetoxins by ingesting copepods that have fed on K. brevis (Tester 2000), 
fish mortality is suspected to occur primarily by absorption of waterborne brevetoxins 
directly across gill membranes (Landsberg 2002).  Marine mammals including whales, 
dolphins, and manatees are also suspected to have died from brevetoxin poisoning 
(Anderson 1992; Trainer and Baden 1999). 
The effects of compounds produced by Karenia brevis on members of the 
planktonic community are unclear. K. brevis blooms alter the composition of co-
occurring phytoplankton species (West et al. 1996), possibly through the production of 
allelopathic compounds (Kubanek et al. 2005). K. brevis has also been reported to 
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adversely affect zooplankton grazers. Studies have suggested that consumption of K. 
brevis is acutely toxic to some copepods (Sykes and Huntley 1987), however others have 
reported that grazers avoid consuming K. brevis (Huntley et al. 1987; Turner and Tester 
1989). K. brevis is a useful model organism for understanding chemically-mediated 
interactions in the plankton, both because K. brevis blooms have major ecological and 
economic effects, and because the influences of K. brevis on the planktonic community 
are largely unknown.  
In the following chapters, I will explore the interactions of Karenia brevis with 
zooplankton grazers and phytoplankton competitors. In the first chapter, I consider the 
effects of K. brevis on a grazing copepod, teasing apart the effects of phytoplankton 
toxicity, nutritional inadequacy, and copepod feeding behavior. In the second chapter, I 
review the state of the field of allelopathy research in marine systems. In chapters three 
through five, I report the results of my investigations into the allelopathic effects of K. 
brevis on co-occurring phytoplankton from the Gulf of Mexico, focusing on mechanisms 
of action of allelopathic compounds, variability in allelopathic effects, competitor 
responses to allelopathy, and characterization of allelopathic compounds. In the sixth and 
final chapter, I discuss the methodological limitations that currently hinder research on 




FITNESS CONSEQUENCES FOR COPEPODS FEEDING ON A RED TIDE 
DINOFLAGELLATE: DECIPHERING THE EFFECTS OF NUTRITIONAL 





Phytoplankton exhibit a diversity of morphologies, nutritional values, and 
potential chemical defenses that could affect the feeding and fitness of zooplankton 
consumers. However, how phytoplankton traits shape plant-herbivore interactions in the 
marine plankton is not as well understood as for terrestrial or marine macrophytes and 
their grazers. The occurrence of blooms of marine dinoflagellates such as Karenia brevis 
suggests that, for uncertain reasons, grazers are unable to capitalize on, or control, this 
phytoplankton growth – making these systems appealing for testing mechanisms of 
grazing deterrence.  
Using the sympatric copepod Acartia tonsa, we conducted a mixed diet feeding 
experiment to test whether Karenia brevis is beneficial, toxic, nutritionally inadequate, or 
behaviorally rejected as food relative to the palatable and nutritionally adequate 
phytoplankter Rhodomonas lens. On diets rich in K. brevis, copepods experienced 
decreased survivorship and decreased egg production per female, but the percentage of 
eggs that hatched was unaffected. Although copepods showed a 6-17% preference for R. 
lens over K. brevis on some mixed diets, overall high ingestion rates eliminated the 
possibility that reduced copepod fitness was caused by copepods avoiding K. brevis, 
leaving nutritional inadequacy and toxicity as remaining hypotheses. Because egg 
production was dependent on the amount of R. lens consumed regardless of the amount 
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of K. brevis eaten, there was no evidence that fitness costs were caused by K. brevis 
toxicity. Copepods limited to K. brevis ate 480% as much as those fed only R. lens, 
suggesting that copepods attempted to compensate for low food quality with increased 
quantity ingested. Our results indicate that K. brevis is a poor food for A. tonsa, probably 
due to nutritional inadequacy rather than toxicity, which could affect bloom dynamics in 
the Gulf of Mexico where these species co-occur.  
 
Introduction 
 Herbivores are affected by plant traits, including morphology, nutritional value, 
and chemical defenses (Fritz and Sims 1992; Rosenthal and Berenbaum 1992). Among 
terrestrial and marine macrophytes, chemical defenses are known to deter herbivore 
feeding and/or negatively affect herbivore fitness (Hay and Steinberg 1992). The relative 
importance of various phytoplankton traits in determining feeding patterns and fitness of 
zooplankton is less clear, although zooplankton grazers are known to differentiate among 
prey and are affected by the chemical composition of phytoplankton (e.g., Teegarden 
1999).  
Several species of marine dinoflagellates, including some that occasionally form 
dense blooms, produce chemical compounds that are neurotoxic to fish and mammals 
(Anderson and White 1992). It is hypothesized that these neurotoxins serve as defenses 
against planktonic grazers, either deterring feeding or killing grazers that do feed, but 
available data only partially support this hypothesis (Turner et al. 1998). In some cases, 
grazers such as copepods have suffered negative consequences of feeding on neurotoxic 
dinoflagellates, with symptoms (e.g., Sykes and Huntley 1987) and lowered fitness (e.g., 
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Colin and Dam 2002a) consistent with toxicity. In other cases, copepods have consumed 
neurotoxic dinoflagellates without obvious adverse effects (e.g., Teegarden and Cembella 
1996), whereas dinoflagellates that do not produce known neurotoxins can negatively 
impact copepod fitness (Ianora et al. 2004b). It is now generally acknowledged that there 
is no single obvious relationship between phytoplankton neurotoxicity and consequences 
for planktonic grazers and that experiments involving sympatric grazer and prey species 
are necessary to understand trophic interactions in the plankton (Smayda 1997; Turner 
and Tester 1997). Studies of plant-herbivore interactions in the marine plankton may also 
provide insights into ecosystem-level (or broader) processes, since phytoplankton blooms 
can move hundreds to thousands of kilometers and affect pelagic, benthic, and coastal 
communities (Hay and Kubanek 2002).  
Karenia brevis (ex Gymnodinium breve, ex Ptychodiscus brevis), an unarmored 
pelagic dinoflagellate, has bloomed periodically in the Gulf of Mexico for at least 
hundreds of years (Steidinger et al. 1998). Ecological effects of K. brevis blooms occur at 
several levels. The phytoplankton community is altered (West et al. 1996), possibly due 
to allelopathic effects of K. brevis (Kubanek et al. 2005). Mass mortalities of clams, 
crabs, polychaetes, and amphipods have been documented in response to K. brevis 
blooms (Simon and Dauer 1972; Tiffany and Heyl 1978). Fish are known to accumulate 
brevetoxins produced by K. brevis, by ingesting copepods that have fed on K. brevis 
(Tester et al. 2000), but fish mortality is suspected to occur primarily via absorption of 
waterborne brevetoxins directly across gill membranes (Landsberg 2002). Marine 
mammals including whales, dolphins, and manatees are suspected to have died from 
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brevetoxin poisoning (Anderson and White 1992; Trainer and Baden 1999; Flewelling et 
al. 2005). 
How Karenia brevis affects sympatric zooplankton grazers is not well understood, 
and may differ significantly among grazers. When five co-occurring copepod species 
were presented with K. brevis collected from a monospecific bloom, two copepod species 
ingested K. brevis at very low rates, whereas three others, including Acartia tonsa, ate 
increasing amounts of K. brevis with increasing availability (Turner and Tester 1989). 
When these authors offered copepods mixed phytoplankton from a bloom where a 
common diatom outnumbered K. brevis, copepods preferentially ate diatoms, suggesting 
that K. brevis somehow avoids or deters grazers. In addition, the copepod Acartia tonsa 
fed only K. brevis suffered lower egg production than A. tonsa fed other foods in lab 
experiments, which could have been due to poor nutritional quality or toxicity of K. 
brevis (Turner et al. 1996).  The copepod Calanus pacificus rejected K. brevis as food 
(Huntley et al. 1986) and suffered loss of motor control, accelerated heart beats, low 
survivorship, and interrupted development when exposed to K. brevis (Huntley et al. 
1987; Sykes and Huntley 1987); however, the geographic range of C. pacificus does not 
overlap with K. brevis, which reduces the ecological relevance of these findings. Overall, 
previous work indicates that both grazer behavior and physiology are affected by K. 
brevis, and that mechanisms could include avoidance, deterrence, nutritional inadequacy, 
and toxicity.   
Deciphering the relative importance of feeding preferences, prey nutritional 
quality, and prey toxicity is possible if fitness parameters and consumption rates are 
considered in mixed diet experiments (Jonasdottir et al. 1998). Comparisons of ingestion 
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rates among grazers offered prey choices can reveal prey deterrence or avoidance 
strategies that may be based upon prey size, motility, feeding stimulants, and feeding 
deterrents (e.g., Wolfe et al. 1997). If ingestion rates, grazer survivorship, and grazer 
reproduction on a suspect phytoplankton food is similar or higher than survivorship and 
reproduction on a control food known to be healthy for grazers, then the suspect food is 
likely to be a non-toxic, nutritionally adequate food. If grazer survivorship or 
reproduction on a suspect food is decreased relative to controls even when the suspect 
food is consumed at similar rates, then the suspect food may be either toxic or 
nutritionally inadequate for the grazer. If the suspect food is nutritionally inadequate, 
consuming it in a mixture with control food should offset the deleterious effects of the 
suspect food, in proportion to the amount of control food consumed. If the suspect food is 
toxic, however, it should detract from the beneficial effects of the control food, and so 
mixing the suspect food with control food will not offset the deleterious fitness effects of 
the suspect food. In addition, grazers may compensate for low nutritional value by 
feeding at higher rates when confined to low value, but non-toxic, foods (e.g., Cruz-
Rivera and Hay 2000). Colin and Dam (2002a; 2003) successfully applied a mixed diet 
approach to establish that a marine dinoflagellate, Alexandrium sp., with high saxitoxin 
content was toxic to some copepods of the genus Acartia and that copepods became 
physiologically incapacitated, although this approach could not reveal which compounds 
(whether specific saxitoxins or other Alexandrium natural products) were the direct cause 
of negative fitness effects. Using the same approach, Prorocentrum minimum was found 
to be nutritionally inadequate, rather than toxic, to a co-occurring copepod (Dam and 
Colin 2005). 
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In this study we used a mixed diet approach, in laboratory experiments, to 
determine whether the red tide dinoflagellate, Karenia brevis, is an adequate, toxic, or 
nutritionally inadequate food, and/or whether it is rejected by the calanoid copepod 
Acartia tonsa. A. tonsa was chosen because it is an abundant generalist feeder, occurs 
throughout the range of K. brevis, is present during K. brevis blooms, will consume K. 
brevis (Turner and Tester 1989), and bioaccumulates brevetoxins (Tester et al. 2000). 
Clarifying the interaction between this important phytoplankter and one of the major 
members of the co-occurring zooplankton should enable a better understanding of the 
community-level interactions involving harmful algal blooms, and plant-herbivore 
interactions in general. 
 
Materials and Methods 
Organisms 
 Phytoplankton strains were obtained from the Provasoli-Guillard Center for the 





 calculated from dimensions [mean + SD] 24.4 + 4.3 µm X 24.4 + 2.0 µm X 12.9 + 
1.3 µm, n = 5, measured using an Olympus IX50 inverted microscope) originally isolated 
off Sarasota, Florida, in August 2001, was maintained in a Percival environmental 
chamber at 22 
o




(PAR measurement using Biospherical Instruments Inc light meter). K. brevis culture 
medium was autoclaved L1 (Guillard and Hargraves 1993) prepared with filtered 36 psu 





 calculated from dimensions 12.4 + 0.7 µm X 6.7 + 0.7 µm X 6.7 + 0.7 µm, n = 5), 
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originally isolated from Bahamian Gulf Stream waters, were maintained at 25 
o
C with a 
20:4 h light:dark cycle. R. lens culture media was L1 media prepared with filtered 
artificial seawater (32 psu). Total carbon and nitrogen for R. lens and K. brevis cells were 
analyzed by Micro-Dumas combustion at the University of Georgia Institute of Ecology. 
 Acartia tonsa was originally collected off Skidaway Island, Georgia, USA, in the 
summer of 2002. Stock cultures were maintained in a 20 
o
C incubator with a 12:12 h 
light:dark cycle, in 2 L bottles with 32 psu filtered artificial seawater with aeration and 
monthly water changes. A. tonsa were maintained with a mixed diet of Rhodomonas 
salina (CCMP 1319; cultured as R. lens above) and R. lens. The sex ratio in stock 
cultures was 60:40 female:male (n = 50 copepods sexed). Typical egg production rates 
for our A. tonsa population were 34 + 8 (mean + SD) eggs per female per day at density 
of 5 copepods per 150 mL; 20 + 3 eggs per female per day at density of 10 copepods per 
150 mL; and 14 + 4 eggs per female per day at density of 30 copepods per 150 mL when 





, n = 5 for all). The highest density of copepods fed R. lens at fives times the 
concentration used in grazing experiments suffered high mortality (61 + 28 %) over two 
days (suggesting that variation in egg production rates were due to crowding and not food 
limitation). To keep the variance in sex ratio low across experimental beakers without 
determining the sex of all 1050 copepods needed for the grazing experiment, a density of 





 Sixteen hours prior to the start of the experiment, Acartia tonsa stock cultures 
were filtered to remove algae and the copepods were transferred to filtered seawater and 
starved overnight, then randomly sorted into groups of 30 adults. Each group was placed 
within a “basket” inside in a 250 mL beaker containing 150 mL of 32 psu filtered 
artificial seawater. Baskets consisted of plexiglass tubing (10 cm length X 5.5 cm 
diameter) with 160 µm nylon mesh covering one end. Mesh size was chosen to be large 
enough for eggs but too small for copepods to pass through. Beakers were randomly 
assigned to one of seven treatments: starvation control, 100% Karenia brevis, 100% 
Rhodomonas lens, or a mixture of the two species with 34% + 9%, 63% + 10%, 81% + 
4%, or 93% + 2% K. brevis (percentages calculated by cell biovolume, not cell number, n 
= 5). In all treatments except starvation controls, total biovolume of phytoplankton 




 per mL (i.e., for 100% K. brevis diet, this corresponds 
to 1500-2400 cells mL
-1
 and for 100% R. lens, 18,100-20,500 cells mL
-1
). For each 
treatment, there were five replicate beakers covered with a plexiglass petri dish. 
Replicates of a treatment were haphazardly interspersed among other treatments in an 
incubator at 20
 o
C with 12:12 h light:dark cycle.  
Phytoplankton were replaced within experimental beakers each day for five days. 
Immediately after each addition, a 10 mL sample was withdrawn from within each basket 
and fixed with Lugol’s solution. Visual cell counts were performed using 2-5 mL of fixed 
sample with a Hydrobios settling chamber and an Olympus IX50 microscope. We ran 
copepod-free controls with mixtures of Karenia brevis and Rhodomonas lens in seawater 
prior to the grazing experiment, which indicated that cell densities of these two species 
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did not significantly change either through growth or settling over 24 h in the absence of 
copepods (K. brevis p = 0.99, n = 4; R. lens p = 0.95, n = 4; 2-tailed paired t test). Thus, 
we decided to forgo interspersed copepod-free controls during the grazing experiment in 
order to maximize the number of experimental treatments and replicates.  
Survivorship, ingestion rates, and reproduction were assessed each day, for five 
days, after the copepods had been allowed to feed for 18 h. The basket containing the 
copepods was removed from the beaker and placed in a petri dish containing artificial 
seawater. Live and dead copepods were counted and dead ones removed. The contents of 
each beaker (minus the basket with copepods) were filtered through a 40 µm mesh in 
order to collect eggs, and 10 mL of remaining sample was fixed with Lugol’s solution for 
phytoplankton cell counts, as described above. Daily ingestion rates on each 






 where C1 is the cell concentration 
immediately after addition of phytoplankton, C2 is the cell concentration after 18 h, V is 
the cell biovolume, and N is the number of live copepods at the end of 18 h. The equation 
is adjusted for a 24 hour day by dividing by 18 and multiplying by 24 (from Frost 1972 
with cell growth term negligeable as determined above). Eggs were transferred to a vial 
filled with filtered seawater. After one, three, and five days, eggs were fixed immediately 
with Lugol’s solution and counted. After two and four days, live eggs were collected, 
counted, and incubated for two days at 20 
o
C in artificial seawater, after which time 
nauplii were counted, to calculate egg hatching success. The experimental beakers were 
filled with 150 mL of fresh filtered seawater and the live copepods in baskets were 
returned to their beakers, and fresh food of the appropriate mixed composition was 
added.  
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To directly test whether compounds exuded by Karenia brevis (including 
brevetoxins) directly affected copepod survivorship, we conducted an additional 
experiment using the same basket design and feeding protocol described above. 
Survivorship of Acartia tonsa was assessed following exposure to one of four treatment 
diets: 1) Rhodomonas lens; 2) R. lens + extracellular K. brevis extract; 3) no food 
(starvation control); 4) no food + extracellular K. brevis extract (starting with 8-11 adults 
per replicate beaker; n = 4 beakers). Extracellular K. brevis extracts were prepared from 
K. brevis stock cultures (13,500 cells mL
-1
), which were incubated for 18 h with a 
mixture of three adsorbent resins (Diaion HP-20 (Supelco), Amberlite XAD-7-HP (Acros 
Organics), Amberlite XAD-16 (Supelco)) designed for extraction of lipophilic 
compounds from aqueous media. Preliminary experiments in our lab confirmed that 
extracellular brevetoxins were efficiently adsorbed by this method, without lysing live K. 
brevis cells. Lipophilic compounds were eluted from the resin with methanol followed by 
acetone, and solvents removed by rotary evaporation. The extracellular extract was 
administered to treatments 2 and 4 each day at the time that food was added, using a 
concentration of extract equivalent to 1450 cells mL
-1
 of K. brevis, first re-dissolving the 
extract in 100 µl dimethyl sulfoxide (DMSO) per beaker. DMSO was added to treatments 
that did not receive extract.    
 
Brevetoxin analysis 
 Karenia brevis stock culture and extracellular filtrate of this stock culture 
(generated using an Amicon ultrafiltration apparatus with 5 µm Millipore membrane to 
separate cells from media without lysing cells) were frozen and sent to the University of 
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North Carolina at Wilmington for type II brevetoxin analysis by competitive ELISA 
(enzyme linked immunosorbent assay) (Naar et al. 2002). Intracellular brevetoxin 
concentration was calculated by subtracting the brevetoxin concentration of the filtrate 
(extracellular brevetoxins) from the brevetoxin concentration in stock cultures, and then 
dividing by the number of K. brevis cells in the sample (n = 3).  
 
Statistical analyses 
 Copepod survivorship and per capita total ingestion rates, egg production rates, 
and egg hatching success on different experimental diets were compared by ANOVA 
(SYSTAT 9). Pair-wise comparisons between treatments were made using a Tukey-
Kramer post hoc test. Survivorship was compared among treatments after five days. In 
order to compare total ingestion rates among treatments for the whole experiment, we 
first averaged feeding data over the five-day period for each replicate, then statistical 
analyses among treatments were performed.   
For each treatment, the percent of Karenia brevis ingested (relative to the total 
ingested biovolume of K. brevis and Rhodomonas lens) was compared with the percent of 
K. brevis offered in the diet using a 1-sample 2-tailed t-test. In this case, results were 
deemed significant when p < 0.013 (sequential Bonferroni adjustment for multiple 
comparisons) (Rice 1989).  
To determine if Karenia brevis undermined, supplemented, or had no effect upon 
egg production, a reference line was constructed connecting the mean egg production 
rates for copepods fed 100% R. lens and 100% K. brevis, and then egg production rate 
data for copepods fed mixed diets was compared with hypothetical values predicted by a 
16 
linear relationship along the reference line (adapted from Jonasdottir et al. 1998). In order 
to make this comparison, the egg production rate data were fit with both linear regression 
and a second-order polynomial equations, and the two models were compared by an extra 
sum-of-squares F test (using GraphPad Prism 4.0), to determine whether the more 
complicated model (second-order polynomial) was necessary to explain the data. This 
method is similar to isobolographical analysis, which tests for non-linear interactions in 
chemical defense and pharmaceutical research (Nelson and Kusar 1999).  
Whether the presence or absence of Karenia brevis affected egg production as a 
function of biovolume of Rhodomonas lens ingested was assessed by comparison of 
slopes and Y intercepts from linear regression on two groups of data: egg production 
rates for copepods that only had R. lens to eat – i.e., copepods that were part of the 100% 
R. lens treatment, vs. egg production rates for copepods in the mixed diet treatments that 




Survivorship of Acartia tonsa declined as the proportion of Karenia brevis 
increased in experimental diets (Figure 1.1A). Measured over a period of five days, 
survivorship of copepods offered 93-100% K. brevis was 29-40% of the survivorship of 
copepods fed only Rhodomonas lens (p < 0.001); whereas there were no significant 
differences in survivorship among copepods offered 34-81% K. brevis and only R. lens. 
All starved copepods were dead after five days. Survivorship of starved copepods was 


































Figure 2.1. Survivorship (mean + SD) of copepods (Acartia tonsa): (A) fed combinations 
of Karenia brevis (0, 34, 63, 81, 93, 100% of diet) and Rhodomonas lens for five days or 
a starvation control (abbreviated Starv.) (n = 5; starting with 30 copepods per replicate) 
and (B) fed R. lens with or without the addition of extracellular extracts of K. brevis for 
five days (n = 4; starting with 8-11 copepods per replicate). Letters indicate significant 



























































significantly lower than survivorship for copepods on other diets (p < 0.005 for all) 
(Figure 1.1A). 
Extracellular extracts of Karenia brevis did not directly affect Acartia tonsa 
survivorship (Figure 1.1B) or consumption rates (data not shown), when copepods were 
exposed to extracts while feeding on Rhodomonas lens (p = 0.92 comparing 5-day 
survivorship of copepods exposed to R. lens vs. R. lens + K. brevis extracellular extract). 
 
Ingestion rates and feeding preferences 
Copepods did not stop feeding when offered Karenia brevis – in fact, ingestion 
rates were highest for copepods on diets rich in K. brevis (Figure 1.2). Averaged over 5 
days, copepods offered only K. brevis consumed 4.8 times as much phytoplankton 
biovolume as copepods fed only Rhodomonas lens (p < 0.001). Copepods offered 93% K. 
brevis consumed 3.4 times as much phytoplankton biovolume as copepods fed R. lens (p 
= 0.007). This enhanced ingestion rate for copepods fed all or mostly K. brevis was most 
pronounced on Days 3-5 (data for individual days not shown).    
To assess whether Karenia brevis was rejected by copepods relative to 
Rhodomonas lens within each mixed diet treatment, we compared the actual proportion 
of K. brevis removed by consumption to the proportion of K. brevis available in each 
experimental diet. Copepods discriminated significantly against K. brevis when offered 
63, 81, and 93% K. brevis, consuming 53, 72, and 87% K. brevis, respectively, in those 
treatments (p = 0.002-0.011), but did not discriminate significantly against K. brevis in 



















Figure 2.2. Ingestion of experimental diets by copepods (Acartia tonsa) (mean + SD, n = 
5). Total daily ingestion rates expressed as phytoplankton biovolume, for copepods fed 
combinations of Karenia brevis and Rhodomonas lens each day for five days. Letters 



















Figure 2.3. Feeding discrimination by copepods (A. tonsa). The percent of Karenia brevis 
ingested (
___
) as a function of the diet offered and the expected proportion of 
phytoplankters ingested (---) if copepods showed no feeding preferences. Asterisks (*) 
indicate data that significantly differed from non-discriminatory behavior (1-sample 2-
tailed t test) at p < 0.013 (determined by a sequential Bonferroni adjustment for multiple 
comparisons). 
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Egg production was lower for copepods on diets richer in Karenia brevis (Figure 
1.4A). By the fifth day, copepods offered 81-100% K. brevis produced only 25-42% as 
many eggs per day as copepods fed only Rhodomonas lens (p = 0.005-0.042) (Figure 
1.4A). Egg production by starved copepods was significantly lower than for copepods fed 
only R. lens (p < 0.001), but was not significantly different from copepods offered 81-
100% K. brevis (p = 0.49-0.99) (Figure 1.4A). A similar but less pronounced effect of K. 
brevis on egg production also occurred on Days 1 and 3 (data not shown). 
 Because proportions of Karenia brevis ingested did not exactly match proportions 
of K. brevis available in mixed diets, we also tested whether there was a significant 
relationship between egg production rates and the proportion of K. brevis ingested on 
Day 5, when the compounded effects of several days of exposure to experimental diets 
could be observed. We found that egg production rates decreased linearly with the 
proportion of K. brevis ingested (r
2 
= 0.57; p < 0.001; Figure 1.4B solid line). When a 
reference line was drawn connecting the mean egg production rate for copepods fed 
100% R. lens and 100% K. brevis (Figure 1.4B dashed line), and actual egg production 
rate data were compared with the reference line, we found that the reference line fell 
within the 95% confidence intervals predicted by the linear regression of the egg 
production rates. In addition, comparison of linear and non-linear (second-order 
polynomial) models using an extra sum-of-squares F test resulted in acceptance of the 
simpler, linear model, rather than the non-linear one (p = 0.34).   
 In order to test whether egg production rates could be predicted by the amount of 















Figure 2.4. Egg production rates for the copepod Acartia tonsa (A) fed combinations of 
Karenia brevis and Rhodomonas lens, measured on Day 5 (mean + SD, n = 5) and (B) as 
a proportion of K. brevis in the diet. Letters indicate significant grouping of treatments 
(ANOVA and Tukey-Kramer test) at p < 0.05. The solid line in (B) represents linear 
regression of all data (r
2 
= 0.57, p < 0.0001), with the shaded area representing 95% 
confidence intervals for this regression. The dashed line connects mean egg production of 
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we compared the relationship between amount of R. lens ingested and egg production 
rates, when K. brevis was present (i.e., mixed diets) vs. absent from the diet (i.e, 100% R. 
lens diet) (Figure 1.5). For copepods fed mixed diets, egg production rates increased 
linearly with consumption of R. lens (r
2
 = 0.55; p = 0.0002), whereas for copepods fed 
only R. lens, this relationship was not significant (r
2
 = 0.24; p = 0.41). Nevertheless, egg 
production appeared to be independent of K. brevis ingestion, since slopes and Y 
intercepts did not significantly differ for copepods fed mixed diets vs. R. lens only (p = 
0.32, 0.44 for comparisons of slope and Y intercept, respectively, for treatments with vs. 
without K. brevis).  
 
Egg hatching 
 Egg hatching rates were statistically indistinguishable across treatments, except 
for starvation controls (Figure 1.6). By Day 4, the hatching rate for eggs produced by 
starved copepods was significantly lower than for copepods offered 34% Karenia brevis 
in their diet (p = 0.036), but indistinguishable from other treatments. It should be noted 
that by the last three days of the experiment, starved copepods were producing few eggs, 
approximately 20% as many as copepods fed Rhodomonas lens (Figure 1.4A).  
 
Brevetoxin and nutrient content of phytoplankton 
 As measured by ELISA, our Karenia brevis stock cultures contained 12.0 + 8.7 
pg cell
-1
 (mean + SD) intracellular type II brevetoxins and 3.6 + 2.1 pg cell
-1
 exuded 
brevetoxins (n = 3 stock cultures). Total carbon was 510 + 70 pg cell
-1
 and total nitrogen 
was 95 + 10 pg cell
-1
 for K. brevis; total carbon was 44.3 + 3.3 pg cell
-1


















Figure 2.5. Egg production rates on Day 5 for the copepod Acartia tonsa as a function of 
Rhodomonas lens ingestion rates. The solid line represents linear regression of data from 
copepods fed 100% R. lens (R. lens only, ■) (r
2
 = 0.24). The dashed line represents linear 
regression of data from mixed diet treatments (R. lens and K. brevis, ○) (r
2
 = 0.55) (p = 





















Figure 2.6. Egg hatching success for the copepod Acartia tonsa fed combinations of 
Karenia brevis and Rhodomonas lens, measured from eggs laid on Day 4 (mean + SD, n 
= 5). Letters indicate significant grouping of treatments (ANOVA and Tukey-Kramer 
test) at p < 0.05. The total number of eggs used to determine hatching success is shown 
within the bars. 
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was 9.92 + 0.66 pg cell
-1
 for Rhodomonas lens (n = 5 for each species). The C/N ratios 
for K. brevis and R. lens were 5.33 + 0.24 and 4.46 + 0.08, respectively. Thus, in the 
100% K. brevis diet, copepods were exposed to (1.22 + 0.19) x 10
3
 µg carbon L
-1
; in the 
100% R. lens diet, copepods were exposed to 874 + 54 µg carbon L
-1
; and for mixed 
diets, carbon levels fell between these two values.  
 
Discussion 
Phytoplankton compounds that are toxic to vertebrates may or may not affect the 
fitness and behavior of invertebrate grazers (Turner and Tester 1997; Turner et al. 1998). 
Historically, assessing the mechanisms by which zooplanktonic grazers are affected by 
phytoplankton food quality has not been straightforward. Toxicity may be confounded 
with starvation, if grazers do not ingest the suspect food. Previous studies that have 
attempted to assess grazer fitness based on egg production or egg hatching have 
sometimes not measured ingestion rates or have assessed toxicity by exposing copepod 
eggs directly to phytoplankton extracts in ways that would not normally occur in the field 
(see discussions in Hay 1996; Jonasdottir et al. 1998). This may have led to over-
reporting of toxic effects of phytoplankton on grazers. On the other hand, we and others 
may have missed toxic effects of phytoplankton by studying single grazer populations, if 
effects on grazers are variable among populations due to evolved resistance (e.g., Colin 
and Dam 2002b) or if lab rearing of copepods affects feeding behavior or food 
assimilation. The copepods used in the current study came from a population with little 
historic exposure to Karenia brevis blooms, making it less likely that our copepods had 
evolved resistance to any putative K. brevis toxins. 
25 
 The effects of the red tide dinoflagellate Karenia brevis on zooplankton grazers 
have been unclear, with some studies suggesting acutely toxic effects of consuming K. 
brevis (Sykes and Huntley 1987) and others suggesting avoidance by grazers (Huntley et 
al. 1986; Turner and Tester 1989). In our experiments, Acartia tonsa significantly 
favored Rhodomonas lens over Karenia brevis by 6-17% when K. brevis made up 63-
93% of the available food (Figure 1.3). However, more strikingly, copepods that were 
offered only or almost only K. brevis consumed 340-480% as much phytoplankton 
biovolume, overall, as copepods fed only R. lens (Figure 1.2). The highest total ingestion 
rates occurred for copepods fed only K. brevis. 
Combining the evidence for high ingestion rates with reduced copepod 
survivorship and reproduction, we established that Karenia brevis is not an adequate food 
for the calanoid copepod Acartia tonsa. Consuming large quantities of K. brevis, even in 
mixed diets with 7-19% Rhodomonas lens, reduced A. tonsa egg production rates by 57-
74% relative to copepods fed only R. lens (Figure 1.4A), although egg hatching success 
remained unaffected (Figure 1.6). Because we did not measure the lifetime reproduction 
of individual copepods, nor did we assess survivorship of juvenile copepods or 
reproduction of distinct age classes of copepods, estimates of fitness calculated from our 
data should not be generalized to natural copepods populations. Yet, using a basic 
population growth rate model (Ricklefs and Miller 2000), with birth rates approximated 
from egg production rates and hatching success, and death rates approximated from adult 
survivorship data, by Day 5 the instantaneous rate of population increase (r) for copepods 
fed only R. lens was approximately 3.5 times greater than r for copepods fed 93-100% K. 
brevis. Compounding this difference with the already-diminished population size for 
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copepods consuming K. brevis for five days (Figure 1.1A) resulted in population growth 
rates that differed among our treatments by more than 10-fold. This ought to translate to 
substantial fitness costs for copepods exposed to K. brevis in the field. 
Despite eating 3.4-4.8 times as much phytoplankton biovolume (Figure 1.2), 
copepods offered diets of 93-100% Karenia brevis had only 29-40% as much likelihood 
of surviving 5 days as copepods fed only Rhodomonas lens (Figure 1.1A). Thus, the 
observed negative fitness effects could not have been caused by decreased feeding rates 
when faced with K. brevis, but these data could be explained by either toxicity or 
nutritional inadequacy of K. brevis. The high ingestion rates we observed for copepods 
on diets rich in K. brevis (Figure 1.2) suggested that copepods did not find K. brevis toxic 
but instead found it nutritionally inadequate, and tried to compensate for low quality by 
consuming greater quantities (see also Cruz-Rivera and Hay 2000; 2003). It remained 
possible that copepods were dealing with toxic prey by expending energy in 
detoxification mechanisms, which may have required additional consumption to offset 
detoxification costs. To further differentiate between nutritional inadequacy and toxicity 
of K. brevis, we analyzed egg production rates as a function of ingestion on mixed diets, 
as recommended by Jonasdottir et al. (1998). 
Because copepod egg production rates (1) decreased with the proportion of 
Karenia brevis ingested (Figure 1.4B, p < 0.001); (2) were similarly dependent on the 
amount of R. lens consumed, whether K. brevis was present or absent from copepod diets 
(Figure 1.5); and (3) did not differ significantly from hypothetical rates predicted linearly 
for mixed diet treatments from the 100% Rhodomonas lens and 100% K. brevis 
treatments (Figure 1.4B); and (4) because copepod survivorship was not directly affected 
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by the presence of K. brevis extracellular extracts (Figure 1.1B), we suggest that there is 
little evidence that K. brevis is toxic to Acartia tonsa. If K. brevis was toxic or reduced 
assimilation efficiency in this copepod, we would expect that ingesting K. brevis would 
detract from the beneficial effects of eating R. lens, such that the number of eggs 
produced on mixed diets of K. brevis and R. lens would be lower than the number of eggs 
predicted solely as a function of the proportion (Figure 1.4B) or quantity (Figure 1.5) of 
R. lens ingested, as previously observed with a high-saxitoxin strain of Alexandrium sp. 
(Colin and Dam 2002a). This did not occur in our experiments, even though our strain of 
K. brevis produced typical concentrations of brevetoxins (Baden and Tomas 1988). The 
most likely explanation is that K. brevis is nutritionally inadequate, with survivorship and 
egg production for copepods fed 100% K. brevis not differing significantly from 
starvation controls (Figures 1.1A, 1.4A). The attempt by copepods to feed 
compensatorily on diets rich in K. brevis (Figure 1.2) is consistent with the conclusion of 
nutritional deficiency rather than toxicity. This pattern has also been observed for other 
marine consumers, as one lowers food quality without the addition of toxins (Cruz-Rivera 
and Hay 2000; 2003). 
Low nutritional value has been suggested to deter consumers (Feeny 1976; Price 
et al. 1980; Augner 1995). However, when food is nutritionally inadequate, herbivores 
may consume more in order to compensate for poor quality (Price et al. 1980). In choice 
feeding experiments, amphipods chose a more nutritious plant food over a less nutritious 
plant food, but also demonstrated compensatory feeding behavior when presented only 
with nutritionally poor food (Cruz-Rivera and Hay 2000; 2003). Copepods are also 
known to compensate for low quality by increasing the quantity consumed (Paffenhofer 
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1976; Koski et al. 1999), but only with some food sources (Koski and Breteler 2003). We 
found that Acartia tonsa did increase its feeding rate on Karenia brevis in the absence or 
near absence of a more desirable alternative after three to five days of receiving the same 
diet (Figure 1.2), although this compensatory feeding behavior did not translate into 
recovered fitness (Figures 1.1A, 1.4A). However, when presented with mixed diets rich 
in K. brevis, A. tonsa demonstrated significant preferences for Rhodomonas lens (Figure 
1.3). The magnitude of discrimination against K. brevis (6-17%) was small relative to the 
magnitude of compensatory feeding (340-480% on diets rich in K. brevis), or to the loss 
of fitness (>50% for copepods fed diets rich in K. brevis), suggesting that feeding 
preferences may not play a dominant role in this grazer-prey system. 
 Several factors may determine the nutritional value of a phytoplankter to grazers, 
including protein and carbohydrate concentrations (Jonasdottir 1994). Rhodomonas lens 
is reported to have more protein per biovolume than Karenia brevis, but lower levels of 
carbohydrates (data from Jonasdottir 1994 and Kamykowski et al. 1998), and we found 
that R. lens had a slightly lower C/N ratio than K. brevis. However, another important 
predictor of nutritional quality may be specific fatty acids or fatty acid ratios (Jonasdottir 
1994; Kleppel et al. 1998). Giner et al. (2003) hypothesized that K. brevis may be 
nutritionally inadequate because of its unusual sterol composition, such that copepods 
may be unable to convert these steroids to cholesterol, the principle steroid used by 
animals, rendering K. brevis nutritionally inadequate for copepods. However, this 
hypothesis has not yet been tested. It is not currently possible to assess which of many 
possible nutritional factors account for the poor food value of K. brevis for Acartia tonsa. 
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Our egg production rates for copepods fed only Rhodomonas lens (Figure 1.4A) 
were 30-77% lower than previously reported for Acartia spp. (Jonasdottir 1994; Dutz 
1998), which we attribute to crowded conditions in our grazing experiment. Separate 
experiments indicated that reducing copepod density, but not adding more food, returned 
egg production to more typical rates (see Materials and Methods). However, the 
reduction in overall fecundity caused by crowding was not likely to have misled our 
conclusions, as dramatic differences were observed between copepods fed R. lens, 
Karenia brevis, and mixed diets, all with the same initial copepod densities. In fact, the 
low survivorship of copepods fed mostly or all K. brevis (Figure 1.1A) should have 
reduced the effects of crowding late in the experiment, which could have led to enhanced 
egg production rates in those treatments. Yet, we observed significantly lower egg 
production rates among copepods fed more K. brevis (Figure 1.4A). For treatments in 
which copepods were fed only R. lens, copepods had access to 874 + 54 µg carbon L
-1
, 
which is below the saturation concentration for ingestion and egg production reported for 
congener A. clausi feeding on R. baltica (Dutz 1998). Saturation on K. brevis has not 
been measured for Acartia copepods; however, in our experiments A. tonsa had access to 
1215 + 186 µg carbon L
-1 
in 100% K. brevis treatments, which is similar to saturation 
levels reported for Acartia spp. on other phytoplankton foods (Berggreen et al. 1987; 
Dutz 1998). Thus, in all treatments, copepods had sufficient carbon for reasonable egg 
production, but not so much that egg production would be expected to be independent of 
ingestion rates. 
The current study contributes to our understanding of the complexity of 
relationships between primary producers and consumers, and demonstrates ecological 
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strategies which are employed by, but not limited to, harmful algal species. Prey may 
benefit by being nutritionally inadequate to consumers either because consumers 
preferentially feed on more nutritious prey or by lowering consumer fitness (Cruz-Rivera 
and Hay 2000; 2003), both of which were observed in our study. However, the adaptive 
benefits of reducing consumer fitness, post-ingestion, should be minimal for single-celled 
prey unless prey populations are genetically homogeneous, which has yet to be shown for 
harmful phytoplankton. Therefore, while low prey nutritional value may negatively affect 
consumer distribution and abundance, consumer pressure is unlikely to select for low 
nutritional value among single-celled prey such as phytoplankton. In contrast, consumer 
pressure ought to strongly select for deterrence mechanisms among prey in general, 
including phytoplankton – especially if alternative prey are available to consumers. Yet, 
in our experiments, copepods discriminated only modestly (6-17%) against Karenia 
brevis in mixed diets (Figure 1.3), and in fact ate the most when they had access to high 
proportions of K. brevis. In the field, copepods would typically be exposed to several 
phytoplankton species as potential prey, except during nearly monospecific blooms of 
phytoplankton species like K. brevis. Overall, it seems likely that the fitness of Acartia 
tonsa would decline if they occurred within K. brevis blooms. Although we did not test 
whether other zooplankton grazers suffer similar negative fitness effects, A. tonsa is itself 
an abundant member of the zooplankton grazing community in the Gulf of Mexico, co-
occurring with K. brevis (Gunter et al. 1948; but see Sutton et al. 2001), and so the failure 
of this copepod to capitalize on phytoplankton growth may impact plankton community 
structure.  It is possible that reductions in copepod populations could contribute to the 
formation or maintenance of K. brevis blooms. However, testing this using additional 
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ALLELOPATHY IN MARINE SYSTEMS: STATE OF THE FIELD 
 
Introduction 
 The field of community ecology was strongly influenced by studies of 
interspecific competition (e.g., MacArthur 1958; Connell 1961; Hutchinson 1961), and 
researchers continue to consider competition an important factor in structuring 
communities (Morin 1999). Competition for limiting resources (e.g., nutrients, space) can 
occur through the differential exploitation of these resources, or through direct 
interference among competitors (Birch 1957). Allelopathy, a form of interference 
competition, occurs when chemical compounds produced by one species inhibit or kill 
another species (Lambers et al. 1998; Morin 1999). While numerous examples of 
allelopathy in marine systems exist, the role of allelopathic interactions in structuring 
marine communities is less well known. Few studies have investigated either whether 
allelopathy is common among marine organisms or the relative importance of allelopathy 
compared to other mechanisms of competition.  
 Because several reviews dealing with allelopathy in marine systems have been 
published in recent years (Gross 2003; Legrand et al. 2003; Graneli & Pavia 2007), we do 
not provide a comprehensive review of marine allelopathic interactions. Instead we focus 
on specific studies and systems that best allow us to focus on the limitations of current 
methods and to emphasize those that have overcome these limitations. For the sake of 
brevity we have chosen to limit the scope of this review mostly to marine systems but the 
principles governing allelopathy in freshwater systems are similar and our conclusions 
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are likely applicable to freshwater environments. We have divided this review into two 
parts. In this introductory chapter, we provide a brief review of the state of the field, 
synthesizing progress made in benthic and pelagic marine systems, highlighting the 
historic differences in research, and focusing on similarities between these environments. 
In the conclusion chapter, we will explore in more detail the current limitations of 
allelopathy research, drawing attention to possible solutions to experimental problems, as 
well as to the most important unanswered questions and fruitful areas for future research. 
 
Allelopathy in benthic and pelagic marine systems 
 Little is known about how common or how important allelopathic interactions are 
in marine systems, either in benthic or pelagic communities. In benthic systems, one 
study indicated that 30% of sponges contained compounds inhibitory to the growth of 
other sponges, suggesting that allelopathy among sponges may be relatively common 
(Engel & Pawlik 2000). However, no similar studies have been conducted for other 
benthic organisms. Likewise, while researchers have detected production of allelopathic 
compounds from a variety of planktonic organisms (reviewed in Legrand et al. 2003), 
researchers have conducted no surveys to assess whether allelopathy is a strategy 
employed by most, or only a few, planktonic organisms. The relative importance of 
allelopathy in competitive interactions is also largely unknown, in both planktonic and 
benthic systems. Models suggest that allelopathy could change the outcome of 
competitive interactions in some systems (Hulot & Huisman 2004), while in other 
systems models indicate that allelopathy is less important than other factors (Mulderij et 
al. 2007). Assessing the relative importance of allelopathy is difficult both because 
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allelopathic interactions are difficult to separate from exploitation competition in the 
field, and because the effects of allelopathy may be variable. For example, experimental 
evidence suggests that, at least in planktonic systems, allelopathy may be more important 
when organisms are nutrient limited (Von Elert & Juttner 1997; Uronen et al. 2005). 
While examples of allelopathic interactions between pairs of species exist in both benthic 
and pelagic systems, the processes shaping these interactions and their ecological 
implications are often considered separately by scientists. However, the factors 
influencing allelopathic interactions in the two systems are often similar, and exploring 
differences between environments has the potential to raise important questions and 
inform future research directions. 
Because competitive environments should select for allelopathy, it is important to 
understand the factors that create intense competition in benthic and pelagic systems in 
order to understand under which conditions allelopathy will be favored. For example, 
nutrients are often the major limiting resource in planktonic communities (Tilman 1982; 
Valiela 1995) and so allelopathy has been hypothesized as a mechanism to prevent 
nutrient limitation by weak exploitation competitors. In contrast, settlement space is often 
limiting in benthic communities (Porter & Targett 1988; Menge & Farrell 1989), leading 
to tests of allelopathic interactions as mechanisms to acquire or retain space (Graneli & 
Pavia 2007). Alternative hypotheses (e.g., that nutrients are limiting in benthic systems or 
space in pelagic systems) are rarely tested. However, several studies suggest that 
phytoplankton do compete for the space that has light of appropriate wavelength and 
intensity necessary for growth (e.g., Huisman et al. 2004; Berger et al. 2006; Stomp et al. 
2007), and that allelopathic interactions may play a role in this competition (Pouvreau et 
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al. 2007). Likewise, nutrient availability may influence allelopathic interactions in 
benthic systems (Suzuki et al. 1998; McCook et al. 2001). Knowledge of the limiting 
resource in a given system (i.e., nutrients or space) may allow scientists to better predict 
the conditions under which allelopathic interactions will occur. For example, in some 
cases the production of allelopathic compounds is induced when a specific nutrient are 
limiting (Von Elert & Juttner 1997; Uronen et al. 2005) indicating that low nutrient 
conditions promote allelopathy and consequences of allelopathic interactions will be 
more likely to be observed under these conditions. 
Allelopathic compounds have been shown to be exuded into the water column by 
planktonic organisms, whereas in benthic systems, allelopathy has usually been shown to 
be mediated by direct contact between organisms co-occurring on the ocean floor. 
However, some phytoplankton compete through direct contact (e.g., Uchida et al. 1995; 
Yamasaki et al. 2007b) and some benthic organisms can inhibit the settlement and growth 
of competitors through exuded compounds (e.g., Dobretsov et al. 2006), indicating that in 
both systems allelopathic interactions may occur through either mechanism. Some 
differences between allelopathy in benthic and pelagic systems may be real, but 
researchers may also be predisposed towards generalizations because of the chosen 
experimental design, for example by working with exudates of cultured planktonic 
organisms vs. whole tissue samples of field-collected benthic organisms. In general, 
allelopathic interactions may not be seen, or may be misinterpreted if researchers fail to 
observe interactions outside of the prevailing paradigm, fail to devise and test alternative 
hypothesis, or incorrectly interpret the results of studies. 
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Identity of allelopathic compounds 
 The identity of allelopathic compounds is largely unknown in pelagic systems, 
however, in benthic systems several allelopathic compounds have been identified from 
whole tissue extracts or surfaces of allelopathic organisms. For example, the red alga 
Plocamium hamatum caused tissue necrosis to the coral Sinularia cruciata, which was 
explained by the monoterpene, chloromertensene (de Nys et al. 1991). The defensive 
compound 7-deacetoxyolepupuane also allowed the sponge Dysidea sp. to overgrow a 
competing sponge, Cacospongia sp. (Thacker et al. 1998). Similarly, researchers have 
found that triterpene glycosides, which also act as antipredator defenses, prevented the 
sponge Ecctyoplasia ferox from being overgrown by competing sponges and another 
sponge, Erylus formosus, from being fouled by propagules (Kubanek et al. 2002). In 
addition, several well-characterized furanones from the surface of the red algae Delisea 
pulchra deterred settlement of fouling organisms at ecologically relevant concentrations 
(Dworjanyn et al. 2006). 
 In pelagic systems, studies have rarely identified pure compounds with 
allelopathic effects at their natural exuded concentrations. Kubanek et al. (2005) found 
that a mixture of pure brevetoxins produced by the dinoflagellate Karenia brevis 
modestly inhibited the growth the diatom Skeletonema costatum, but unidentified 
compounds, rather than brevetoxins, were primarily responsible for the allelopathic effect 
on S. costatum (Prince et al. submitted). In some cases pure compounds that inhibited the 
growth of competitors have been identified (Kajiwara et al. 1992; Windust et al. 1996; 
Perez et al. 1997; Ribalet et al. 2007), but either these compounds were not allelopathic at 
natural concentrations (Kajiwara et al. 1992; Sugg & Van Dolah 1999) or allelopathic 
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effects were not tested at natural concentrations (Perez et al. 1997). Polyunsaturated 
aldehydes have been shown to inhibit the growth of phytoplankton species from several 
different genera (Ribalet et al. 2007), but since these compounds are produced by diatoms 
upon cell lysis (Pohnert 2005) it is not clear whether they are allelopathic under 
ecologically relevant conditions. In other cases, researchers have partially characterized 
allelopathic compounds, but the structures were not determined. For example, polar lipids 
have been isolated from the exudates of dinoflagellate Karlodinim micrum (Deeds et al. 
2002), and have been shown to inhibit the growth of some co-occurring phytoplankton 
(Adolf et al. 2006). Additionally, a polyphenolic pigment has been isolated from exudates 
of the diatom Haslea ostrearia, which inhibits the growth of competing phytoplankton 
(Pouvreau et al. 2007).  
 
Physiological effects of allelopathic compounds on competitors 
The outcomes of allelopathy are usually reported as inhibition of competitor 
growth among phytoplankton (e.g., Schmidt & Hansen 2001; Kubanek et al. 2005; 
Yamasaki et al. 2007a) and tissue necrosis among benthic organisms (e.g., de Nys et al. 
1991; Aceret et al. 1995; Thacker et al. 1998). In addition, allelopathic compounds have 
been shown to prevent organisms from being overgrown (e.g., Engel & Pawlik 2000; 
Kubanek et al. 2002) or to inhibit fouling and settlement of competitor larvae (e.g., Maida 
et al. 1995; Koh & Sweatman 2000; Dobretsov et al. 2006). Only a few studies have 
considered mechanisms of action of allelopathic compounds, but from these studies some 
physiological targets have been identified, including inhibition of photosynthesis, 
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inhibition of specific enzymes, cell membrane disruption, loss of cell motility, and life 
history changes. 
Several studies involving both benthic and pelagic systems have reported 
decreased photosynthetic efficiency (usually measured as the maximum quantum yield of 
photosystem II [Parkhill et al. 2001]) of organisms exposed to allelopathic compounds. 
For example, Prince et al. (2008) reported that compounds exuded by Karenia brevis 
blooms and cultures inhibited the photosynthetic efficiency as well as growth of five 
competing phytoplankton species. Similarly, polyunsaturated aldehydes, compounds 
produced by some diatoms upon cell lysis, resulted in chlorophyll degradation several 
phytoplankton including the dinoflagellate Alexandrium carterae (Ribalet et al. 2007).  In 
a benthic system, caulerpenyne, a terpenoid compound produced by the invasive seaweed 
Caulerpa racemosa, inhibited the photosynthesis of native seagrass (Raniello et al. 2007). 
Because corals contain symbiotic zooxanthellae, corals may also be subject to decreased 
photosynthetic efficiency due to allelopathy. Pawlik et al. (2007) found that sponges had 
two mechanisms to decrease coral photosynthesis. Compounds extracted from some 
sponges negatively affected the hard coral Diploria labyrinthiformis by decreasing total 
number of zooxanthellae within coral tissue (i.e., coral bleaching) while compounds 
extracted from other sponges decreased the photosynthetic efficiency of zooxanthellae. 
Aceret et al. (1995) found that the hard corals Acropora formosa and Porites cylindrical 
expelled zooxanthellae in response to flexibilide, a terpene extracted from competing soft 
corals; however it is not clear whether the hard corals would be exposed to this 
compound at allelopathic concentrations in the field.  
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In pelagic systems, the effects of allelopathic compounds on a few specific 
enzymes have been described. For example, okadaic acid, a diarrhetic shellfish toxin 
produced by several dinoflagellates including Prorocentrum lima, inhibited protein 
phosphatases in vitro (Bialojan & Takai 1988), and also suppressed growth of a variety of 
phytoplankton species (Windust et al. 1996). Okadaic acid is hypothesized to enter 
competitor cells in the form of okadaic acid diol-ester, (Windust et al. 1997; Windust et 
al. 2000), where it may be converted to the more polar and more toxic okadaic acid (Hu 
et al. 1995; Sugg & Van Dolah 1999). The mechanism of action has been characterized 
for allelopathy among planktonic organisms in the freshwater Sea of Galilee. Compounds 
exuded by Microcystis sp. which inhibited the growth of the dinoflagellate Peridinium 
gatunense (Vardi et al. 2002) also inhibited photosynthesis in P. gatunense. Because 
photosynthesis inhibition occured with a build-up of internal carbon stores, the authors 
suggested that it was caused by suppression of carbonic anyhydrase in P. gatunense 
(Sukenik et al. 2002). 
Studies of allelopathy in pelagic systems have occasionally reported damage to 
competitor cell membranes.  For example, compounds exuded by blooms and cultures of 
the red tide dinoflagellate, Karenia brevis, increased the membrane permeability of three 
of five competitor species, indicating that compounds exuded by K. brevis damage the 
cell membrane integrity of competing phytoplankton (Prince et al. 2008). Since an 
increase of membrane permeability was observed before competitors died, it is likely that 
this represents a mechanism of allelopathy rather than a side effect of cell death. 
Additionally, the freshwater dinoflagellate Peridinium aciculiferum may cause membrane 
damage in competitor cells; Rengefors & Legrand (2001) observed that filtrates of P. 
40 
aciculiferum caused blisters on the surface of Rhodomonas lacustris and eventually cell 
death. Exposure to polyunsaturated aldehydes also resulted in the membrane disruption of 
several other phytoplankton species, including the prymnesiophyte Isochrisis galbana 
and the prasinophyte Micromonas pusilla (Ribalet et al. 2007). 
Exposure to allelopathic compounds may also change the behavior or life history 
of competitor species. In co-incubation experiments, several strains of dinoflagellates 
Alexandrium spp. inhibited the cell motility of the heterotrophic dinoflagellates Oblea 
rotunda and Oxyrrhis marina and autotrophs Dunaliella salina, and Thalassiosira 
weisflogii (Tillmann & John 2002). Exposure to Alexandrium ostenfeldii caused 
Rhodomonas sp. cells to swim irregularly (Tillmann et al. 2007). The autotrophic 
dinoflagellate Scrippsiella trochoidea underwent a life history change in response to 
allelopathy, forming temporary cysts in response to compounds produced by 
Alexandrium spp., Karenia mikimotoi, and Chrysomulina polylepsis (Fistarol et al. 2004a; 
Tillmann et al. 2007). Although no experiments were performed to determine if S. 
trochoidea cysts grew vegetatively after compounds were removed, the authors suggested 
that cyst formation might be a mechanism that allows S. trochoidea to escape allelopathic 
compounds and then to re-emerge when conditions have improved. In benthic 
communities, larval recruits may also have strategies to avoid negative fitness effects of 
allelopathy. For example, compounds produced by Caulerpa racemosa prevented 






 Research on allelopathy in marine communities has provided many examples of 
allelopathic interactions between pairs of species, indicating that benthic invertebrates, 
macroalgae and plankton use compounds that kill or inhibit the growth of competitors. At 
the sub-cellular level, the physiological consequences to target organisms are varied, but 
may include reductions in photosynthesis (Raniello et al. 2007), inhibition of specific 
enzyme activities (Windust et al. 1996), and damage to cell membranes (Prince et al. 
2008). Competitors may avoid exposure to allelopathic compounds with behavioral 
(Tillmann et al. 2007) or life history changes (Fistarol et al. 2004a). With increasing 
examples of allelopathic interactions in marine systems, role of allelopathy in structuring 






EFFECTS OF HARMFUL ALGAL BLOOMS ON COMPETITORS: 






Because competitive interactions may have led to adaptations enabling bloom-
forming phytoplankton to dominate pelagic communities, we explored the allelopathic 
effects of one red tide dinoflagellate, Karenia brevis, on competing phytoplankton 
species. Exposure to waterborne compounds from natural K. brevis blooms resulted in 
growth inhibition or death for four out of five co-occurring species tested, whereas 
compounds exuded by K. brevis cultures suppressed three of these same competitors (the 
diatoms Asterionellopsis glacialis and Skeletonema costatum and the dinoflagellate 
Prorocentrum minimum) plus one additional species (the dinoflagellate Akashiwo cf. 
sanguinea) that was unaffected by bloom exudates. K. brevis exudates lowered 
photosynthetic efficiency and damaged cell membranes of competing phytoplankton, but 
had no effect on competitor esterase activity, nor did they limit competitor access to iron. 
Overall, during blooms, K. brevis exudes potent allelopathic compounds, competitors 
vary in their susceptibility to K. brevis allelopathy, and K. brevis may achieve nearly 
monospecific blooms by lowering the photosynthetic efficiency of competitor species and 
increasing competitor membrane permeability, eventually resulting in competitor growth 





 Because the composition of phytoplankton communities is determined by a wide 
variety of abiotic and biotic factors, the plankton environment has been used as a model 
system to understand species interactions and diversity through the lens of disturbance 
(Hutchinson 1961), predator-prey interactions (Leibold 1989), and resource competition 
(Tilman 1982). In addition to competing for limiting resources, phytoplankton may 
exclude each other more directly. The inhibition of competitors by the release of 
compounds, a process known as allelopathy, may be important in planktonic systems 
(reviewed in Legrand et al. 2003). Allelopathy has been hypothesized to play a role in 
species succession (Keating 1977), the formation of harmful algal blooms (Smayda 
1997), and the establishment of invasive species (Figueredo et al. 2007). 
 Despite its likely importance, our understanding of allelopathy is still in the early 
stages. Allelopathy is difficult to conclusively demonstrate in the field, and responsible 
compounds have rarely been identified. Co-culturing experiments and observations of 
phytoplankton dynamics in the field have supported the possibility of allelopathy (e.g., 
Schmidt and Hansen 2001; Vardi et al. 2002), but have not definitively separated its 
effect from exploitative competition. Although lab experiments using high nutrient 
concentrations have helped to shed light on the process of allelopathy, their value has 
often been undermined by the use of whole cells extracts rather than exudates (Freeburg 
et al. 1979), which places phytoplankton in contact with a suite of compounds not usually 
waterborne. We need to simultaneously better understand how allelopathy happens, and 
what its consequences are in the field (e.g., Fistarol et al. 2003).  
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 Although allelopathic compounds remain mostly unidentified, mechanisms for 
allelopathy have been proposed in some cases. Possible modes of action include 
oxidative damage, loss of competitor motility, inhibition of photosynthesis, inhibition of 
enzymes, and membrane damage (reviewed in Legrand et al. 2003). For example, Vardi 
et al. (2002) found that the presence of the cyanobacterium Microcystis sp. caused a 
build-up of apoptosis-inducing reactive oxygen species in the competing dinoflagellate 
Peridinium gatunense. Further, compounds produced by two dinoflagellate species have 
been reported to cause loss of motility in competitor cells, although there are likely 
multiple mechanisms. Cell contact with dinoflagellate Heterocapsa sp. was required for a 
loss of competitor motility (Uchida et al. 1995), whereas cell-free filtrates of the toxic 
dinoflagellate Alexandrium spp. caused loss of motility in the heterotrophic dinoflagellate 
Oxyrrhis marina (Tillmann and John 2002).  
 Several studies have indicated that photosystem II (PSII) may be a target for 
allelopathy. Unknown compounds produced by the cyanobacterium Trichormus doliolum 
inhibited PSII in other cyanobacteria (Von Elert and Juttner 1997). However, a decrease 
in photosynthetic efficiency may be a symptom of allelopathy even if PSII is not the 
target. For example, Sukenik et al. (2002) found that compounds produced by the 
cyanobacterium Microcystis sp. inhibited carbonic anhydrase activity of the 
dinoflagellate Peridinium gatunense, leading to CO2 limitation and inhibition of 
photosynthesis. A decrease in PSII efficiency has also been reported for a variety of 
general cell stresses, including nutrient stress (Parkhill et al. 2001), temperature stress 
(Lesser and Gorbunov 2001), and metal toxicity (Miller-Morey and Van Dolah 2004). 
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 In addition to carbonic anhydrase inhibition observed by Sukenik et al. (2002), 
other studies have reported enzyme inhibition as a mechanism for allelopathy. When 
tested as a pure compound, okadaic acid, produced by the dinoflagellate Prorocentrum 
lima, was shown to inhibit the growth of three microalgal species (Windust et al. 1996), 
perhaps because okadaic acid is a potent phosphatase inhibitior (Bialojan and Takai 
1988). However, compounds other than okadaic acid appeared to be responsible for 
allelopathic effects of P. lima filtrates (Sugg and Van Dolah 1999). Microcystins, 
produced by the cyanobacterium Microcystis aeruginosa, were also shown to inhibit 
phosphatases (Dawson 1998), but no studies have demonstrated that microcystins are 
allelopathic at ecologically relevant concentrations (Babica et al. 2006). As with a 
decrease in photosynthetic efficiency, phytoplankton enzyme activity may be a general 
indicator of cell stress. For example, esterase activity in several species of marine and 
freshwater algae can be either enhanced or suppressed by copper toxicity (Franklin et al. 
2001).  
 Damage to cell membranes is another proposed mechanism for allelopathy 
(Legrand et al. 2003). Microalgal compounds have been shown to damage red blood cell 
membranes which suggests that competing phytoplankton could be similarly affected 
(Igarashi et al. 1998), and fatty acids potentially produced by microalgae have been 
shown to increase permeability of the plasma membranes of chlorophytes and 
cyanobacteria (Wu et al. 2006). The freshwater dinoflagellate Peridinium aciculiferum 
may cause membrane damage in competitor cells; Rengefors and Legrand (2001) 
observed that filtrates of P. aciculiferum caused blisters on the surface of Rhodomonas 
lacustris and eventually cell death. However, more research is needed to definitively 
46 
establish that compounds exuded by phytoplankton at realistic waterborne concentrations 
cause membrane damage in competing phytoplankton. 
 Blooms of Karenia brevis, a red tide dinoflagellate occurring in the Gulf of 
Mexico and occasionally along the Southeastern coast of the United States (Tester et al. 
1991), cause ecosystem-wide effects, mostly due to the production of neurotoxic 
compounds (brevetoxins) that kill fish and accumulate in shellfish (Landsberg 2002). 
Like many dinoflagellates, K. brevis has a low nutrient affinity and growth rate compared 
to most diatoms and other phytoplankton taxa (Smayda 1997; Steidinger et al. 1998). 
This suggests that K. brevis does not achieve densities of millions of cells L
-1
 (Steidinger 
and Haddad 1981), altering the phytoplankton community (West et al. 1996), by 
exploitation competition. One possible explanation for its occasional dominance is that K. 
brevis uses allelopathy to out-compete other phytoplankton species, as previously 
demonstrated using cultured strains of K. brevis (Kubanek et al. 2005).  
  Herein, we tested whether natural Karenia brevis blooms are allelopathic, and we 
investigated allelopathic mechanisms of action using both field samples and cultures of 
K. brevis. In order to better understand the mode of action of K. brevis allelopathy, we 
tested whether compounds exuded by K. brevis inhibit the photosynthetic efficiency or 
esterase activity of competitor species, damage competitor cell membranes, or limit 






Materials and Methods 
Collection of field samples 
Three field samples of Karenia brevis (referred to as bloom samples) were 
collected approximately 10 m apart during a red tide at Long Boat Key beach, near the 
city of Bradenton on the west coast of Florida, in September 2006. One natural seawater 
sample containing no K. brevis (referred to as a non-bloom sample) was collected from 
the nearby beach at Green Key, near New Port Richey, on the same day. K. brevis and 
other phytoplankton species were identified from samples stained with Lugol’s solution, 
counted by light microcopy using an Olympus IX-50 inverted microscope with a Palmer-




 in the 
bloom samples, considered to be a medium-density bloom according to criteria set by the 
Florida Fish and Wildlife Research Institute (FWRI; http://research.myfwc.com/). 
Because the bloom began several weeks before samples were taken, and persisted several 
weeks after collection, we designated the bloom to have been in maintenance stage 
(described in Steidinger et al. 1998). Although in our hands K. brevis could not be 
conclusively distinguished from morphologically similar congeners such as K. mikimotoi, 
reports by FWRI stated that K. brevis constituted the majority of Karenia spp. present 
during this bloom. Each bloom and non-bloom sample was maintained at approximately 







Experiments were performed using five species of phytoplankton whose growth 
was previously shown to be suppressed by Karenia brevis live cells or filtrates (Kubanek 
et al. 2005). The following non-axenic clones were obtained from the Provasoli-Guillard 
National Center for Culture of Marine Phytoplankton (CCMP): the dinoflagellates 
Akashiwo cf. sanguinea (CCMP 1740) and Prorocentrum minimum (CCMP 695), and the 
diatoms Amphora sp. (CCMP 129), Asterionellopsis glacialis (CCMP 137), and 
Skeletonema costatum (CCMP 775). All species are known to co-occur with K. brevis in 
the Gulf of Mexico, were isolated from the Gulf of Mexico or the Caribbean, and to 
tolerate similar light, nutrient, and temperature conditions. Cultures were maintained at 
22 °C with a 12 h light:dark cycle in a Percival incubator with Philips F32T8/TL741 





 throughout the incubator (measurement using Biospherical Instruments 
Inc light meter model QSL2100), in F/2 + silicate media (Sigma-Aldrich Co) made with 
filtered Maine seawater (salinity 36). Cultures of K. brevis (CCMP 2228) used to 
generate extracellular extracts were grown in 2.5 L Fernbach flasks in L1 + silicate media 
(CCMP) made with filtered Maine seawater (36). Growth curves were generated by 
visual cell count data using an Olympus IX-50 inverted microscope with a Palmer-
Maloney settling chamber on culture samples preserved with Lugol’s solution.  
 
Generation of extracellular extracts 
Exuded organic compounds were extracted from each field sample and Karenia 
brevis culture by adding a mixture of three adsorbent resins (Diaion HP-20 (Supelco), 
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Amberlite XAD-7-HP (Acros Organics), Amberlite XAD-16 (Supelco)) optimized for 
extraction of lipophilic compounds from aqueous media (Prince et al. 2006). Preliminary 
experiments in our lab confirmed that organic compounds with a range of polarity were 
extracted by this method, without lysing live K. brevis cells. We determined that a small 
proportion of inorganic nutrients contained in L1 media (6% of nitrate and 8% of 
phosphate) was also extracted from media using this method, but this did not cause an 
increase in the growth of any of the phytoplankton species relative to a solvent control 
(data not shown; p = 0.31-1.00 for all species). The ability to largely separate inorganic 
nutrients from organic exudates reduces the problem of nutrient artifacts in experiments, 
and is an advantage over traditional methods of generating cell-free filtrates. The resin 
was left in live field samples and cultures for 12-15 h, then recovered by slow filtration 
through 100 µm Nitex mesh and rinsed with deionized water. Lipophilic compounds 
were eluted from the resin with methanol followed by acetone, and solvents removed by 
rotary evaporation. Extracts of L1 + silicate media were generated in the same way, 
except without the presence of live cells. Brevetoxin B (PbTx-2) was quantified from K. 
brevis extracts by liquid chromatography-mass spectrometry (LC-MS) as described in 
(Kubanek et al. 2007). No other brevetoxins were present at concentrations above the 
detection limit.  
 
Experiments 
Experiment 1 tested whether compounds exuded by a bloom of Karenia brevis 
inhibit the growth of competing phytoplankton. We combined the three field sample 




bloom water (i.e., from (3.2 + 1.8) x 10
2
 K. brevis cells mL
-1
; representing an average of 
8.5 pg of PbTx-2 exuded by each live K. brevis cell). We used a 48 h assay to test the 
effect of this combined K. brevis bloom extract on the growth of four competing 
phytoplankton species: Amphora sp., Asterionellopsis glacialis, Prorocentrum minimum, 
and Skeletonema costatum, and a 96 h assay to test its effect on the slower-growing 
dinoflagellate Akashiwo cf. sanguinea. For all species except A. cf. sanguinea, a 200 µL 
inoculum of the competitor species and 2.8 mL of L1 + silicate media were added to each 
of 14 small culture tubes. Tubes with A. cf. sanguinea contained a 1.0 mL inoculum and 
2.0 mL of L1 + silicate media. All tubes were placed haphazardly in an incubator at 22 
°C until competitor species reached exponential growth stage (approximately 3-5 d; cell 
densities of competitors in exponential growth ranged from 3.3 x 10
3





). At that time, tubes were paired based on similar in vivo fluorescence 
measurements and assigned arbitrarily to be either treatments or controls. In order to 
approximate natural concentrations of bloom and non-bloom waterborne compounds, we 
added an amount of extract equivalent to that generated from 3.0 mL of K. brevis bloom 
or non-bloom sample (dissolved in 3.3 µL dimethyl sulfoxide (DMSO); n = 7 replicate 
culture tubes for bloom treatment and non-bloom control). Using a Turner Designs TD-
700 fluorometer calibrated with chlorophyll a (for all species used in these experiments, 
relationships between visual cell counts and fluorescence were linear; r
2
 = 0.75-0.99), in 
vivo fluorescence (used as a proxy for relative cell concentrations) was assessed 
immediately before addition of extracts. Pairs were placed randomly in the incubator at 
22 ºC after extract addition, and 48 or 96 h later the percent change in in vivo 






. In order to normalize the percent 
change in in vivo fluorescence by species we also calculated the percent reduction in 






, where ∆ control and ∆ treatment are the percent changes 
in in vivo fluorescence for the control and treatment, respectively, over the course of the 
experiment. 
Because laboratory cultures provide a renewable source of allelopathic material to 
compare with bloom samples, we tested the effects of 16 independently generated 
extracts of Karenia brevis cultures in exponential growth stage on the growth of one 
susceptible competitor, Asterionellopsis glacialis, using the 48 h assay described above 
(with DMSO as control). The five K. brevis extracts that resulted in the strongest 
allelopathic effects against A. glacialis were pooled, and the effects of this pooled extract 
were tested on the growth of Amphora sp., Akashiwo cf. sanguinea, A. glacialis, 
Prorocentrum minimum, and Skeletonema costatum (competitor cell density at onset of 
experiment ranged from 3.6 x 10
3




), using five to ten replicates 
with the assay method described above. The combined extract came from cultures with 
an average concentration of 3.02 x 10
4
 K. brevis cells mL
-1
, and contained 55 ng PbTx-2 
mL
-1
 of culture (i.e., representing an average of 1.8 pg PbTx-2 exuded by each live K. 
brevis cell). 
Experiment 2 tested whether Karenia brevis exudates reduce competitor 
photosynthetic efficiency as a potential mechanism for allelopathy. For each of the same 
five competitor species used in Experiment 1, 5-6 pairs of 10 mL culture tubes containing 
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2.8 mL of L1 + silicate media were inoculated with 200 µL of phytoplankton culture. 
When the competitor species reached exponential growth stage, bloom or non-bloom 
extract (from Experiment 1, generated from 3.0 mL of field sample) was dissolved in 5.0 
µL DMSO and added to each tube. All tubes were incubated in the dark for 1 h. For each 
species, we determined photosynthetic efficiency of photosystem II, measured as Fv:Fm, 
where Fv=Fm-F0 (e.g., Parkhill et al. 2001; Miller-Morey and Van Dolah 2004). F0 (initial 
fluorescence) was determined using a Turner Designs TD-700 fluorometer. Fm (maximal 
fluorescence) was determined by adding 9.6 µL of 10 mol µL
-1
 aqueous 3'-(3,4-
dichlorophenyl)-1',1'-dimethylurea (DCMU), waiting 30 s, and measuring the 
fluorescence.  
 To determine the competitor growth stage at which photosynthetic efficiency is 
most inhibited, we repeated this experiment using extracts of Karenia brevis cultures, 
adding extracts during competitor lag, early exponential growth, and stationary growth 
stages. Sixty culture tubes for each species were prepared by inoculating 2.8 mL of L1 + 
silicate media with 200 µL of phytoplankton culture. For each species, 20 tubes were 
removed from the pool at each of three separate growth stages; the remaining tubes were 
allowed to grow until reaching later growth stages. K. brevis extract (combined 
allelopathic extract used in Experiment 1, generated from 3.0 mL of culture) dissolved in 
5.0 µL DMSO was added to each of ten tubes and 5.0 µL DMSO (control) was added to 
the other ten tubes. Preliminary experiments indicated no significant difference between 
solvent controls and media extract controls for any of the species considered (data not 
shown; p = 0.31-1.00; Wilcoxon sign-rank test). Five pairs of tubes were then incubated 
in the dark for 1 h, and Fv:Fm was determined as described above. The other five pairs 
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were allowed to grow for 23 h and then incubated in the dark for 1 h before Fv:Fm was 
determined. This process was repeated with competitor cultures in early exponential 
growth and stationary stages. 
Because enzyme activity has been reported to be a target of allelopathy (Windust 
et al. 1996; Sukenik et al. 2002) and active esterases are indicative of healthy, functional 
cells (Agusti et al. 1998; Agusti and Sanchez 2002), Experiment 3 assessed whether 
Karenia brevis exudates inhibit competitor esterase activity as a potential mechanism for 
allelopathy, using the fluorescent dye fluorescein diacetate (FDA) (Agusti and Sanchez 
2002). This dye passes freely through the membrane of phytoplankton cells; once inside, 
cells with active esterases hydrolyze the ester bonds of FDA. The hydrolyzed dye is 
fluorescent, and cannot exit the cell. Thus, cells with active esterases fluoresce, and cells 
without active esterases do not. For each competitor species, 10 mL tubes containing 2.0 
mL of phytoplankton culture were incubated at 22 °C with K. brevis extract (from 
Experiment 1, combined allelopathic extract generated from 2.0 mL of K. brevis culture) 
in 3.3 µL DMSO (or 3.3 µL DMSO for control tubes) (n = 7). Preliminary experiments 
indicated no differences in the esterase activity of cultures exposed to DMSO or extract 
of L1 + silicate media in DMSO (data not shown; p = 0.50-1.00; Wilcoxon sign-rank 
test). After 2 h, 500 µL of each culture was stained with 2.5 µL of 25 mol µL
-1
 FDA in 
DMSO (to assess the number of cells with active esterases) and 500 µL of each culture 
was stained with Lugol’s solution (to determine the total cell concentration). Samples 
stained with FDA were kept in the dark for 10-30 min before excitation at 451 nm. FDA-
stained cells emitting light at 510 nm were counted using fluorescence microscopy on an 
Olympus IX-50 inverted microscope with a Palmer-Maloney settling chamber. Samples 
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preserved with Lugol’s solution were counted with light microscopy using the same 
instrument. We assessed the proportion of cells with active esterases by dividing the 
number of cells stained with FDA by the number of cells stained with Lugol’s solution 
for each sample. 
Experiment 4 determined the effect of Karenia brevis allelopathic compounds on 
competitor cell membrane permeability using the fluorescent dye SYTOX green 
(Brussaard et al. 2001). This dye binds to cellular nucleic acids but cannot permeate 
healthy membranes; thus only cells with damaged membranes fluoresce. The combined 
allelopathic K. brevis culture extract from Experiment 1 was added to each competitor 
species as described for Experiment 3 (n = 7-8). Preliminary experiments indicated no 
differences in membrane permeability from cultures exposed to DMSO or extract of L1 + 
silicate media in DMSO (data not shown; p = 0.25-1.00; Wilcoxon sign-rank test). After 
2 h, 500 µL of each culture was stained with 5.0 µL of 0.50 mol µL
-1
 SYTOX green in 
DMSO (to assess the number of cells with permeable membranes) and 500 µL was 
stained with Lugol’s solution (to determine the total cell concentration). Samples stained 
with SYTOX green were kept in the dark for 10-30 min before excitation at 504 nm. 
SYTOX green-stained cells emitted light at 523 nm. Cells stained with SYTOX green 
and Lugol’s solution were counted and the proportion of cells with permeable membranes 
was assessed as in Experiment 3. In addition to the total proportion of cells with 
permeable membranes, we also assessed the fraction of stained cells that were motile 
(actively swimming) for the two dinoflagellates (Prorocentrum minimum and Akashiwo 
cf. sanguinea). Motility could not be assessed by microscopy for the three diatom 
species. 
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Experiment 5 tested whether Karenia brevis exudates strongly chelate iron, 
potentially limiting the access of other phytoplankton species to this essential nutrient. 
We analyzed K. brevis extracellular extracts for the presence of siderophores, compounds 
that bind to iron, using a universal chemical assay, in which siderophores compete with 
chrome azurol S (CAS) for Fe(III) (Schwyn and Neilands 1987). When bound to iron, 
CAS absorbs strongly at 630 nm. A decrease in absorption at this wavelength indicates 
iron is bound to a siderophore. Made according to Schwyn and Neilands (1987), 1.5 mL 
of the CAS shuttle solution was combined with extract of K. brevis generated from 3.0 
mL of culture dissolved in 1.5 mL of deionized (DI) water, extract of K. brevis generated 
from 30 mL of culture (i.e., 10X natural concentration) dissolved in 1.5 mL of DI water, 
or extract of L1 + silicate generated from either 3.0 mL or 30 mL of media (control) 
prepared the same way (n = 3 each). All samples were equilibrated for 4.5 h after which 
the absorbance of each sample was measured at 630 nm using a Spectronic 21D 
spectrophotometer. This experiment was performed both for the allelopathic combined 
extract of K. brevis culture (used in Experiment 1), and non-allelopathic extract of K. 





containing 17 ng PbTx-2 mL
-1
, representing an average of 1.1 pg PbTx-2 exuded by each 
K. brevis cell). The relative abundance of siderophores normalized to media controls was 








 where A(media) is the absorbance of media extracts 
combined with the CAS shuttle solution and A(K. brevis) is the absorbance of K. brevis 




Preliminary analysis using the Kolmogorov-Smirnov statistical test determined 
that the percent growth of all phytoplankton species used in our experiments was 
normally distributed (Zar 1999). Therefore, Experiment 1 was analyzed using parametric 
tests. However, we were unable to perform similar analyses for the data acquired in 
Experiments 2-5, because sample sizes were too small; therefore these experiments were 
analyzed using non-parametric tests. 
To analyze the Experiment 1 data testing allelopathic effects of Karenia brevis 
bloom and culture extracts, the percent change in fluorescence was compared for 
treatments vs. controls of each species using a paired two-tailed t-test (GraphPad Prism 
4.0). To analyze data testing allelopathic effects of several extracts of K. brevis cultures 
assayed concurrently, the percent growth of Asterionellopsis glaclialis after 48 h was 
compared to controls using a one-way ANOVA with Tukey post-hoc test (SYSTAT 9). 
Differences were accepted as significant when p < 0.05. 
For Experiment 2, treatments and controls were compared by two methods 
(GraphPad Prism 4.0). We used a one-tailed Wilcoxon sign-rank test to test whether the 
photosynthetic efficiency of treatments was lower than that of controls (p < 0.05 deemed 
significant). However, non-parametric tests are less powerful than their parametric 
counterparts, so no adjustment could be made for multiple comparisons without losing 
the ability to detect significant differences. In order to limit the possibility that we 
committed a type I error, we also analyzed data using a paired two-tailed t-test with a 
Bonferroni adjustment (thus, p < 0.017 was deemed significant).  
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Experiments 3 and 4 were analyzed using a two-tailed Wilcoxon sign-rank test 
(GraphPad Prism 4.0). We compared the effect of Karenia brevis extracts vs. controls for 
each species, for which differences were deemed significant when p < 0.05. Because 
several comparisons were made for each species, statistical tests comparing the 
proportion of stained cells that were motile between treatments and controls were 
analyzed using a Wilcoxon sign-rank test (GraphPad Prism 4.0) with a Bonferroni 
adjustment for multiple comparisons such that differences were accepted as significant 
when p < 0.017.  
Experiment 5 was analyzed by comparing results of siderophore activity tests for 
an allelopathic vs. non-allelopathic Karenia brevis extract with a Mann Whitney U-test. 




Approximately 80% of the cells in the three field samples collected from a single 
Florida bloom in 2006 were Karenia species. However, we estimate that low 
concentrations of at least 15 other species were also present. The most abundant included 
Oxyphysis oxytoxoides, and Skeletonema costatum, as well as species from the 
Chaetoceros, Baceriastrum, and Scrippsiella genera. Several unidentified dinoflagellates 
and pennate diatoms were also present. The composition of the non-bloom sample 
collected on the same day was quite different, containing only a few of the species also 
present in bloom samples. More than half of cells present in the non-bloom sample were 
pennate diatoms, including Nitzchia longissima. One dinoflagellate, Prorocentrum 
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mexicanum, made a significant contribution to the non-bloom community. Several other 
species, including the dinoflagellate Ceratium furca and a small number of unidentified 
centric diatoms, were also present. 
 
Allelopathic effects of extracellular extracts from Karenia brevis bloom samples and 
cultures 
Compounds exuded by a Karenia brevis bloom inhibited the growth of four of 
five competitor species when compared to effects of extracts of non-bloom seawater, but 
the degree of inhibition varied among species (Figure 3.1A). Three competitor species, 
Asterionellopsis glacialis, Prorocentrum minimum, and Skeletonema costatum, were 
strongly inhibited by the K. brevis bloom extract, such that their cell concentrations were 
lower after 48-96 h than at the start of the experiment when they were in exponential 
growth stage (p < 0.001 for all). The growth of one competitor, Amphora sp., was 
inhibited by 16 + 9% (p = 0.007), and another species, Akashiwo cf. sanguinea was not 
inhibited (p = 0.40).  
Seven of 16 Karenia brevis cultures were allelopathic to Asterionellopsis glacialis. Five 
of these were strongly allelopathic, suppressing A. glacialis growth by > 90% in 48 h (p < 
0.001), and two were moderately allelopathic (22-41% suppression; p < 0.05). Nine 
extracts did not suppress A. glacialis growth at all (p = 0.13-0.94; data not shown). The 
five most allelopathic extracts were combined, and found to adversely affect four of five 
competitor species tested (Figure 3.1B). This combined extract killed one species, 















Figure 4.1. Effects of extracellular extracts of (A) K. brevis bloom or (B) cultures on the 
growth of 5 competing phytoplankton species (Experiment 1). Changes in cell 
concentration were assessed by in vivo fluorescence after 48 h for all species except the 
slow-growing A. cf. sanguinea whose final concentration was measured after 96 h. Error 
bars in this and subsequent figures indicate one standard deviation. Significance is 
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glacialis, Prorocentrum minimum, and Skeletonema costatum (all p < 0.001). One 
species, Amphora sp., was stimulated by K. brevis extracts (p < 0.001).  
 
Reduction of competitor photosynthetic efficiency by Karenia brevis allelopathy 
 All five competitor species experienced decreased photosynthetic efficiency 
within 1 h of exposure to Karenia brevis bloom extract (Figure 3.2A). Skeletonema 
costatum was intensely affected, with a 68% reduction in photosystem II efficiency. The 
photosynthetic efficiencies of Akashiwo cf. sanguinea, Amphora sp., Asterionellopsis 
glacialis, and Prorocentrum minimum were inhibited by 19-43% (Wilcoxon sign-rank 
test: p < 0.031 for all; t-test: p < 0.016 for all). 
Consistent with effects of the bloom extract, extracellular extracts of cultured 
Karenia brevis inhibited the photosynthetic efficiencies of all five competitor species 
during at least one stage of their growth (Figure 3.2B). A. glacialis, P. minimum, and S. 
costatum photosystem II was inhibited during their lag, exponential growth, and 
stationary stages (p = 0.031 for each species, Wilcoxon sign-rank test; p < 0.01 for each 
species, t-test). The photosynthetic efficiency of S. costatum was consistently strongly 
suppressed by 65-77%, whereas A. glacialis and P. minimum were most inhibited during 
lag stage (49-67%), rather than in exponential growth (39-48%) or stationary stage 
(20%). A. cf. sanguinea’s photosynthetic efficiency was lowered by 33-53% by K. brevis 
extracts generated in lag and exponential growth stage (p = 0.031 in both cases, Wilcoxon 
sign-rank test; p < 0.01, t-test) but not in stationary stage (p = 0.41, Wilcoxon sign-rank 
test). Interestingly, Amphora sp., whose growth over 48 h was not suppressed by cultures 





















Figure 4.2. Effects of K. brevis allelopathy on competitor photosynthetic efficiency 
(Experiment 2). (A) During exponential growth stage, competitor species were treated 
with extracellular extracts of either K. brevis bloom or non-bloom sample. (B) 
Competitor species were treated with an allelopathic extracellular extract of cultured K. 
brevis or a solvent control at three different competitor growth stages (lag, exponential 
growth (log), or stationary (stat) phases). Insets show growth curve of competitors, where 
number of days is on the x axis, and fluorescence (µg Chl a L
-1
) is on the y axis.  Arrows 
indicate the place in the growth curve where competitors were harvested for this 
experiment. Significance is marked with an asterisk (*) (p < 0.017, t-test; p < 0.05, 
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exposed to K. brevis extracts for 1 h in lag phase (p = 0.031, Wilcoxon sign-rank test; p < 
0.001, t-test), but photosynthetic efficiency was unaffected if K. brevis extracts were 
added at later growth stages (exponential growth stage, p = 0.16; stationary stage, p = 
0.31; Wilcoxon sign-rank test) (Figure 3.2B). Additional measurements of photosynthetic 
efficiency generated 24 h after the addition of extract were similar for all species except 
A. cf. sanguinea and S. costatum, which showed even more dramatically reduced 
photosynthetic efficiency after 24 h (data not shown) than after 1 h (Figure 3.2B). 
 
Effects of Karenia brevis allelopathy on competitor esterase activity 
Karenia brevis extracellular extracts had no effect on the esterase activity of any 
competitor species tested (Figure 3.3). For each species, no significant difference was 
found in the proportion of competitor cells with active esterases for those exposed to 
cultured K. brevis extract vs. those exposed to a solvent control (p = 0.11-0.81, Wilcoxon 
sign-rank test). 
 
Effects of Karenia brevis allelopathy on competitor membrane permeability 
Exposing competitors to cultured K. brevis extracellular extracts increased the 
proportion of cells with permeable (damaged) membranes for three species: Akashiwo cf. 
sanguinea (p = 0.016; Wilcoxon sign-rank test), Asterionellopsis glacialis (p = 0.016), 
and Prorocentrum minimum (p = 0.008) (Figure 3.4A). The effects on membrane 
permeability of two species, Skeletonema costatum and Amphora sp., were insignificant 
(p = 0.47 and 0.38, respectively). For A. cf. sanguinea and P. miniumum, whose motility 


































Figure 4.3. Allelopathic effect of cultured K. brevis extracellular extract on the esterase 
activity of five competing phytoplankton species measured with fluorescein diacetate 
(FDA) (Experiment 3).  For all five species, contrasts between treatments and controls 
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Figure 4.4. Allelopathic effect of cultured K. brevis extracellular extract on the membrane permeability of five competing 
phytoplankton species using SYTOX green to assess damaged (permeable) cells (Experiment 4). (A) Cells with damaged membranes 
for all species tested (p < 0.05; n = 7-8). (B) Akashiwo cf. sanguinea and (C) Prorocentrum minimum. Motile (swimming) cells with 
damaged membranes (p < 0.017; n = 8). Significant difference between treatments and controls is marked with an asterisk (*). 
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increased the proportion of motile cells with damaged membranes (p = 0.016 and 0.008, 
respectively) (Figure 3.4B). The proportion of membrane-permeable non-motile A. cf. 
sanguinea cells was not significantly different between cells exposed to extracts vs. those 
exposed to a solvent control (p = 0.31), and was only marginally significant for P. 
minimum (p = 0.042). 
 
Siderophore activity of Karenia brevis extracts 
No significant differences were detected in iron-chelating activity between 
Karenia brevis allelopathic and non-allelopathic extracts (Figure 3.5), regardless of the 
concentration at which the extracts were tested (p = 0.40 for 1X natural concentration and 
p = 0.70 for 10X natural concentration of cultured K. brevis extract).  
 
Discussion 
Karenia brevis blooms are allelopathic 
 The growth of three Gulf of Mexico phytoplankton species was strongly inhibited 
by compounds exuded during blooms of the red tide dinoflagellate, Karenia brevis, and 
the growth of one species was very slightly inhibited, providing strong evidence that K. 
brevis is allelopathic in the field (Figure 3.1A). We found that cultures of K. brevis also 
inhibited the growth of competitor species (Figure 3.1B), consistent with previous studies 
using cultured strains of K. brevis (Freeburg et al. 1979; Kubanek et al. 2005). Thus, 
allelopathy may play a role in enabling K. brevis to out-compete other phytoplankton 































Figure 4.5. Test of siderophore activity for cultured K. brevis extracellular extracts 
(Experiment 5).  The presence of iron binding compounds in K. brevis extracellular 
extracts was tested at natural (1X) and ten times natural (10X) concentration using a 
chrome azurol S (CAS) shuttle solution (Schwyn and Neilands 1987). Data depict the 
proportion of siderophore-bound iron relative to the appropriate media control. Contrasts 
between allelopathic and non-allelopathic extract treatments yielded p > 0.40 at both 
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Three competitor species strongly inhibited K. brevis cultures were at least as 
inhibited by compounds exuded by Karenia brevis blooms (Figure 3.1), even though K. 
brevis cell concentrations in cultures were almost 100 times greater than in natural bloom 
samples. Waterborne concentrations of PbTx-2, the major brevetoxin present in bloom 
waters (Pierce et al. 2005), were nearly 20 times higher in K. brevis cultures than in field 
samples, supporting the previous finding that brevetoxins are unlikely to be responsible 
for most cases of K. brevis allelopathy (Kubanek et al. 2005).  
The composition of the plankton community is likely to play a role in the 
allelopathic potency of K.  brevis blooms. Approximately 20% of cells in bloom samples 
belonged to non-Karenia taxa, and the representation of these community members 
differed between bloom and non-bloom samples collected on the same day (see Results). 
Therefore, it is possible that species other than K. brevis contributed to bloom 
allelopathy, possibly accounting for the observation that growth of Amphora sp. was 
modestly suppressed by bloom but not cultured K. brevis exudates (Figure 3.1). However, 
since none of the non-Karenia species made up more than 5% of the bloom community, 
it is difficult to predict which other species may be involved in bloom allelopathy. 
Because allelopathic effects of cultured K. brevis and bloom samples were similar for 
three of five species tested (Asterionellopsis glacialis, Prorocentrum minimum, 
Skeletonema costatum; Figure 3.1), it appears likely that K. brevis is responsible for most 
of the allelopathic potency of bloom samples. 
It is not clear why one competitor, Akashiwo cf. sanguinea, was inhibited by 
Karenia brevis cultures but not by waterborne compounds from K. brevis blooms (Figure 
3.1). It is possible that A. cf. sanguinea is less sensitive to K. brevis allelopathy than other 
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species, and that the 2006 bloom we sampled K. brevis was not dense enough to inhibit 
this competitor’s growth. Kubanek et al. (2005) reported that A. cf. sanguinea was not 
inhibited by filtrates of cultured K. brevis. However, in that case, filtrates were tested at 
lower concentrations than extracellular extracts used in this study, supporting the 
hypothesis that A. cf. sanguinea may be suppressed only by compounds from high 
concentrations of K. brevis cells. It is also possible that A. cf. sanguinea was not 
susceptible to the K. brevis strains present in the 2006 bloom. Our laboratory cultures of 
K. brevis consisted of a single strain, whereas the field population was likely more 
diverse. No studies have addressed the genetic diversity of K. brevis blooms, but 
phytoplankton blooms are often genetically complex (e.g., John et al. 2004; Wilson et al. 
2005). A. cf. sanguinea may be unaffected by bloom extracts because the allelopathic 
potency of K. brevis varies among strains, possibly in a species-specific manner. K. 
brevis also may produce compounds allelopathic to A. cf. sanguinea only under certain 
conditions which may have been absent during field sampling (e.g., under a particular 
nutrient regime or in the presence of particular plankton community members). 
 
Production of allelopathic compounds and their effects on competitors are variable 
Both the susceptibility of competitor species to allelopathy and the production of 
allelopathic compounds by Karenia brevis were variable. Of the 16 extracts generated 
from exponential growth stage cultures of a single K. brevis strain, seven were 
allelopathic to the diatom Asterionellopsis glacialis (see Results). Allelopathic effects 
also varied for natural K. brevis bloom samples; allelopathic effects of ten bloom samples 
collected during two separate years ranged from complete suppression of competitor 
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growth to no suppression at all, although the pooled data indicate that K. brevis blooms 
are significantly allelopathic (Figure 3.1A; Prince et al., unpublished).  
Variability of allelopathic effect among cultures may be influenced by nutrient 
limitation, associated bacteria, and lack of selection pressure, as well as other factors such 
as growth stage and pH (Schmidt and Hansen 2001). Previous research on Karenia brevis 
indicated that allelopathic effects of cultures varied among strains and growth stages 
(Kubanek et al. 2005). Although attempts were made to consistently control growth 
conditions, it is likely that K. brevis cultures had small differences in pH, were extracted 
at slightly different growth stages and cell densities, were inoculated with cultures at 
different growth stages, or had accumulated mutations over time due to lack of selective 
pressure. Thus, we are currently unaware of which factors control the production of 
allelopathic compounds by K. brevis, although this issue begs further investigation. 
Even when allelopathic compounds were produced by Karenia brevis, they did 
not affect all species to the same extent (Figure 3.1). Akashiwo cf. sanguinea was more 
susceptible to K. brevis culture than bloom exudates, whereas Amphora sp. was slightly 
suppressed by bloom exudates but actually stimulated by K. brevis culture exudates, 
suggesting that these two competitor species are affected by different K. brevis 
compounds. Our finding of the species-specific nature of allelopathy is consistent with 
results from previous studies involving K. brevis (Freeburg et al. 1979; Kubanek et al. 
2005) and other bloom-forming dinoflagellates (Arzul et al. 1999; Sugg and Van Dolah 
1999). Kubanek et al. (2005) and Freeburg (1979) found that compounds produced by K. 
brevis inhibited the growth of the diatoms Asterionellopsis glacialis and Skeletonema 
costatum, species that we also report to be susceptible to K. brevis allelopathy. In general, 
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however, we saw stronger allelopathic effects than Kubanek et al. (2005), probably 
because of the enhanced efficiency and avoidance of inorganic nutrient artifacts of the 
extracellular extraction method used in the current study.  
The observed variability of Karenia brevis allelopathy may have implications for 
bloom dynamics. K. brevis blooms typically occur in four general stages: initiation, 
growth, maintenance, and termination (Steidinger et al. 1998). Because our K. brevis 
extracts came from exponential growth stage cultures with high cell concentrations 
reminiscent of a dense bloom, our data (Figure 3.1B) support the hypothesis that K. 
brevis uses allelopathy to maintain blooms, but we cannot assess whether allelopathy is 
important during bloom initiation. Extracts of a K. brevis bloom sampled during 
maintenance stage were strongly allelopathic (Figure 3.1A), further supporting the idea 
that allelopathy may allow K. brevis to maintain blooms. Future studies should consider 
the allelopathic activity of K. brevis blooms at different cell concentrations and bloom 
stages. 
 
Karenia brevis lowers photosynthetic efficiency of competitors 
Compounds exuded by Karenia brevis inhibited photosynthesis of competing 
phytoplankton, suggesting a potential mechanism for allelopathy (Figure 3.2). The 
maximum quantum yield of photosystem II (PSII) is frequently used as a proxy for 
photosynthetic efficiency and consequently as a general measure of cell stress (e.g., 
Parkhill et al. 2001; Miller-Morey and Van Dolah 2004); a decrease in PSII efficiency 
can result from a variety of factors including nutrient limitation (Parkhill et al. 2001), 
shading (Villareal and Morton 2002), metal toxicity (Miller-Morey and Van Dolah 2004), 
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and allelopathy (Figueredo et al. 2007). However, several studies have warned about the 
limitations of this method, claiming that nutrient limitation cannot be detected with 
balanced growth conditions (Parkhill et al. 2001), that a decrease in maximal quantum 
yield is specific to some stressors but others (e.g., heat shock) cannot be detected (Miller-
Morey and Van Dolah 2004), and that nutrient stress may be missed due to the time 
required for a fluorescence response to nutrient starvation (Singler and Villareal 2005). 
These studies indicate that results of experiments measuring photosynthetic efficiency 
should be interpreted with care, and a lack of inhibition of PSII may not indicate that 
cells are not stressed. However, in our experiments, compounds exuded by K. brevis 
inhibited the PSII of competitors within 1 h, strongly indicating competitor stress (Figure 
3.2). 
 Inhibition of competitor photosynthesis by Karenia brevis extracellular extracts 
appeared to parallel the negative effects on competitor growth (Figures 3.1-3.2). Species 
whose growth was strongly suppressed by bloom extracts (Asterionellopsis glacialis, 
Prorocentrum minimum, and Skeletonema costatum) also experienced substantial 
reduction in photosynthetic efficiency (Figures 3.1A and 3.2A). Parallels between 
reduced photosynthesis and growth inhibition were not as strong when competitor species 
were exposed to K. brevis culture extracts. However, the species least sensitive to general 
allelopathic effects, Amphora sp., appeared most resistant to PSII inhibition (Figures 
3.1B and 3.2B). The efficiency of PSII measured after 1 h exposure to allelopathic 
extracts may be a more sensitive indicator of competitor stress than effects on growth 
measured over 2-4 d, since K. brevis bloom extracts slightly inhibited PSII of Akashiwo 
cf. sanguinea but did not significantly suppress A. cf. sanguinea growth (Figures 3.1A 
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and 3.2A). Because of the sensitivity and speed of this assay, decreases in PSII efficiency 
may also provide information about when competitors are most susceptible to 
allelopathy. We found that K. brevis compounds most strongly suppressed competitor 
photosynthetic efficiency when competitor cell concentrations were low (i.e., lag stage 
prior to exponential growth) (Figure 3.2B), although we did not determine if this effect is 
due to low cell concentrations or increased physiological susceptibility during lag stage. 
Thus, one way K. brevis may be able to maintain nearly monospecific blooms is by 
preventing competitors from reaching high cell densities. 
Inhibition of PSII is commonly proposed as a mechanism for allelopathy; 
however, it is difficult to determine whether reduced efficiency of PSII is a direct target 
or a symptom of allelopathy-induced stress. Both bloom and culture filtrates of the 
cyanobacterium Cylindrospermopsis raciborskii inhibited the photosynthetic efficiency 
of competing cyanobacteria (Figueredo et al. 2007). Other studies have further elucidated 
the mechanism by which photosynthetic efficiency is inhibited. Von Elert and Juttner 
(1997) showed that while photosystem I of a cyanobacterial competitor was unaffected 
by compounds produced by the cyanobacterium Trichormus doliolum, overall oxygen 
evolution was reduced due to inhibited electron flow in PSII. In addition, Srivastava et al. 
(1998) found when the cyanobacterium Anabaena P9  was exposed to fishcherellin A, 
electron transport in PSII decreased, followed by inactivation of reactive centers, then 
grouped units within PSII were separated. However, neither our nor any of these studies 
have yet shown that PSII is the primary target of allelopathy rather than a secondary 
effect of another target.  
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Karenia brevis reduces competitor membrane integrity but not cellular esterase 
activity 
 Using the fluorescent stain SYTOX green, we found that allelopathic compounds 
exuded by Karenia brevis increased the membrane permeability of three competitor 
species (Figure 3.4). SYTOX green is usually used to distinguish between live and dead 
cells (Brussaard et al. 2001), but we found that many dinoflagellate cells with membranes 
permeable to this dye were swimming and therefore certainly not dead after 2 h exposure 
to K. brevis extracts (Figure 3.4B). In fact, K. brevis exudates primarily increased the 
proportion of motile cells with damaged membranes indicating that allelopathic 
compounds increased membrane permeability before competitor cells died or ceased 
swimming. This suggests that membrane damage is not a side effect of cell death, but 
rather a likely target for allelopathic compounds. We therefore propose that K. brevis 
may out-compete other phytoplankton by producing allelopathic compounds that damage 
the cell membranes of competitors.  
 We did not detect significant differences in esterase activity for competitor 
species exposed to allelopathic compounds vs. controls, using the fluorescent stain 
fluorescein diacetate (FDA) (Figure 3.3), suggesting that compounds produced by 
Karenia brevis do not initially target esterases as a mechanism for allelopathy. In other 
systems, esterase activity is used as a proxy for “metabolic vigor” (Dorsey et al. 1989), 
and has been shown to decrease due to viral infection (Lawrence et al. 2006), nutrient 
limitation (Brookes et al. 2000), and metal toxicity (Franklin et al. 2001). Although no 
previous studies have investigated whether esterase activity is a target for allelopathic 
compounds, other enzymes can be affected including phosphatases (Windust et al. 1996) 
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and carbonic anhydrase (Sukenik et al. 2002). Thus, establishing that K. brevis did not 
target the esterases of competitors ruled out a potentially important allelopathic pathway. 
 
Karenia brevis allelopathy is not mediated by removal of waterborne iron 
 Iron availability is an important factor governing phytoplankton abundance, 
especially in high nutrient, low chlorophyll areas in the ocean (Hutchins et al. 1999) and 
may play a role in triggering harmful algal blooms (Wells et al. 1991). Several species of 
the bloom-forming diatom genus, Pseudo-nitzchia, have been shown to increase toxin 
production in response to iron limitation (Wells et al. 2005), indicating that harmful algal 
bloom species may exude compounds in order to compete for iron. More than 99% of 
iron in oceanic waters is chelated by organic ligands (Rue and Bruland 1995), some of 
which are siderophores, iron binding compounds produced by marine bacteria and 
cyanobacteria and utilized by eukaryotic phytoplankton in response to iron limitation ( 
Wilhelm and Trick 1994; Hutchins et al. 1999). We hypothesized that Karenia brevis 
cultures may be allelopathic because K. brevis or its symbiotic bacteria produce iron-
binding compounds that competitors were unable to access. However, we found no 
differences in iron-chelating activity between allelopathic and non-allelopathic K. brevis 
extracellular extracts (Figure 3.5), demonstrating that removal of iron from cultures could 
not be the mechanism K. brevis uses to suppress competitor growth. 
Overall, we found that Karenia brevis blooms were allelopathic to four of five 
competing phytoplankton tested, and that K. brevis cultures exuded compounds with 
similar inhibitory effects. Competitor species whose growth was most inhibited by K. 
brevis bloom exudates also suffered substantial decreases in photosynthetic efficiency. In 
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addition, compounds exuded by K. brevis damaged cellular membranes of three 
competitor species, indicating a potential mechanism for K. brevis allelopathy. Our 
results suggest that K. brevis exudes allelopathic compounds that may facilitate its 














Biotic interactions in the plankton can be both complex and dynamic. 
Competition among phytoplankton is often chemically-mediated, but no studies have 
considered whether allelopathic compounds are modified by biotic interactions. Here, we 
show that compounds exuded during Karenia brevis blooms were allelopathic to the 
cosmopolitan diatom Skeletonema costatum, but that bloom allelopathy varied 
dramatically among collections and years. We investigated several possible causes of this 
variability and found that neither bloom density nor concentrations of waterborne 
brevetoxins correlated with allelopathic potency. However, when we directly tested 
whether the presence of competing phytoplankton influenced bloom allelopathy, we 
found that S. costatum reduced the growth-inhibiting effects of bloom exudates, 
suggesting that S. costatum has a mechanism for undermining K. brevis allelopathy. 
Additional lab experiments indicated that competitor-mediated changes to K. brevis 
allelopathy were restricted to two diatoms among ten phytoplankton species tested.  Our 
results suggest that S. costatum possesses an effective and previously undescribed method 
for resisting K. brevis allelopathy, potentially influencing community structure and 





Competition, one of the dominant processes structuring ecological communities, 
can occur through differential exploitation of limiting resources, but also through direct 
inhibition of competing organisms (Morin 1999; Krebs 2000). The direct inhibition of 
competitors via chemical compounds, allelopathy (Rice 1974; Lambers et al. 1998), can 
influence community-wide processes. For example, in microbial communities, 
allelopathic interactions can promote biodiversity if weak exploitation competitors persist 
in a community by directly inhibiting strong exploitation competitors (Czaran et al. 
2002). Allelopathy has also been implicated in patterns of succession in both terrestrial 
(Gant & Clebsch 1975) and planktonic communities (Keating 1977; Vardi et al. 2002). 
Recent studies have indicated that allelopathy may also facilitate the spread of invasive 
species (Bais et al. 2003; Figueredo et al. 2007), if naïve native competitors have not 
evolved resistance to allelopathic compounds of exotic competitors (Vivanco et al. 2004).  
Recent studies have shown that phytoplankton allelopathy can alter aquatic 
community structure, including patterns of species dominance. For example, while 
allelopathic compounds produced by the haptophyte Prymnesium parvum suppressed the 
overall phytoplankton assemblage, dinoflagellates and cyanobacteria increased in relative 
abundance (Fistarol et al. 2003). Similarly, after exposure to allelopathic compounds 
exuded by the dinoflagellate Alexandrium tamarense, the dominant species within a 
natural phytoplankton community changed from the dinoflagellate Scrippsiella 
trochoidea to the diatom Leptocylindrus sp. (Fistarol et al. 2004b). However, how some 
phytoplankton resist allelopathic compounds is largely unknown. 
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Although rarely studied, competitors may fight back against allelopathy. For 
example, upon exposure to the allelopathic plant Centaurea maculosa, two resistant 
plants produce oxalate, which prevents oxidative damage from the allelopathic compound 
(+)-catechin by scavenging the reactive oxygen species it produces (Weir et al. 2006). 
Resistant phytoplankton may also respond to allelopathic compounds from competitors; 
however, reports of such reciprocal interactions are rare, possibly because these 
interactions are difficult to detect in laboratory experiments. If we are to understand the 
dynamic process and consequences of chemical signaling in competition, we need to 
design experiments that allow detection of reciprocal interspecific interactions. 
 In the Gulf of Mexico, the red tide dinoflagellate Karenia brevis can form nearly 
monospecific blooms of thousands to millions of cells per liter (Tester & Steidinger 
1997). K. brevis produces brevetoxins, polyketide-based natural products that cause 
neurotoxic shellfish poisoning in humans and massive fish kills (Landsberg 2002). 
Previous studies with K. brevis have shown that although both blooms and cultures exude 
compounds that inhibit the growth of competing phytoplankton, brevetoxins are rarely 
responsible for these effects (Prince et al. unpublished; Kubanek et al. 2005; Prince et al. 
2008). Only the diatom Skeletonema costatum was modestly but significantly suppressed 
by a mixture of three common brevetoxins at natural concentrations (Kubanek et al. 
2005). However, no previous studies have considered how the presence of competitors 
changes the allelopathic effects of K. brevis on those competitors, or indeed whether 




Materials and Methods 
Phytoplankton culturing 
Experiments were performed using ten species of phytoplankton whose growth 
was previously shown to be affected by Karenia brevis live cells or filtrates (Kubanek et 
al. 2005). The following non-axenic (i.e., bacteria-containing) clones were obtained from 
the Provasoli-Guillard National Center for Culture of Marine Phytoplankton (CCMP): the 
dinoflagellates Akashiwo cf. sanguinea (CCMP 1740), Peridinium sp. (CCMP 626), 
Prorocentrum mexicanum (CCMP 687) and Prorocentrum minimum (CCMP 695); the 
diatoms Amphora sp. (CCMP 129), Asterionellopsis glacialis (CCMP 137), Rhizosolenia 
cf. setigera (CCMP 1694), Skeletonema costatum (CCMP 775), and Thalassiosira sp 
(CCMP 1055); and the cryptophyte Rhodomonas lens (CCMP 739). All species are 
known to co-occur with K. brevis in the Gulf of Mexico, were isolated from the Gulf of 
Mexico or the Caribbean (except Rhizosolenia cf. setigera available as an isolate from the 
Arabian Sea), and tolerate similar light, nutrient, and temperature conditions. Cultures 
were maintained as described in Kubanek et al. (2005). Experiments were also conducted 
in L1 + silicate media (CCMP) made with filtered Maine seawater (36 ppt). 
 
Collection of field samples 
Field samples of Karenia brevis blooms (“bloom samples”) and nearby field 
samples containing no K. brevis (“non-bloom samples”) were collected during 2005 and 
2006. In October 2005, three bloom samples (3 l each) were collected during a red tide 
from St. Joseph’s Peninsula near the town of Port St. Joe in Florida, USA. Three non-
bloom samples (3 l each) were collected on the same day from Apalachicola Bay near the 
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town of Apalachicola, FL. In September 2006, eight bloom samples (2 l each) were 
collected during a red tide at Long Boat Key beach, near the city of Bradenton, FL. Seven 
non-bloom samples (2 l each) were collected on the same day from the nearby beach at 
Green Key, near New Port Richey, FL. Collections at each site were approximately 10 m 
apart. Karenia brevis concentrations, assessed as described in Prince et al. (2008), ranged 




 in bloom samples. K. brevis was not detected in non-bloom 




, the limit of detection for 
this study.  We also identified common species from aliquots using samples stained with 
Lugol’s solution. We allowed 5 ml of each of three bloom and three non-bloom samples 
from each year to settle in a Palmer-Maloney settling chamber and identified all 
morphologically distinct species to the lowest taxonomic level possible by comparison 
with descriptions, pictures, and drawings available in several taxonomic guides (Tomas et 
al. 1997; Horner 2002). Exuded organic compounds were extracted from each sample 
using the method described in Prince et al. (2008). Type II brevetoxins (e.g., PbTx-2,-3, 
and -9) in K. brevis cultures were quantified by competitive ELISA (Naar et al. 2002) 
using the method described in Kubanek et al. (2005), and brevetoxin B (PbTx-2) was 
quantified from all field samples using liquid chromatography/mass spectrometry (LC-
MS) (Kubanek et al. 2007). 
 
Variability of Bloom Allelopathy (Experiment 1)  
We assessed the variability of allelopathic effects of Karenia brevis blooms on the 
growth of Skeletonema costatum, by exposing cultured S. costatum to extracellular 
extracts of bloom and non-bloom field samples. The experimental design and extract 
81 
addition was conducted as described in Prince et al. (2008) except that extracts were 
added on the day the cultures were inoculated and again after 7 d to counteract the 
probable decomposition of allelopathic compounds. In 2005, culture tubes of S. costatum 
initially contained 6.0 ml of media and were inoculated with 250 µl of S. costatum culture 
and in 2006 culture tubes initially contained 5.0 ml of media. Final concentration of S. 
costatum in each tube was (1.8 + 0.3) x 10
4
 (n = 10 in 2005; n = 3 in 2006). One 
additional 2006 bloom sample was tested using six replicates. Relative cell growth of 
each culture was assessed as described in Kubanek et al. (2005). 
 
Effect of Skeletonema costatum on Bloom Allelopathy (Experiment 2) 
We tested how the competitor Skeletonema costatum affected Karenia brevis 
bloom allelopathy by exposing field bloom samples to S. costatum before extractions. 
After collection, half of each bloom sample was exposed to live cultured Skeletonema 
costatum cells (filtered onto GF/F filter paper and re-suspended in filtered seawater to 
avoid adding nutrients to field samples), and the other half was exposed only to filtered 
seawater (collected from Boothbay Harbor, Maine). In 2005, 100 ml of S. costatum was 
added to each of three bloom samples and three non-bloom samples. In 2006, 50 ml of S. 
costatum was added to each of seven bloom samples and seven non-bloom samples 
(controls received the same volume of filtered seawater). The final density of S. costatum 









 in 2006. Samples to which S. costatum was added were referred to as either “bloom 
+ S. costatum samples” or “non-bloom + S. costatum samples”. Because one 2006 bloom 
sample (number 11) was not exposed to S. costatum, the total number of “bloom + S. 
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costatum” samples was 10, even though the total number of “bloom” samples was 11. 
After 36 h of exposure to S. costatum, samples were extracted using the methods 
previously described.  
The growth of Skeletonema costatum exposed to bloom extracts, bloom + S. 
costatum extracts, non-bloom + S. costatum, and non-bloom extracts was measured using 
methods described in Experiment 1. Each treatment was normalized to non-bloom 







− x 100%, where [S. c.] ctrl is the average maximum 
fluorescence of S. costatum exposed to non-bloom controls and [S. c.] trt is the maximum 
fluorescence of S. costatum exposed to each of the other treatments. Cultures of S. 
costatum exposed to non-bloom + S. costatum extracts were never significantly different 
from the maximum density growth of S. costatum exposed to non-bloom extract controls 
(data not shown; non-linear regression, p = 0.88 in 2005, and p = 0.47 in 2006). 
 
Effect of Competitors on Allelopathy of Karenia brevis Cultures (Experiment 3) 
Experiment 3 was conducted with cultured phytoplankton to determine whether 
the ability to alter Karenia brevis allelopathy was common among phytoplankton, or 
specific to Skeletonema costatum. The experimental design is presented in supplementary 
material. Initially, two 1 l cultures were inoculated with K. brevis, and two 1 l seawater 
control flasks were set-up on the same day for each of ten phytoplankton competitor 
species. Once the K. brevis cultures reached exponential growth stage (usually after 5-10 
d), 150 ml of either a target competitor culture or seawater was added to each culture. All 
flasks remained in the incubator for 36 hours, and then were extracted using the method 
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 for the slow 




 for Thalassiosira sp.  
To test the allelopathic activity of each extract, ten species of competing 
phytoplankton (Akashiwo cf. sanguinea, Amphora sp., Asterionellopsis glacialis, 
Peridinium sp., Prorocentrum mexicanum, Prorocentrum minimum, Rhizosolenia cf. 
setigera, Rhodomonas lens, Skeletonema costatum, and Thalassiosira sp.) were each 
grown in 60 ml culture tubes. For each species except A. cf. sanguinea and P. 
mexicanum, tubes containing 29.0 ml of L1 + silicate media were inoculated with 1.0 ml 
of phytoplankton. A 2.5 ml inoculum plus 27.5 ml of media was used for slow growing 
A. cf. sanguinea and P. mexicanum. Each tube received extracts generated from 30.0 ml 
of one of the four treatments (each dissolved in 50 µl of DMSO) (n = 8). Extracts were 
added initially on the day the experiment began and again after 7 d. Relative cell 
concentration of each tube was measured as described above. Experiment 3 was repeated 
five additional times for S. costatum at a smaller scale (using the same experimental 
design used in experiment 1, 2005; n = 5), with independent extracts generated for each 
experiment. 
We normalized allelopathic effects using an equation similar to the equation used 






− x 100%, 
where [C.P.] ctrl is the average maximum fluorescence of the competing phytoplankter 
exposed to the seawater extract control and [C.P.] trt is the maximum fluorescence of the 
competing phytoplankter exposed to either K. brevis extracts, K. brevis + competitor 
extracts, or competitor extracts. 
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Statistical analysis 
Before testing for differences in allelopathic effects among treatments and among 
collections, data was tested for normality using both a Kolmogorov-Smirnov and a 
D’Agostino-Pearson test (Dagostino et al. 1990). Although the Kolmogorov-Smirnov test 
suggested that data from all experiments was distributed normally, the D’Agostino-
Pearson test indicated results of experiment 2 had a non-normal distribution. Experiments 
1 and 2 were analyzed using nested ANOVA (SYSTAT 9), with the random effects of 
collection nested within the fixed effects of treatment (Zar 1999). We analyzed the results 
of 2005 and 2006 experiments separately, as well as together. Pair-wise comparisons 
between treatments were made using a Tukey post-hoc test. However, because we cannot 
be sure that data from experiment 2 was normally distributed, the results (i.e., the average 
effect of each collection) were analyzed using the non-parametric Mann-Whitney test 
(GraphPad Prism 4.0). Differences were accepted as significant when p < 0.05. 
For Experiment 3, growth curves were compared among treatments using 
nonlinear regression with an F test (GraphPad Prism 4.0). A Gompertz (bacterial growth) 
equation successfully fit the data in most cases. All treatments were compared to the 
“seawater” control, and “K. brevis” treatments were compared to “K. brevis + target 
competitor” treatments with respect to maximum cell concentration. Differences were 
accepted as significant when p < 0.05. In the cases where nonlinear regression failed to fit 
the data, the maximum density data were compared for treatment vs. seawater control via 
2-tailed t-tests. When this led to two contrasts using a single control dataset, we used a 
Bonferroni adjustment to determine that differences were accepted as significant when p 
< 0.025. 
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We used regression analysis to test for a correlation between concentrations of 
brevetoxins and allelopathic potency of Karenia brevis blooms and cultures as well as for 
a correlation between K. brevis cell concentration in blooms and cultures and allelopathic 
potency of blooms and cultures (GraphPad Prism 4.0). We accepted a trend as 
significantly non-zero when p < 0.05. 
 
Results 
Phytoplankton community composition of bloom and non-bloom samples 
In both 2005 and 2006, the vast majority of phytoplankton cells present in bloom 
samples were Karenia brevis, and no species other than K. brevis made up more than 5% 
of phytoplankton cells in the community. In 2005, the remainder of the bloom 
community was largely composed of unidentified species of pennate diatoms. Other 
dinoflagellate species, including Ceratium furca and Prorocentrum mexicanum, were 
also present in low numbers. In contrast, the 2005 non-bloom community did not have a 
single dominant species, and included at least 20 morphologically distinct species, 
including nearly all of the species present in the bloom community except K. brevis. The 
centric diatom, Skeletonema costatum, was not observed in 2005 bloom nor 2005-2006 
non-bloom samples. The 2006 bloom samples contained dinoflagellates Oxyphysis 
oxytoxoides and Scrippsiella sp., and diatoms of the Chaetoceros and Baceriastrum 
genera. S. costatum was present at 67 + 25 cells ml
-1
 in 2006 bloom samples (n = 8). The 
composition of the 2006 non-bloom community was quite different from the 2006 bloom 
community; nearly half of cells present belonged to one of a few species of pennate 
diatoms, including Nitzchia longissima. One dinoflagellate, Prorocentrum mexicanum, 
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also made a significant contribution to the 2006 non-bloom community, as did several 
other species at lesser abundance, including the dinoflagellate Ceratium furca and a small 
number of unidentified centric diatoms. 
 
Variability of Bloom Allelopathy (Experiment 1): 
 Skeletonema costatum exposed to extracellular extracts of Karenia brevis blooms 
reached a significantly lower final cell density than when exposed to non-bloom extract 
controls (p < 0.001; Fig. 1). However, the allelopathic effects of K. brevis blooms were 
highly variable. Although on average, S. costatum exposed to bloom extracts grew to 
73% of the density of controls, final densities ranged from <1% to 122% of controls. 
Allelopathy varied not only among bloom collections (p < 0.001), but also across years: 
in 2005, the overall allelopathic effect was quite strong, with bloom extracts suppressing 
S. costatum by an average of 66% relative to non-bloom controls (p < 0.001; n = 3), 
whereas in 2006 allelopathic effects of the K. brevis bloom samples were only marginally 
significant, with bloom extracts suppressing S. costatum by 13% relative to non-bloom 
controls (p = 0.063; n = 8). 
 
Effects of Skeletonema costatum on Bloom Allelopathy (Experiment 2): 
 Allelopathic effects of Karenia brevis blooms decreased when exposed to live 
Skeletonema costatum (Fig. 2). Extracts of five allelopathic bloom samples from 2005-
2006 (samples 2-3 and 8-10; Fig. 1) all inhibited the growth of S. costatum cultures by 
more than 30%, with an average suppression of 62%. When each of these five bloom 
























Figure 5.1. Effects of extracellular extracts of Karenia brevis blooms and non-bloom 
controls on the growth of Skeletonema costatum (Experiment 1). Each bar represents the 
average maximum growth of S. costatum treated with extract of an independent field 
sample and measured after 14-18 d. Black lines indicate the grand mean of each 
treatment. Error bars indicate standard error. The grand mean is significantly different 
between treatments (p < 0.001; n = 10-11), and the effect of sample within treatments is 
significant (p < 0.001; n = 3-10). 
 
 











































resulting extracts suppressed the growth of S. costatum by only 6%, significantly less 
than extracts of bloom samples that were incubated without S. costatum for this same 
period of time (p < 0.001, nested ANOVA; p = 0.032, Mann-Whitney test; Fig. 2). In 
2005, reduction of K. brevis allelopathic potency by S. costatum was dramatic, with the 
allelopathic potency of bloom samples reduced by >99% (samples 2-3, Fig 2; p < 0.001, 
nested ANOVA). When the 2006 bloom data were considered alone (i.e., samples 8-10; 
Fig. 1), the trend was towards a reduction in allelopathy, with the allelopathic potency of 
bloom samples reduced by 53%, however, the effect was not significant (p = 0.29). 
 
Effects of Competitors on Allelopathy of Karenia brevis Cultures (Experiment 3): 
 Of the ten competitor species tested, only Asterionellopsis glacialis and 
Skeletonema costatum significantly altered the allelopathic potency of cultured Karenia 
brevis (Fig. 3). Three species, Akashiwo cf. sanguinea, Amphora sp., and Prorocentrum 
minimum were significantly inhibited by extracts of K. brevis cultures and K. brevis + 
competitor cultures, indicating  susceptibility to K. brevis allelopathy (p < 0.01 for all, 
using contrasts of maximum cell concentration). Five species, Peridinium sp., 
Prorocentrum mexicanum, Rhizosolenia cf. setigera, Rhodomonas lens, and 
Thalassiosira sp., were not inhibited by K. brevis extracts or K. brevis + competitor 
extracts, suggesting insensitivity to K. brevis allelopathy (p = 0.097-0.87). A. glacialis, in 
contrast, was significantly inhibited by K. brevis extracts (p < 0.001), but not by K. brevis 
+ A. glacialis extracts (p = 0.70), indicating loss of K. brevis allelopathy caused by 































Figure 5.2. Effects of live Skeletonema costatum cells on the allelopathic effects of 
Karenia brevis bloom extracts (Experiment 2). Paired samples are connected by a line. 
Error bars indicate standard error. The mean is significantly different between treatments 


























































(p = 0.083-0.83), although R. cf. setigera and P. mexicanum were stimulated by their own 
exudates (data not shown). 
 The effects of Skeletonema costatum on cultured Karenia brevis allelopathy were 
extremely variable. In two separate experiments, S. costatum strongly undermined the 
allelopathic potency of K. brevis cultures (p < 0.001 for both; Fig. 3B-2, 3B-4). However, 
in two other experiments S. costatum strongly induced allelopathic potency in K. brevis 
cultures (p < 0.001 for both; Fig. 3B-1, 3B-3), and in one case weakly induced K. brevis 
allelopathy (p = 0.038; Fig. 3B-5). In one case, K. brevis cultures were not allelopathic to 
S. costatum whether or not K. brevis was exposed to S. costatum (p = 0.30; Fig. 3B-6). 
 
Correlation of Allelopathy with Karenia brevis Cell Density and with Brevetoxin 
Concentration: 
 We detected no quantitative relationship between the magnitude of inhibition of 
Skeletonema costatum by Karenia brevis and the concentration of K. brevis cells present 
in cultures (r
2
 = 0.26; p = 0.13) or 2005-2006 blooms (r
2
 = 0.053; p = 0.50) over the 









 present in blooms). When non-
bloom samples were included in analysis of field data (consisting of 0 cells ml
-1
 K. 
brevis), we detected a weak but significant positive correlation between bloom density 
and allelopathy (r
2
 = 0.19; p = 0.046). We detected no relationship between the inhibition 
of S. costatum by K. brevis blooms and concentration of waterborne brevetoxin B (PbTx-
2) in the 2005-2006 samples (r
2
 = 0.19; p = 0.18) or PbTx-3 in the 2006 samples (r
2
 = 














Figure 5.3. (A) The effects of extracellular extracts of Karenia brevis cultures exposed to 
seawater or competitor culture, on the growth of nine competitor species. Each bar 
represents the maximum cell density of a phytoplankton species normalized to growth of 
the same species exposed to a seawater control. (B) Six independent tests of the growth 
of Skeletonema costatum exposed to the same treatments as A. Asterisks (*) indicate a 
significant allelopathic effect relative to seawater control and plus signs (+) indicate a 
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and the concentration of all waterborne type-II brevetoxins (which include PbTx-2, -3, -
9) were marginally inversely related over the range of brevetoxins present in K. brevis 




 = 0.32; p = 0.054) 
 
Discussion 
Skeletonema costatum undermines allelopathy of Karenia brevis blooms 
In this study, we provide the first example of allelopathy undermined by a 
phytoplankton competitor. Karenia brevis allelopathic effects decreased significantly 
when bloom samples were exposed to live Skeletonema costatum cells (Fig. 2), indicating 
that S. costatum possesses a mechanism to undermine the allelopathic potency of K. 
brevis blooms.  S. costatum also undermined allelopathy in two independent experiments 
with cultured K. brevis (Fig. 3B), but there was substantial variability in this process for 
both natural bloom and cultured K. brevis (Figs. 3-4). 
Although rare, other studies have proposed mechanisms by which phytoplankton 
resist or lessen the effects of allelopathy. Reports of co-occurring phytoplankton 
reciprocally inhibited by each other’s exudates suggest that some phytoplankton may 
counter allelopathic effects by producing their own allelopathic compounds (e.g., Vardi et 
al. 2002; Yamasaki et al. 2007a). If Skeletonema costatum was allelopathic to Karenia 
brevis we would have expected that live S. costatum added to blooms would affect the 
number, morphology, or behavior of K. brevis cells. However, we observed no such 
effects in bloom samples over 36 h. Using a different mechanism to resist allelopathy, the 
dinoflagellate Scrippsiella trochoidea formed temporary cysts in response to exudates 
from potentially allelopathic phytoplankton (including dinoflagellates Alexandrium spp. 
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and Karenia mikimotoi) which may have enabled S. trochoidea to escape mortality from 
allelopathic compounds (Fistarol et al. 2004a; Tillmann et al. 2007). However, the direct 
interference of K. brevis allelopathy by S. costatum (Fig. 2) appears to be markedly 
different from these previously observed instances of allelopathy resistance.  
 Skeletonema costatum is known to exhibit higher growth rates and lower nutrient 
requirements than Karenia brevis (Furnas 1990; Steidinger et al. 1998), suggesting that it 
may out-compete K. brevis for resources, and indirectly undermine allelopathy by 
depriving K. brevis of the resources needed for the production of allelopathic compounds. 
Alternatively, S. costatum may stop biosynthesis or exudation of K. brevis allelopathic 
compounds, a mechanism used by pathogenic bacteria to avoid defenses of terrestrial 
plants (Abramovitch & Martin 2004; Bais et al. 2005). Third, S. costatum may 
metabolize or degrade allelopathic compounds released by K. brevis, a strategy used by 
the fungal pathogen Septoria lycopersici in response to the defensive compounds of the 
tomato plant (Bouarab et al. 2002). Finally, S. costatum may produce compounds 
counteracting the physiological damage of allelopathy, observed for two plants 
responding to the allelopathic plant Centaurea maculosa (Weir et al. 2006).  
 
The ability of competitors to influence Karenia brevis allelopathy is rare 
 When we tested ten species of phytoplankton common to the Gulf of Mexico for 
their ability to influence the allelopathy of cultured Karenia brevis, we found that 
competitor-mediated changes in allelopathic potency were rare. Two dinoflagellates and 
a diatom had no effect on K. brevis allelopathic potency, and two dinoflagellates, two 
diatoms, and a cryptophyte were not susceptible to K. brevis allelopathy at all (Fig. 3). 
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Only two diatoms, Asterionellopsis glacialis and Skeletonema costatum, affected the 
allelopathic potency of K. brevis cultures (Fig. 3), suggesting that like S. costatum, A. 
glacialis possesses a mechanism for undermining K. brevis allelopathy. Although the 
concentration and biovolume of competitor cells added to K. brevis cultures varied by 
several orders of magnitude among the ten competitor species tested, concentrations and 
biovolumes of A. glacialis and S. costatum represented neither the highest nor the lowest 
values, indicating the ability to undermine K. brevis allelopathy was not dependent on 
cell abundance alone.  
Exposure to S. costatum affected the allelopathic potency of K. brevis cultures in 
a manner that was dramatic, but highly variable. The factors that influence allelopathy 
may differ between cultured vs. field phytoplankton, since we occasionally observed 
induction of allelopathic potency of cultured K. brevis by exposure to S. costatum (Fig. 
3B-1, 3B-3) but allelopathic induction was not observed with natural bloom samples (Fig. 
2). However, the variability in the allelopathic potency of K. brevis blooms and cultures 
indicates that although competitors significantly influence K. brevis allelopathy, other 
factors are likely at play. 
 
Allelopathic potency of Karenia brevis blooms and cultures is variable 
 As previously established, compounds exuded during natural blooms of Karenia 
brevis and from cultures of K. brevis were significantly allelopathic to the diatom 
Skeletonema costatum (Prince et al. 2008), but the magnitude of allelopathic effects 
varied widely among field samples and cultures of K. brevis (p < 0.001; Fig. 1 and 3B). 
We tested a total of 11 samples from Karenia brevis blooms over two years, of which 
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three suppressed growth of S. costatum by more than 95%, three suppressed growth of S. 
costatum by at least 30%, and five did not suppress S. costatum growth (Fig. 1). 
Similarly, of six extracts of K. brevis cultures, two suppressed the growth of S. costatum 
by more than 95%, two modestly but significantly suppressed S. costatum, and two had 
no effect (Fig. 3B).  However, the variability of allelopathic potency in K. brevis blooms 
and cultures was not related to concentration of water-borne brevetoxins (see Results), 
indicating that other K. brevis compounds were responsible for the majority of observed 
allelopathic effects 
While published reports indicate that allelopathy varies with cell concentration 
(e.g., Vardi et al. 2002; Yamasaki et al. 2007a), we found no direct relationship between 
cell density and allelopathic potency for either bloom or cultures of K. brevis (see 
Results). When non-bloom samples (none of which contained K. brevis) were included in 
our analysis, a weak but significant correlation between K. brevis cell concentration and 
allelopathy was detected (see Results) in bloom samples, confirming that some K. brevis 
cells are necessary for allelopathy. All of the bloom samples contained hundreds of cells 
ml
-1
, which is considered the low end of a medium-density bloom (Florida Fish and 
Wildlife Research Institute; http://research.myfwc.com/). Cell concentrations of K. brevis 
cultures were near 10,000 cells ml
-1
, corresponding with high density blooms. However, 
K. brevis concentrations in the Gulf of Mexico range from undetectable to thousands of 
cells/mL (Steidinger & Haddad 1981). It is possible that K. brevis blooms with 
concentrations of thousands of cells ml
-1
 are more consistently allelopathic than the less 
concentrated blooms used in this study, or that there is an approximate cell density 
threshold, above which blooms are more likely to be allelopathic.  
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 In a previous study of Karenia brevis, Kubanek et al. (2005) found that 
allelopathy of cultured K. brevis did vary with growth stage, as previously observed in 
other systems (e.g., Schmidt & Hansen 2001; Wang et al. 2006).  However, in the current 
study, all cultures of K. brevis were extracted during exponential growth stage yet had 
widely variable allelopathic effects (Fig. 3B), indicating that K. brevis growth stage alone 
cannot explain variance in allelopathic potency among cultures. Because allelopathic 
potency of field samples has not been previously assessed, it is difficult to determine if 
allelopathy varies with bloom development stage. In this study, all samples of K. brevis 
blooms were taken from established blooms during “maintenance” stage, a time 
characterized by low growth rates and probable nutrient limitation (Steidinger et al. 
1998). Bloom samples from the same year were collected within 1 h of each other, no 
more than 70 m apart, suggesting samples of a given year contained K. brevis of 
approximately the same growth stage. However, allelopathy varied dramatically among 
the field samples (Fig. 1), indicating that factors other than K. brevis bloom stage must 
play a role in allelopathy. 
The observed variability in allelopathic effects may have been caused by a variety 
of factors. Plankton community interactions are known for their variable and even chaotic 
outcomes (Beninca et al. 2008).  It has previously been noted that competitor 
physiological status affects susceptibility to allelopathy (Fistarol et al. 2005). S. costatum 
used in Experiment 2 was in stationary phase but S. costatum was growing exponentially 
at the time of Experiment 3, indicating that the physiological status of S. costatum was 
different in these two experiments. However, these differences cannot explain the high 
variance within Experiments 2 and 3. Although the production of secondary metabolites 
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has also been shown to vary with time of day for some phytoplankton (Taroncher-
Oldenburg et al. 1997), this factor could not have been responsible because we started 
and terminated lab experiments at the same time of day for all tests. In contrast, S. 
costatum was added to field samples of K. brevis blooms at varying times of day in 2005 
versus 2006, which may have been partially responsible for differences in allelopathy 
(Fig. 2). However, because allelopathy of bloom samples also varied within years, factors 
other than time of day must also influence allelopathic potency of K. brevis blooms. The 
variability of allelopathic potency among cultures of K. brevis may have also been 
influenced by factors that we did not measure in this experiment, including bacteria 
present in cultures. Likewise, the variability of allelopathic potency among K. brevis 
bloom samples may have been caused by localized differences in field conditions 
including nutrient concentrations, light levels, mixing intensity, as well as the presence of 
other community members. 
 
Chemically-mediated interactions among competitors may have community-wide 
consequences 
Our results suggest that the dynamics of Karenia brevis blooms may be 
influenced by the presence of a few specific competitors, such as Skeletonema costatum 
and Asterionellopsis glacialis, which occasionally undermine bloom allelopathy (Figs. 2-
3). We focused on the cosmopolitan diatom, S. costatum, because it is one of the 
dominant phytoplankton species present in the Gulf of Mexico (Saunders & Glenn 1969) 
and routinely found at densities greater than a million cells per liter during the fall 
(Turner 1974; Badylak et al. 2007) when K. brevis blooms frequently occur (Tester & 
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Steidinger 1997). We found that while S. costatum was not present in any 2005 samples 
nor in 2006 non-bloom samples, the concentration of S. costatum was 67 + 25 cells ml
-1
 
in 2006 bloom samples, making it one of the most abundant phytoplankton species other 
that K. brevis. Although a number of factors including levels of light, nutrients, and 
turbulence, may have influenced the allelopathic potency of K. brevis bloom samples, the 
presence of S. costatum in field samples may explain differences in allelopathic potency 
between 2005 and 2006 samples. If S. costatum undermines K. brevis allelopathy in the 
field, then its presence in 2006 may help explain why these bloom samples were only 
marginally allelopathic (Fig. 1) and why the addition of S. costatum cells to K. brevis 
blooms did not significantly decrease the allelopathic potency of 2006 samples (Fig. 2), 
since live K. brevis cells in bloom samples had already been exposed to S. costatum in the 
field. The fact that S. costatum was relatively common in the 2006 blooms compared to 
other, non-Karenia species, also suggests that the undermining of K. brevis allelopathy 
by S. costatum is ecologically meaningful: the ability of S. costatum to co-exist with K. 
brevis may provide it with a competitive advantage over other phytoplankton species, 
potentially altering the composition of the bloom community.  
In conclusion, we found Karenia brevis blooms to be allelopathic, but the 
magnitude of allelopathy varied dramatically between collections and years (Fig. 1). 
Neither brevetoxin concentration nor K. brevis cell density explained the variance in 
allelopathy. However, when we directly tested whether competitive interactions 
influenced allelopathy, we found that the diatom Skeletonema costatum was able to 
substantially undermine the allelopathic potency of K. brevis blooms (Fig. 2). This ability 
is not common to most Gulf of Mexico phytoplankton (Fig. 3), suggesting that S. 
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costatum may be able to occur during K. brevis blooms because of an effective method to 
overcome allelopathy. Our results indicate that phytoplankton competitors may play an 
important role in K. brevis bloom dynamics, and underscore the importance of reciprocal 







CHARACTERIZATION OF ALLELOPATHIC COMPOUNDS FROM THE RED 





 Blooms and cultures of the red tide dinoflagellate Karenia brevis exude 
compounds that inhibit the growth of competing phytoplankton, but the identity of these 
compounds is unknown. We partially purified and characterized allelopathic compounds 
from K. brevis using a variety of chromatographic and spectroscopic techniques. K. 
brevis produced multiple compounds which inhibited the growth of the competing 
diatom, Asterionellopsis glacialis. However, brevetoxins, potent neurotoxins responsible 
for massive fish kills and neurotoxic shellfish poisoning in humans, had no effect on A. 
glacialis growth. We determined that allelopathic compounds produced by K. brevis are 
unstable polar organic molecules produced at low concentrations, which are either neutral 
or positively charged. The two allelopathic compounds characterized in more detail had 
molecular weights between 500 and 1000 Da and possessed aromatic functional groups. 
Our results indicate that the ability of K. brevis to out-compete co-occurring 
phytoplankton may be facilitated by the production of multiple allelopathic compounds, 
but that red tide neurotoxins are not allelopathic. 
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Introduction 
A number of phytoplankton taxa, including cyanobacteria (Suikkanen et al. 2004), 
dinoflagellates (Tillmann et al. 2007), diatoms (Yamasaki et al. 2007a), and haptophytes 
(Fistarol et al. 2003) are known to exude compounds which inhibit the growth of 
competitors, potentially with community-wide effects. Because competitors exhibit 
different levels of susceptibility to allelopathic compounds, allelopathy can influence the 
species composition of phytoplankton assemblages (Fistarol et al. 2003; Fistarol et al. 
2004b). Allelopathic interactions may also influence or drive patterns of succession. For 
example, in a series of experiments Keating (1977; 1978) found that phytoplankton 
isolated from a temperate pond exuded compounds that inhibited the growth of species 
that occurred before them in succession but either stimulated or had no effect on species 
succeeding them. Allelopathic interactions may also facilitate invasion. The range of the 
cyanobacterium Cylindrospermopsis raciborskii is expanding potentially in part because 
C. raciborskii exudes compounds that inhibits photosynthesis of native phytoplankton in 
lakes that it invades (Figueredo et al. 2007).  
Allelopathy has been hypothesized to facilitate the formation of harmful algal 
blooms (reviewed in Legrand et al. 2003). Some bloom-forming species produce potent 
toxins, which can kill fish, birds, and marine mammals and accumulate in shellfish, 
rendering them unsafe for human consumption (Landsberg 2002); however, these toxins 
are rarely linked to allelopathic effects. For example, the allelopathic dinoflagellates 
Alexandrium spp. produce a group of sodium channel blockers which cause paralytic 
shellfish poisoning in humans (Baden et al. 1998), but these toxins do not account for the 
negative effects (growth inhibition, paralysis, and cell lysis) of Alexandrium spp. filtrates 
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towards cultures and natural assemblages of phytoplankton competitors (Tillmann and 
John 2002; Fistarol et al. 2004b). Similarly, while the allelopathic dinoflagellate 
Prorocentrum lima produces the toxin okadaic acid which causes diarrhetic shellfish 
poisoning in humans, bioassay-guided fractionation of P. lima exudates indicated that 
okadaic acid was not present within the allelopathic fraction (Sugg and Van Dolah 1999).  
Considering the attention that allelopathy has recently received as an important 
mediator of competition in the plankton (Gross 2003; Legrand et al. 2003), very few 
studies have identified compounds that are allelopathic to competitors at natural, 
waterborne concentrations. In one case, methyl esters of fatty acids isolated from the 
green alga Nannochloris oculata were shown to inhibit the growth of a competing 
dinoflagellate (Perez et al. 1997), and in another, a sesquiterpene alcohol isolated from 
the dinoflagellate Gymnodinium nagasakiense caused cell lysis of several competitor 
species (Kajiwara et al. 1992). However, neither study demonstrated that these 
compounds were allelopathic at naturally exuded concentrations. Similarly, fischerellins 
which were found to be exuded by the cyanobacterium Fischerella mucosa (Gross et al. 
1991) and whose structures were later determined (Hagmann and Juttner 1996; Papke et 
al. 1997), inhibited the growth of photosynthetic competitors, but whether waterborne 
concentrations of fischerellins are high enough to inhibit competitors is unknown. In 
some cases, compounds that are allelopathic at natural, waterborne concentrations have 
been isolated, but their structures remain unknown. For example, karlotoxins exuded by 
the dinoflagellate Karlodinium micrum were found to inhibit the growth of competing 
phytoplankton (Adolf et al. 2006), but the complete structures of these molecules have 
not been reported. 
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Because allelopathic compounds have so rarely been identified, most studies 
testing allelopathy among planktonic organisms have used mixtures of exuded 
compounds, either in the form of filtrates (Schmidt and Hansen 2001; Tillmann et al. 
2007) or extracellular extracts of phytoplankton (Prince et al. in press; Prince et al. 
submitted). Although the occurrence of allelopathy can be established using filtrates or 
extracellular extracts, the identification of specific allelopathic compounds is expected to 
enable researchers to explore the nature of allelopathic interactions in more depth. With 
pure compounds of known molecular structure in hand, the biosynthesis, cellular release, 
and waterborne transport of allelopathic compounds could be experimentally studied. 
Knowledge of the molecular structures of allelopathic compounds could help researchers 
determine whether their effects are general or species-specific, as well as the molecular 
mechanisms of action involved. 
Karenia brevis is an ecologically and economically important dinoflagellate that 
blooms seasonally in the Gulf of Mexico, altering the phytoplankton community (West et 
al. 1996), perhaps in part through the production of allelopathic compounds (Kubanek et 
al. 2005). Compounds exuded by K. brevis cultures and natural blooms have been shown 
to inhibit the growth of several co-occurring phytoplankton species (Kubanek et al. 2005; 
Prince et al. in press; Prince et al. submitted). Two mechanisms of action have been 
identified in this system: allelopathic extracellular extracts of K. brevis lowered the 
photosynthetic efficiency of five competitors and damaged cell membranes of three of 
these five species (Prince et al. in press).  K. brevis produces a group of neurotoxic 
compounds called brevetoxins which cause massive fish kills and neurotoxic shellfish 
poisoning in humans (Baden et al. 1998), but in laboratory experiments brevetoxins were 
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allelopathic to only one competitor, the diatom Skeletonema costatum (Kubanek et al. 
2005). However, in subsequent experiments, concentrations of brevetoxins in cultures 
and field samples of K. brevis did not correlate with allelopathic effects of K. brevis on S. 
costatum, suggesting that brevetoxins may play, at most, a minor role in allelopathy 
(Prince et al. submitted). In addition, seven other species of competing phytoplankton, 
including the diatom Asterionellopsis glacialis, were found to be susceptible to 
unidentified allelopathic compounds produced by K. brevis (Kubanek et al. 2005; Prince 
et al. in press) but were not inhibited by pure brevetoxins at realistic waterborne 
concentrations (Kubanek et al. 2005). 
Here, we report the partial characterization of allelopathic compounds exuded by 
Karenia brevis, using a variety of chromatographic and spectroscopic techniques. We 
assess the polarity, charge, molecular weight, and functional group composition of K. 
brevis compounds found to be allelopathic to the diatom Asterionellopsis glacialis. A. 
glacialis was chosen as a model competitor because it was consistently inhibited by 
extracellular compounds extracted from both K. brevis cultures and K. brevis blooms 
(Kubanek et al. 2005; Prince et al. in press; Prince et al. submitted). In addition, the strain 
of A. glacialis used in this experiment was originally isolated from the Gulf of Mexico, 
and A. glacialis has been found in the Tampa Bay estuary (Badylak et al. 2007) and in 
along the Florida panhandle (T. L. Myers, personal observation), areas that experience 





Materials and Methods 
Phytoplankton culturing 
Non-axenic clones of the diatom Asterionellopsis glacialis (CCMP 137) and the 
red tide dinoflagellate Karenia brevis (CCMP 2228) were obtained from the Provasoli-
Guillard National Center for Culture of Marine Phytoplankton (CCMP).  Both species 
were originally isolated from the Gulf of Mexico. Cultures were maintained at 22 °C with 
a 12 h light:dark cycle in a Percival incubator with Philips F32T8/TL741 Universal/Hi-





 throughout the incubator (measurement using Biospherical Instruments Inc light meter 
model QSL2100). Cultures of K. brevis used to generate extracellular extracts were 
grown in 2.5 L Fernbach flasks in L1 + silicate media (CCMP) made with filtered Maine 
seawater. Experiments with A. glacialis were also conducted in L1 + silicate media, but 
A. glacialis stock cultures were maintained in F/2 + silicate media (Sigma-Aldrich Co). 
Initial growth curves for all species were generated by visual cell count data using an 
Olympus IX-50 inverted microscope with a Palmer-Maloney settling chamber on culture 
samples preserved with Lugol’s solution. 
 
Generation of extracellular extracts 
When Karenia brevis cultures were in exponential growth stage, extracellular 
organic materials were extracted from each culture using a mixture of three adsorbent 
resins optimized for the extraction of lipophilic materials from aqueous media (Prince et 
al. 2006). The advantages of this method over traditional methods of generating cell-free 
filtrates is described in Prince et al. (in press). The resin was incubated within K. brevis 
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cultures for 12-15 h, and then recovered by slow filtration through Nitex nylon mesh. The 
recovered resin was rinsed with deionized water, and organic compounds were eluted 
from the resin using methanol followed by acetone, and the solvents were removed by 
rotary evaporation. The extracellular extract used for high performance liquid 
chromatography (HPLC) fractionation (described below) was generated from cultures 
containing 1.23 x 10
4
 K. brevis cells mL
-1
 and the extract used for size-exclusion 












Partial purification of allelopathic compound(s) exuded by Karenia brevis  
HPLC fractionation of extracellular Karenia brevis extracts 
We fractionated extracellular extracts generated from 500 mL of Karenia brevis 
culture using a Waters 1525 binary HPLC pump and a Waters 2487 dual wavelength 
detector set at 215 and 254 nm, coupled to Waters Breeze software. We used a C-18 
reversed-phase silica column (4.6 x 250 mm with a 5 µm particle size Zorbax SB-C18) 
and a flow rate of 1 mL min
-1
. A 1:1 ratio of methanol/water was used as the mobile 
phase for the first 10 min, after which the proportion of methanol linearly increased to 
100% over a period of 20 min. The mobile phase remained at 100% methanol for 10 min, 
and then returned to starting conditions over the next 3 min. Thus, more polar compounds 
were eluted from the column before less polar compounds. We collected 23 fractions 
based on peak shape. In order to assess the overall effects of K. brevis extracellular 
extracts and to test whether allelopathic compounds were decomposed by HPLC, we 
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recombined half of each fraction into a single treatment. The effects of each individual 
HPLC fraction and the recombined treatment on the growth of Asterionellopis glacialis 
were tested using the assay described below. 
 
Allelopathy assay of HPLC fractions  
In order to balance the need for statistical power with keeping the number of 
experimental units manageable, six individual treatments were blocked with each control. 
For example, fractions A-F were grouped with control 1, fractions G-L with control 2, 
etc. The recombined fraction (“ALL”) was tested with fraction S, T, U, V, and W. On the 
first day of the experiment, ten replicate culture tubes each containing 6.0 mL of L1 + 
silicate media were inoculated with 250 µL of Asterionellopsis glacialis in stationary 
stage for each treatment and control (280 total culture tubes, with an initial concentration 




). Prior to addition of HPLC fractions, the initial cell concentration 
of each culture was approximated using a Turner Designs TD-700 fluorometer calibrated 
with chlorophyll a (the relationship between fluorescence and visual cell counts was 
linear for A. glacialis; r
2
 = 0.95). In order to counteract the probable partial 
decomposition of the allelopathic compounds during fractionation, twice the approximate 
natural concentration of compounds exuded by K. brevis cultures was added to each 
experimental tube (i.e., the amount of each fraction equivalent to that generated from 
12.5 mL of K. brevis culture was tested in a total volume of 6.25 mL). Each experimental 
tube received a given fraction dissolved in 10 µL DMSO (dimethyl sulfoxide); solvent 
control tubes also received 10 µL DMSO. Next, treatments for each group (i.e., A – F, G 
– L, M – R, and S – ALL) were blocked by replicates and randomly placed in the 
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incubator at 22 °C with a 12 h light:dark cycle. Tubes were inverted every 1-2 d and their 
position in the incubator randomly reassigned. Fluorescence of each culture was 
measured again after 1, 3, 5, 7, 10, 14, 18, and 21 d. Subsequent additions of extracts 
were made 7 and 14 d after the experiment was begun, in order to counteract probable 
decomposition of allelopathic compounds in experimental tubes. The maximum 






Characterization of Karenia brevis allelopathic compound(s) 
HP20ss column separation of Karenia brevis extracellular extract  
We used an HP20ss column to assess the polarity of allelopathic compound(s) 
exuded by K. brevis. First, we packed a column of HP20ss (Supleco) 2.5 cm high and 1 
cm in diameter in methanol, and then rinsed with deionized water.  Extracellular extract 
of K. brevis equivalent to the amount exuded by 100 mL of culture was dissolved in 500 
µL of deionized water and loaded onto the column. The column was flushed with 35 mL 
of deionized water. The eluate was collected and the solvent removed by rotary 
evaporation. Next, the column was rinsed with 20 mL of methanol followed by 15 mL of 
acetone. The combined methanol-acetone eluate was collected and dried under rotary 
evaporation. Half of the material from each fraction was used to make a recombined 
treatment to test for possible decomposition of allelopathic compounds. The effects of the 
fraction that was eluted from the column with water (“WATER”), the fraction that eluted 
from the column with organic solvents (“ORGANIC”), and the recombined treatment 
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(“ALL”) were each tested on the growth of A. glacialis using the allelopathy assay 
described below. 
 
SAX column separation of Karenia brevis extracellular extract  
We tested whether the allelopathic compounds produced by Karenia brevis are 
negatively charged using strong anion exchange (SAX) chromatography. First, a column 
of 1.2 g of LC-SAX (Supelclean) was packed and rinsed with 1:1 methanol/water 
mixture. Extracellular extract of K. brevis equivalent to the amount exuded by 100 mL of 
culture was dissolved in a basic solution of 2 mL of a 1:1 mixture of 5 mM aqueous 
ammonium hydroxide and methanol, and loaded onto the column. Compounds were 
eluted from the column in three steps: first with a mobile phase of 15 mL of 75:25 
methanol/water (“SAX1”), second with 15 mL of 75:23:2 methanol/water/1M aqueous 
formic acid (“SAX2”), and finally with 15 mL of 75:25 methanol/1M aqueous formic 
acid (“SAX3”). Each eluate was dried by rotary evaporation.  Half of the material from 
each fraction was recombined. The allelopathic effects of SAX1, SAX2, SAX3, as well 
as the recombined treatment (“ALL”) were each tested using the 48 h assay described 
below. 
 
 Dialysis membrane separation of Karenia brevis extracellular extract 
This method was used to test whether allelopathic compounds exuded by K. 
brevis were larger or smaller than 1000 daltons (Da).  Extracellular extract of K. brevis 
equivalent to the amount exuded by 100 mL of culture was dissolved in 5.0 mL of 
deionized water and placed inside a 1000 Da molecular weight cut-off dialysis membrane 
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tube (Spectrum Laboratories). The membrane was clamped at both ends, placed in a 
beaker containing 500 mL of deionized water, and gently stirred at 4 °C. After 7 h, the 
material inside (i.e., the > 1000 Da fraction) and outside (i.e., the < 1000 Da fraction) the 
membrane was collected and the deionized water removed by rotary evaporation.  In 
order to assess the overall effects of K. brevis extracellular extracts and to test whether 
allelopathic compounds were decomposed by dialysis, we recombined half of each 
fraction into a single treatment (“ALL”). The effects of the > 1000 Da, the < 1000 Da, the 
recombined fraction, and a portion of the original unfractionated K. brevis extract 
(“WHOLE EXTRACT”) were tested on the growth of A. glacialis using the 48 h 
allelopathy assay described below. 
 
Size-exclusion chromatographic separation of Karenia brevis extracellular extract 
Approximate molecular weight ranges of the allelopathic compound(s) from 
Karenia brevis were determined using size-exclusion chromatography. A P-2 Biogel 
column (Bio-Rad Laboratories), 31 cm tall and 0.5 cm in diameter, was flushed with 30 
mM aqueous ammonium formate. Extracellular extract of K. brevis equivalent to the 
amount exuded by 500 mL of culture was dissolved in 250 µL of 30 mM aqueous 
ammonium formate, loaded onto the column, and substances were eluted with a mobile 
phase of 30 mM aqueous ammonium formate (high-molecular weight materials eluted 
before lower-molecular weight materials). Fraction 1 contained the first 2 mL eluting 
from the column; subsequently fractions (2-7) contained between 0.5 and 1 mL; and 
fraction 8 contained all remaining materials washed from the column in 20 mL. Fractions 
1-8 and a recombined fraction (“ALL”) were tested using the allelopathy assay described 
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below.  The allelopathic size-exclusion fraction (fraction 8) was further fractionated using 
the same size-exclusion column and mobile phase. Fraction 8’1 contained first 5 mL 
eluted from the column; fractions 8’2 to 8’9 each contained 2 mL; and fraction 8’10 
consisted of a final 20 mL collected from the column. The allelopathic effects of each of 
these fractions, and a recombined fraction (“ALL”), were assessed using the assay 
described below. Two groups of fractions, 8’2-4 and 8’5-7, which were adjacent to one 
another and similar in allelopathic potency, were combined, tested again, and subjected to 
NMR and mass spectral analysis (see below). Allelopathic effects of the combined 
fractions were assessed using the same assay eight months after initial tests, and the 
combined fractions were again subjected to NMR and mass spectral analysis.  
The molecular weight of each fraction was approximated by comparison of 
elution patterns with molecular weight standards. A mixed solution of cyclodextrin 
(Sigma, MW 1135), napthol blue-black (Sigma, MW 570 Da), rhodamine (Aldrich, MW 
443 Da), penicillin (FisherBiotech, MW 333 Da), and glucose (Aldrich, MW 180 Da) 
was prepared (approximately 4 µg mL
-1
 of each compound in 30mM ammonium 
formate). We loaded 200 µL of the solution onto the size-exclusion column, and collected 
fractions of the same volume described for the second size-exclusion fractionation of K. 
brevis extract. Three compounds, cyclodextrin, napthol blue-black, and rhodamine eluted 
from the column within the elution volumes reported earlier. The relative concentration 





48 h Allelopathy assay 
We determined the allelopathic activity of each fraction generated from dialysis, 
HP20ss chromatography, and SAX chromatography using a 48 h assay with the model 
competitor Asterionellopsis glacialis. Culture tubes containing 2.8 mL of L1+silicate 
media made with filtered Maine seawater (36 ppt) were inoculated with 200 µL of A. 
glacialis. When A. glacialis reached exponential growth stage (approximately 3 to 7 d), 
initial fluorescence measures were taken and replicates were created by grouping cultures 
with similar fluorescence (n = 7 for all experiments). Next, to each treatment tube we 
added the amount of extract or fraction generated from 3.0 mL of K. brevis culture (i.e., 
approximately natural concentration) dissolved in 20 µL deionized water, and 20 µL 
deionized water was added to each control. Groups of experimental tubes were randomly 
placed in the incubator at 22 °C with a 12 h light:dark cycle. After 48 h, the approximate 
cell concentration within each experimental tube was assessed by measuring its 
fluorescence, and the percent growth of A. glacialis within each tube was calculated 








 We also used a 48 h assay to determine the allelopathic activity of each fraction 
generated from size-exclusion chromatography. However, in order to assure adequate 
statistical power, we grouped size exclusion fractions as described for HPLC fractions. 
Three treatments were tested with one control following the first column separation (n = 
5). Three or four treatments were tested with one control for the fractions generated from 
the second size-exclusion column (n = 7). These assays were conducted in the same way 
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as assays of fractions generated from dialysis, HP20ss, and SAX. The growth of A. 
glacialis in each experimental tube was also calculated using equation 2. However, in 
order to enable direct comparisons among treatments, we also normalized the growth of 











For the results of the allelopathy assay for HPLC fractions of K. brevis 
extracellular extracts, the maximum fluorescence of each treatment after 21 d was 
compared within groups using a 1 way ANOVA with a Tukey post-hoc test using the 
software program SYSTAT 9 (Zar 1999). Differences between treatments were accepted 
as significant when p < 0.05. For the results of the other assays, the percent growth of A. 
glacialis over 48 h was compared within groups using the same statistical test. 
 
Characterization of allelopathic fractions 
The combined size-exclusion fractions 8’2-4 and 8’5-7 were characterized by 
1
H 
nuclear magnetic resonance (NMR) spectroscopy, with data acquired in D2O at 25 °C 
using a Bruker 500 MHz spectrometer. The same fractions were analyzed by the Georgia 
Institute of Technology mass spectrometry lab by high resolution electrospray ionization 
(ESI) mass spectrometry (MS) in positive mode using an Applied Biosystems QSTAR 
XL spectrometer. Identical analyses for all samples were conducted again after eight 
months storage at -20 °C. 
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LC-MS analysis of brevetoxins and molecular weight standards 
We analyzed by LC-MS all HPLC fractions for the presence of brevetoxin B and 
brevetoxin 3 (PbTx-2 and PbTx-3, respectively). We determined PbTx-2 concentrations 
by comparison to a PbTx-2 standard curve (5-7 standard concentrations of 0–2 µg mL
-1
).  
Because PbTx-2 and PbTx-3 shared almost identical standard curves below 1 ug mL
-1
, 
we also quantified PbTx-3 concentrations by comparison to a PbTx-2 standard curve 
(PbTx-3 concentrations in all samples were < 1 ug mL
-1
) (Kubanek et al. 2007; Myers et 
al. submitted).  We also used LC-MS to assess relative concentrations of molecular 
weight standards by comparing ion profiles of size-exclusion fractions to the ion profiles 
of pure molecular weight standard samples. 
 
Results 
Polarity of allelopathic compounds from Karenia brevis 
HPLC fractionation of Karenia brevis extracellular extract yielded 23 fractions 
(Figure 5.1A), of which five (fractions B, G, H, I, and S) significantly inhibited the 
growth of Asterionellopsis glacialis (Figure 5.1B), and four (fractions C, D, E, and M) 
significantly stimulated the growth of A. glacialis. When all HPLC fractions were 
combined and tested at natural concentration, the recombined extract completely 
suppressed A. glacialis growth (p < 0.001), with cultures of A. glacialis never growing 
beyond starting concentrations. Thus, although K. brevis exudates contained multiple 
allelopathic and stimulatory compounds, the overall effect of K. brevis on its competitor 







Figure 6.1. HPLC fractionation of Karenia brevis extracellular extracts. (A) C-18 
reversed-phase HPLC chromatogram of K. brevis extracellular extracts in a gradient of 
aqueous methanol, with absorbance measured at 215 and 254 nm. Vertical lines indicate 
fractions collected. (B) Growth of the diatom Asterionellopsis glacialis exposed to HPLC 
fractions normalized to a solvent control. “ALL” represents a treatment containing 
recombined HPLC fractions. Bars above the reference line indicate increased A. glacialis 
growth relative to solvent controls, while bars below the reference line indicate 
suppressed A. glacialis growth relative to solvent controls. Asterisks indicate A. glacialis 























































































Only one K. brevis HPLC fraction (B) completely suppressed the growth of A. 
glacialis (p = 0.001), explaining most of the allelopathic effect of the K. brevis 
extracellular extract (Figure 5.1B). Fraction B eluted from the reversed-phase HPLC 
column with 50% aqueous methanol very shortly after the solvent front, indicating that 
allelopathic compound(s) within this fraction were polar relative to other compounds 
exuded by K. brevis (Figure 5.1A). Three other allelopathic fractions (G, H, and I), which 
also eluted relatively early in the fractionation, suppressed A. glacialis growth by 50-57% 
relative to solvent controls (p < 0.001 for all; Figure 5.1). The most lipophilic allelopathic 
fraction (S), corresponding with no obvious UV absorption, suppressed A. glacialis 
growth by 39% relative to controls (p = 0.040). Some allelopathic fractions were 
characterized by a single UV peak (i.e., fractions G and I; Figure 5.1A), suggesting that 
these fractions contained only one major UV-absorbing compound. Others (i.e., fractions 
B and H; Figure 5.1A) were each associated with multiple UV peaks, indicating that they 
contained several compounds. However, allelopathic compounds in all fractions 
decomposed with further attempts at purification and characterization (data not shown). 
Brevetoxin B (PbTx-2) and brevetoxin 3 (PbTx-3) co-eluted with HPLC fraction 
P (Figure 5.1A). As determined by LC-MS analysis, PbTx-2 was present at 2.50 ng mL
-1
 
and PbTx-3 at 7.61 ng mL
-1
 in the extracellular portion of Karenia brevis culture. Other 
brevetoxins were not observed. Since extracellular extracts were generated from K. brevis 




, this represents 0.20 pg PbTx-2 and 0.62 pg 
PbTx-3 exuded per K. brevis cell. The growth of Asterionellopsis glacialis exposed to 
fraction P was not significantly different from A. glacialis exposed to a DMSO control (p 
= 0.84; Figure 5.1B). No brevetoxins were detected in any of the other HPLC fractions, 
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including the allelopathic fractions, indicating that brevetoxins appear to play no role in 
the allelopathy of K. brevis towards A. glacialis. 
 Allelopathic extracts of Karenia brevis were retained on an HP20ss column 
(Figure 5.2A). Compounds that eluted from the column with water did not inhibit 
Asterionellopsis glacialis growth (p = 1.00). However, compounds present in the fraction 
that eluted from the column with organic solvents did inhibit A. glacialis (p = 0.014). 
When fractions were combined, the resulting treatment also significantly inhibited A. 
glacialis growth (p = 0.003) but not significantly more than the organic fraction (p = 
0.92), indicating that the allelopathic compounds were not extremely water-soluble. 
 
Charge status from ion exchange chromatography 
 Anion exchange chromatography failed to retain allelopathic compounds (Figure 
5.2B), indicating they were not negatively charged. Allelopathic compounds eluted from 
the column with a basic-to-neutral eluant as part of fraction SAX1 (p < 0.001). 
Compounds collected with increasing concentrations of formic acid (fractions SAX2 and 
SAX3), did not inhibit A. glacialis growth (p > 0.84 for both). The recombined treatment 
did inhibit the growth of A. glacialis (p < 0.001), similarly to fraction SAX1 (p = 0.84). 
Cation exchange chromatography lead to inadequate separation of allelopathic 
compounds with positively charged functional groups (data not shown). 
 
Molecular weights of allelopathic compounds 
Dialysis membrane separation of Karenia brevis extracellular extracts yielded two 





   
Figure 6.2. Growth of A. glacialis exposed to Karenia brevis extracellular extracts fractionated by three methods. (A) HP20ss 
fractionation. Fractions represent substances eluted from the column with water (“WATER”), with methanol/acetone (“ORGANIC”), 
and recombined fractions (“ALL”). (B) Strong anion exchange chromatography. Fractions represent those that were not negatively 
charged (“SAX1”), to those that were charged (“SAX2”, “SAX3”), and a recombined fraction (“ALL”). For panels (A) and (B) 
asterisks represent treatments significantly different from controls (n = 7; p < 0.05) (C) Dialysis membrane separation. A. glacialis 
was exposed K. brevis materials greater than 1000 Daltons (>1000), less than 1000 Daltons (< 1000), the recombined fraction 
(“ALL”), unfractionated extract (“WHOLE EXTRACT”), and solvent control (“CTRL”). Letters represent treatments significantly 
different from one another (n = 7; p < 0.05). 
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and another with compounds of molecular weight less than 1000 Da. Of these, only 
compounds < 1000 Da inhibited the growth of Asterionellopsis glacialis relative to 
controls (p = 0.008; Figure 5.2C). When the two fractions were recombined, the resulting 
treatment also inhibited the growth of A. glacialis (p < 0.001), but not significantly more 
than the low molecular weight fraction (p = 0.67). The recombined treatment did not 
inhibit the growth of A. glacialis as strongly as K. brevis extract prior to dialysis (p = 
0.017), indicating that some of the allelopathic effect was lost by decomposition during 
dialysis. 
 When exposed to fraction 8 from the size-exclusion column, Asterionellopsis 
glacialis growth was inhibited by 71% relative to solvent controls (p < 0.001; Figure 
5.3A). The growth of A. glacialis exposed to fractions 1-7 was not significantly different 
from controls (p = 0.70-0.94 for all), indicating that all significantly allelopathic 
compounds eluted with fraction 8. The recombined fraction from the size-exclusion 
column also inhibited the growth of A. glacilalis relative to controls, and actually caused 
the cell density of A. glacialis culture to decrease by approximately 6% over 48 h (p < 
0.001). 
 When fraction 8 was further separated by size-exclusion chromatography, the 
allelopathic effects were spread among several fractions (Figure 5.3C), supporting the 
hypothesis that multiple allelopathic compounds are exuded by K. brevis. While fractions 
8’1 and 8’8 modestly inhibited the growth of A. glacialis, by 37% (p = 0.003) and 73% (p 
< 0.001) respectively, fractions 8’2, 8’3, and 8’4 inhibited the growth of A. glacialis more 
dramatically, by 81-85% (p < 0.001 for all). However, the most allelopathic fractions 





Figure 6.3. Effects of fractions from size exclusion column on growth of A. glacialis, 
normalized to solvent controls. (A) Initial separation (n = 5). (B) The relative 
concentrations of molecular weight standards in each fraction (in panel C). The solid line 
represents the relative abundance of cyclodextrin (1135 Da), the dashed line napthol blue 
black (570 Da), and the dotted line rhodamine (433 Da). (C) Further separation of 
fraction 8 (n = 7). The inset shows effects of combined fractions 8’2-4 and 8’5-7 on the 
growth of A. glacialis after eight months storage at -20 °C  (n = 7). For all panels, 




for all), indicating substantial A. glacialis cell death, not just inhibition of cell growth. 
Two fractions, 8’9 and 8’10, did not significantly inhibit the growth of A. glacialis (p = 
0.39-0.82). When all of the fractions were recombined and tested for allelopathic effects, 
A. glacialis growth was inhibited by 110% (p < 0.001).  
 Three standards with molecular weights of 433-1135 Da eluted from the column 
within the retention window of fractions 8’1-10 (Figure 5.3B). These results indicate that 
the molecular weights of allelopathic compounds from K. brevis extracellular extracts 
(eluting in fractions 8’1-8 but peaking in fractions 8’5-7) were likely between 500 and 
1000 Da, and that the compounds in fractions 8’2-4 were of higher molecular weight than 
the compounds in fraction 8’5-7. When the allelopathic effects of combined fractions 
8’2-4 and 8’5-7 were tested again after eight months storage at -20 °C, neither combined 
fraction inhibited the growth of A. glacialis (p = 0.60-1.00; inset Figure 5.3C), indicating 
decomposition of allelopathic compounds over time. 
The initial mass spectral analyses of two allelopathic size-exclusion fractions 
showed several peaks in the molecular weight range of 500-1000 Da. In combined size-
exclusion fraction 8’2-4, peaks with a mass-to-charge ratios of 663, 963, and 991 (which 
each likely represent the molecular weight of a compound plus proton) were visible 
(Figure 5.4A). However, when the sample was analyzed after decomposition, the only 
peaks visible were from a polyethylene glycol (PEG) impurity (Figure 5.4B). This PEG 
impurity, likely from laboratory plastic materials (e.g., pipet tips), was probably also 
present in the initial sample, but because peaks from the candidate molecular ions of 
allelopathic compounds were much larger, the PEG-associated peaks were hidden in 
baseline noise. A similar pattern was observed in the mass spectrum of the combined  
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Figure 6.4. Spectroscopic analysis of combined size exclusion fraction 8’2-4. High 
resolution electrospray positive ion mass spectrum (A) before, and (B) after 
decompostion. 
1
H NMR spectrum (C) before, and (D) after decomposition. 
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fraction 8’5-7. Initially, peaks at mass-to-charge ratios of 663, 685, 907, and 991 were  
visible (Figure 5.5A) but after decomposition only peaks from the PEG impurity were 
obvious (Figure 5.5B). 
 
Functional group composition from NMR spectral data 
1
H NMR spectral analyses of combined size-exclusion fractions 8’2-4 and 8’5-7 
acquired prior to decomposition suggested mixtures of substituted aromatic compounds 
with relatively few hydrogen atoms attached to carbons (Figures 5.4C, 5.5C). However, 
the poor signal-to-noise ratio for each NMR spectrum indicated that compounds were 
present in low abundance, and thus full molecular structures could not be determined. 
Because the peak shapes corresponding to the aromatic protons indicated a different 
substitution pattern around putative benzene rings for each of the two combined size-
exclusion fractions, major compound(s) associated with fractions 8’2-4 (Figure 5.4C) 
were likely different from major compound(s) present in fractions 8’5-7 (Figure 5.5C). 
When the same samples were analyzed by 
1
H NMR spectroscopy after they had lost 
allelopathic activity, no aromatic protons were detected in combined fraction 8’5-7, and 
other proton signals decreased in intensity (Figure 5.5D). In contrast, the aromatic 
protons were still obvious in combined fraction 8’2-4, although all proton signals 








Figure 6.5. Spectroscopic analysis of combined size exclusion fraction 8’5-7. High 
resolution electrospray positive ion mass spectrum (A) before, and (B) after  
decompostion. 
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Characterization of allelopathic Karenia brevis compounds 
 Karenia brevis exuded multiple compounds that inhibited the growth of a model 
competitor, the diatom Asterionellopsis glacialis (Figure 5.1B, Figures 5.4-5.5). 
Allelopathic compounds were not negatively charged (Figure 5.2B), and possessed 
molecular weights in the range of 500-1000 Da (Figures 5.2-5.5). Whereas allelopathic 
compounds were lipophilic enough to be retained on a hydrophobic resin column (Figure 
5.2A), the most potent compounds eluted by reversed-phase HPLC with 50% aqueous 
methanol shortly after the solvent front, indicating greater polarity than most other 
compounds exuded by K. brevis (Figure 5.1B). The 
1
H NMR spectral data indicated the 
presence of aromatic moieties on at least two allelopathic compounds, with relatively few 
(< 20) hydrogen atoms bound to carbons (Figures 5.4-5.5). These allelopathic compounds 
were unstable and present in low abundance (Figures 5.4-5.5).  
 
Brevetoxins are not allelopathic to Asterionellopsis glacialis 
 Brevetoxin-B and brevetoxin-3 (PbTx-2 and PbTx-3, respectively), the two most 
abundant brevetoxins in water samples during Karenia brevis blooms (Pierce et al. 2005), 
eluted by HPLC as part of fraction P (Figure 5.1A), but the growth of Asterionellopsis 
glacialis was not affected by this fraction (Figure 5.1B). Other brevetoxins were not 
evident in K. brevis extracellular extracts when analyzed by LC-MS. Thus, although 
brevetoxins act as potent neurotoxins to mammals (Baden et al. 1998), our results 
indicate that brevetoxins at naturally exuded concentrations do not inhibit the growth of 
A. glacialis. This is consistent with previous studies (Kubanek et al. 2005; Prince et al. 
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submitted), which reported that allelopathic effects of K. brevis can rarely be attributed to 
brevetoxins. Kubanek et al. (2005) found that a mixture of three common brevetoxins 
(PbTx-2, -3, -9) totaling 8.8 ng mL
-1
 did not inhibit the growth of A. glacialis. Indeed, 
brevetoxins consistently inhibited the growth of only one competitor, the diatom 
Skeletonema costatum. However, Prince et al. (submitted) found no correlation between 
waterborne concentrations of brevetoxins during K. brevis blooms and the allelopathic 
potency of these blooms to S. costatum, suggesting that compounds other than 
brevetoxins were responsible for allelopathic effects of natural K. brevis blooms.  
 Smayda (1997) suggested that some microalgae may be able to form blooms in 
part by the production and exudation of allelopathic compounds; however, he noted more 
experiments must be conducted in order to determine whether compounds previously 
identified as neurotoxins and hepatotoxins act as allelopathic compounds. Since that time, 
the allelopathic effects of many microalgal metabolites toxic to vertebrates have been 
tested. Neither saxitoxin nor its derivatives, nor the spirolides produced by Alexandrium 
spp. were allelopathic (Tillmann and John 2002; Fistarol et al. 2004b; Tillmann et al. 
2007). Similarly, okadaic acid and derivatives produced by Prorocentrum lima, did not 
inhibit the growth of competitors at naturally exuded concentrations (Sugg and Van 
Dolah 1999). Domoic acid, a neurotoxin produced by the diatoms Pseudo-nitzschia spp., 
also caused no allelopathic effects towards competitors (Lundholm et al. 2005). Neither 
have cyanobacterial toxins, including microcystins and nodularin, been found to be 
allelopathic (Babica et al. 2006; Suikkanen et al. 2006). While exceptions are likely to 
exist, based on the current evidence the generalization that algal compounds toxic to 
vertebrate animals function as allelopathic compounds should be rejected. 
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Karenia brevis produces multiple allelopathic compounds 
 Karenia brevis produces multiple allelopathic compounds that differ in polarity 
and allelopathic potency.  When K. brevis extracellular extract was separated into 23 
fractions by reversed-phase HPLC, five fractions (most containing distinct UV peaks) 
significantly inhibited the growth of Asterionellopsis glacialis (Figure 5.1). Additionally, 
allelopathic compounds fractionated by size-exclusion chromatography differed in 
potency (Figure 5.3B), molecular weight (Figure 5.3B), and functional group 
composition (Figures 5.4–5.5). Four HPLC fractions of Karenia brevis extracellular 
extracts stimulated the growth of A.glacialis (Figure 5.1B). However, the recombined 
HPLC fraction totally suppressed the growth of A. glacilalis indicating that the overall 
effect of compounds exuded by K. brevis is inhibition of competitors. 
Previous studies that have attempted to identify allelopathic compounds have also 
suggested the involvement of multiple compounds. For example, fractionation of filtrates 
from cultures of the allelopathic cyanobacterium Trichormus doliolum yielded three 
fractions that inhibited growth of a cyanobacterial competitor, Anabaena variabilis (Von 
Elert and Juttner 1997). Multiple compounds inhibitory to competitor growth have been 
isolated from whole cell extracts of other cyanobacteria, including Fischerella mucosa 
(Gross et al. 1991; Hagmann and Juttner 1996; Papke et al. 1997) and Nostoc 31 
(Todorova and Juttner 1995; Juttner et al. 2001). However, since the natural waterborne 
concentrations of these compounds are unknown, it is difficult to determine whether they 
are allelopathic in natural systems. In contrast to these studies, Sugg and Van Dolah 
(1999) found that allelopathic effects of filtrates of Prorocentrum lima were confined to 
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two adjacent HPLC fractions, suggesting that one or a few structurally similar 
compounds may be responsible for P. lima allelopathy. 
 Production of multiple allelopathic compounds by Karenia brevis (Figures 5.1, 
5.3B) seems unnecessary given that the compound(s) contained in only one HPLC 
fraction (B) were sufficient to completely suppress the growth of Asterionellopsis 
glacialis (Figure 5.1). However, because K. brevis blooms occur within a complex 
ecological community, multiple allelopathic compounds may be advantageous to K. 
brevis. First, in some cases multiple allelopathic compounds may be necessary to inhibit 
the growth of A. glacialis if A. glacialis is more or less susceptible to allelopathic 
compounds depending upon its own physiological state. As a precedent for this concept, 
the diatom Thalassiosira weissflogii was more resistant to allelopathic compounds from 
the haptophyte Prymnesium parvum (Fistarol et al. 2005) when grown under nutrient 
replete, rather than nutrient limited conditions. Because in the current study A. glacialis 
was grown in nutrient replete culture media, it may have been more resistant to 
allelopathic compounds that it would typically be in the field. Second, K. brevis competes 
with a complex assemblage of phytoplankton species in the field, rather than a single 
species. K. brevis may produce multiple allelopathic compounds because not all 
competitors are equally susceptible to the same compounds. 
 Because allelopathic compounds produced by phytoplankton have generally not 
been identified, determining whether a single compound is allelopathic to multiple 
species or whether multiple allelopathic compounds are produced with species-specific 
effects has been difficult. However, different competitors clearly have differing 
susceptibilities to allelopathic compounds. For example, yet-uncharacterized allelopathic 
129 
compounds (karlotoxins) of the mixotrophic dinoflagellate Karlodinium micrum inhibited 
the growth of some competitors, including the chryptophyte Storeatula major and the 
raphidophyte Heterosigma akashiwo, but did not inhibit chryptophyte Pyrenomonas 
salina or the dinoflagellate Amphidinium carterae. Similar patterns have been found for 
other allelopathic phytoplankton, including dinoflagellates Alexandrium spp. (Fistarol et 
al. 2004a; Tillmann et al. 2007), the haptophyte Prymnesium parvum (Fistarol et al. 
2003), and Karenia brevis (Kubanek et al. 2005; Prince et al. in press). Kubanek et al. 
(2005) found that some filtrates of K. brevis were allelopathic to some species, and other 
filtrates were allelopathic to other species, suggesting allelopathy may be mediated by 
several species-specific compounds.  
 
Most of the allelopathic compounds produced by Karenia brevis are polar and either 
neutral or positively charged 
 Allelopathic compounds produced by Karenia brevis are organic, polar molecules 
with no negative charge. All allelopathic activity from K. brevis extracellular extracts was 
retained on a hydrophobic resin column, eluting when the column was rinsed with 
methanol and acetone (Figure 5.2A), indicating that allelopathic effects were attributable 
to organic compounds. Yet, when K. brevis extracts were fractionated by reversed-phase 
HPLC, the most potent fraction eluted with 50% aqueous methanol, and three other 
allelopathic fractions eluted from the column in 50-70% aqueous methanol, indicating 
that these compounds were also relatively polar compared to the majority of compounds 
exuded by K. brevis (Figure 5.1). Using anion exchange chromatography we determined 
that allelopathic compounds exuded by Karenia brevis are not negatively charged (Figure 
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5.2B). These results indicate that no K. brevis allelopathic compounds contain carboxylic 
acid functional groups. Our method to determine whether allelopathic compounds contain 
positively charged functional groups using cation exchange chromatography yielded 
inadequate separation of the active compound (data not shown). Therefore, it is unclear 
whether K. brevis allelopathic compounds contain ammonium or some other positively 
charged group. 
 In contrast to our results, many previous studies of other planktonic systems 
reported lipophilic allelopathic compounds. For example, several studies have claimed 
that long-chain fatty acids or their methyl esters are allelopathic (Perez et al. 1997; Wu et 
al. 2006). However, the concentrations of methyl palmitate and methyl stearate necessary 
to cause allelopathic effects (Perez et al. 1997) probably do not occur in the field. 
Similarly, several fatty acids including linoleic and oleic acids caused the chlorophyte 
Monoraphidium contortum to leak K
+
 ions, suggesting physiological stress (Wu et al. 
2006). Although some microalgae have been documented to contain these fatty acids 
(Chiang et al. 2004), it is not clear than they are exuded at concentrations high enough to 
be allelopathic. In addition, fischerellins A and B isolated from the cyanobacteria 
Fischerella muscicosa are quite lipophilic (Hagmann and Juttner 1996; Papke et al. 
1997), but these compounds have not been shown to be allelopathic at naturally exuded 
concentrations.  
Several studies have partially characterized allelopathic compounds from 
extracellular filtrates of phytoplankton. The allelopathic compounds present in 
Trichormus doliolum filtrates eluted from a reversed-phase HPLC column with 90-100% 
aqueous methanol (Von Elert and Juttner 1997), indicating that they were less polar that 
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the allelopathic compounds exuded by K. brevis. In contrast, allelopathic compound(s) 
present in Prorocentrum lima filtrates eluted from a reversed-phase HPLC column with 
50% aqueous acetonitrile (Sugg and Van Dolah 1999), indicating that allelopathic 
compounds contained in this fraction may have been similar in polarity to those reported 
in this study. Although only a few naturally exuded allelopathic compounds have been 
partially characterized, the results of these studies indicate that allelopathic compounds 
may possess a wide range of polarities. 
 The polarity of allelopathic compounds has implications for their mechanisms of 
action and transport through the environment. Von Elert and Juttner (1997) suggested 
that hydrophobic compounds are more likely to be allelopathic than hydrophilic 
compounds, because they are better able to pass through cell membranes of competitors 
and to attack intracellular targets. However, transport across cell membranes may not be 
passive, or the site of action for allelopathy may be outside the cell. Previously we found 
that allelopathic compounds exuded by Karenia brevis increased the membrane 
permeability of competitor species resulting in cell membrane damage (Prince et al. in 
press), although the mechanism by which this occurred is unknown. Alternatively, 
exuded compounds may be chemically modified to become more allelopathic once they 
enter target cells. This “trojan horse” hypothesis has been proposed for okadaic acid and 
derivatives, but whether this mechanism is effective in natural systems is unclear (Hu et 
al. 1995; Sugg and Van Dolah 1999).  
In order for allelopathic molecules to be effective, they must be transported 
through the environment to the target organism. The polarity of a compound influences 
its solubility in an aqueous medium, and polar and charged molecules can be hydrated 
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with water, changing their diffusion rate (Cussler 1997).  Extremely lipophilic 
compounds may remain associated with producing cells or adsorb onto abiotic particles 
instead of diffusing freely through the surrounding aqueous environment. Additional 
allelopathic compounds will need to be characterized for scientists to be able to discern a 
general trend in the chemical characteristics of these compounds, and to determine the 
mechanisms by which they are transported through the environment and into competitor 
cells.  
 
Allelopathic compounds produced by Karenia brevis have molecular weights of 500-
1000 Da 
 Because allelopathic compounds were not retained by dialysis using a 1000 Da 
molecular weight cut-off membrane, it appears that they were smaller than 1000 Da 
(Figure 5.2C). This was confirmed using size-exclusion chromatography (Figure 5.3), 
whose outcome indicated that most allelopathic compounds eluted between the 1135 and 
433 Da standards. Thus, we predict that the molecular weights of allelopathic compounds 
fall between 500 and 1000 Da, suggesting that K. brevis allelopathy is mediated by small 
organic molecules rather than large proteins or other polymers. Many putative 
allelopathic compounds have molecular weights in a similar range, including fischerellin 
A (409 Da) (Hagmann and Juttner 1996) and cyanobacterin (430 Da) (Mason et al. 1982). 
Molecular weight ranges for naturally exuded allelopathic compounds have not been 
confirmed; however, the allelopathic dinoflagellate Alexandrium taylori was reported to 
exude a protein-like molecule of molecular weight > 10,000 Da that lyses some 
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mammalian red blood cells (Emura et al. 2004), although the effects of this compound on 
competitors is unknown. 
 When two allelopathic fractions of K. brevis extracellular extracts were analyzed 
by high resolution positive-ion electrospray ionization mass spectrometry (MS), several 
candidate molecular ions were observed (Figures 5.4A, 5.5A). A unique peak with mass-
to-charge ratio (m/z) of 963 was observed in allelopathic fraction 8’2-4 (Figure 5.5A) and 
fraction 8’5-7 contained a unique peak with m/z 907. Both samples produced ions with 
m/z of 663 and 991, suggesting that compounds with molecular weights of 662 and 990 
Da were present in both fractions. These two fractions eluted from the size exclusion 
column adjacent to one another, making it likely that some compounds were spread 
between fractions. Because the peak heights were normalized to the most abundant ion in 
each sample, the actual concentration of these compounds in each sample cannot be 
quantified directly from these spectra, but 
1
H NMR data indicates that the major 
component of each fraction is not the same. The shared compounds in each fraction may 
be minor components responsible for allelopathic effects, or the unique major 
components may be responsible for allelopathy. When these fractions were analyzed by 
mass spectrometry after decomposition (Figures 5.4B, 5.5B), only impurities were 
visible. In order to determine which candidate molecular weights can be attributed to the 
allelopathic compound, the allelopathic fractions must be more pure. However, further 




Allelopathic compounds produced by Karenia brevis have aromatic functional 
groups 
 Analysis by 
1
H NMR spectroscopy of two allelopathic fractions generated by 
size-exclusion chromatography prior to decomposition indicated that both fractions 
contained an aromatic moiety, but had different substitution patterns around the putative 
benzene ring (Figures 5.4C, 5.5C). Only a few proton signals were visible upfield of the 
aromatic proton resonances, indicating that the allelopathic compounds contained fewer 
than 20 hydrogen atoms bonded to carbon atoms. While these NMR data acquired with 
poor signal-to-noise ratio were insufficient for determining the complete molecular 
structures or even the biosynthetic class of allelopathic compounds, it is possible for 
some molecular characteristics to be confirmed. Because ions observed after mass 
spectrometry analysis were likely protonated, all of the observed candidate molecular 
weights were even-numbered (1 Da less than the observed m/z), indicating that 
allelopathic compounds contained either no nitrogen atoms or an even number of 
nitrogen atoms according to the nitrogen rule (Silverstein et al. 2005). No characteristic 
m+2 peaks were apparent in the mass spectra of allelopathic fractions, indicating than 
allelopathic compounds were unlikely to contain chlorine, bromine, or sulfur atoms.  
Although the molecular weight range of 500-1000 Da for our compounds rules 
out the possibility that allelopathy is mediated by proteins, the allelopathic compounds 
could be peptides containing aromatic amino acids but without positively charged groups. 
Several putative allelopathic aromatic cyclic peptides produced by the cyanobacterium 
Nostoc 31 have been described (Juttner et al. 2001). Dinoflagellates including Karenia 
brevis are known to produce polyketides (Baden et al. 1998), although these metabolites 
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are not aromatic. However, aromatic polyketides are commonly produced by bacteria, 
fungi, and plants (Shen 2000), so it is possible that they might also be produced by a 
dinoflagellate.  Aromatic alkaloids can be biosynthesized through the shikimic acid 
pathway (Ganem 1978). The allelopathic compounds produced by K. brevis may belong 
solely to one class of these metabolites, or may be products of some mixture of 
biosynthetic pathways. A small number of natural products have previously been 
identified that would fit the characteristics of the compounds present in our allelopathic 
fractions (i.e., organic, polar aromatic compounds containing an even number of 
nitrogens but no chlorines, bromines, or sulfurs). For example, an aromatic polyester with 
a molecular weight of approximately 662 which inhibits cell wall biosynthesis in fungi 
has been identified from a marine fungus (Schlingmann et al. 2002). Additionally, several 
aromatic peptides with molecular weights of approximately 962 have been identified 
from other marine organisms (Luesch et al. 2000; Milanowski et al. 2004). 
 
Allelopathic compounds are produced by Karenia brevis in low concentrations and 
are unstable 
 We were unable to purify and fully characterize the molecular structures of 
allelopathic compounds exuded by Karenia brevis, in part because allelopathic 
compounds were unstable.  Several of the methods that we used to purify compounds 
from K. brevis extracellular extracts resulted in loss of allelopathic effects, including the 
use of two additional reversed-phase HPLC columns (C-30 and CHP5C) (data not 
shown). Attempts to purify the allelopathic compounds by C-18 reversed-phase HPLC 
(Figure 5.1) resulted in eventual decomposition of allelopathic compounds (data not 
136 
shown). Although in some cases extracts and fractions remained allelopathic for weeks 
when stored in the dark at -20 °C under nitrogen gas, after several months allelopathic 
compounds decomposed even in these conditions (Figures 5.4B, 5.4D, 5.5B, 5.5D). 
Because allelopathic compounds were unstable, their presence in the environment is 
likely to be fleeting. The production of allelopathic compounds with a short lifespan may 
be advantageous to K. brevis by reducing the risk that grazers or parasites use these 
compounds as a cue to locate prey or hosts or that other, resistant but non-allelopathic 
phytoplankton benefit from allelopathic effects towards susceptible competitors. 
 Allelopathic compounds exuded by Karenia brevis were also present at low 
concentrations. Extraction of 1 L of K. brevis culture of high cell density yielded 
approximately 200 mg of extracellular organic extract, of which, the allelopathic 
fractions made up only a small percentage. When K. brevis extracellular extracts were 
separated by HPLC, the most potent allelopathic fraction (B) comprised only 2.5% of 
mass of the total, and the combined mass of all five allelopathic fractions represented 
only 13.7% of the total. Although all of the allelopathic material collected from 250 mL 
of K. brevis cultures was analyzed by 
1
NMR spectroscopy, the low signal-to-noise ratio 
of the resulting spectra indicated that only microgram quantities of each compound were 
present in these fractions (Figures 5.4C, 5.5C). Additional efforts to access a greater 
abundance of allelopathic compounds directly from cultured K. brevis cells also met with 
failure, since compounds with chemical characteristics that matched those described 





 We found that Karenia brevis produced multiple compounds that inhibited the 
growth of Asterionellopsis glacialis (Figure 5.1). Although one HPLC fraction accounted 
for most of the observed allelopathic effects, the production of multiple allelopathic 
compounds may be advantageous in some situations – for example, in the presence of 
multiple competitors of differing susceptibility. Most allelopathic compounds were 
relatively polar (Figure 5.1), indicating that they may be soluble in the surrounding water 
column, but raising questions about how such polar allelopathic compounds can cross 
competitor cell membranes. Partial characterization of two allelopathic compounds 
revealed molecular weights between 500 and 1000 Da (Figure 5.3), neutral or positive 
charge (Figure 5.2B) and aromatic moieties (Figures 5.4C, 5.5C) for both compounds. 
Compounds were produced at low concentrations and were unstable, suggesting that their 
presence in the environment is fleeting. The short lifespan of allelopathic compounds 
suggests that allelopathic effects of K. brevis on the plankton community dissipate with 
blooms. Future studies should attempt to elucidate the structures of K. brevis allelopathic 
compounds and to determine whether multiple compounds have species-specific effects 




ALLELOPATHY IN MARINE SYSTEMS: PERSPECTIVES AND FUTURE 
DIRECTIONS 
 
 Recent experimental evidence supports the hypothesis that allelopathy plays an 
important role in competitive interactions between pairs of species in planktonic and 
benthic marine communities. However, in order for research on allelopathy to continue to 
contribute to the understanding of marine ecology, future studies must first address 
current methodological concerns and constraints, focusing on the production and release 
of allelopathic compounds, the transport of these compounds through the environment, 
and the physiological effects of allelopathy on competitors. More importantly, in order to 
understand the consequences of allelopathic interactions, future research must investigate 
the effects of allelopathy on marine communities and must place allelopathic interactions 
in an evolutionary context. 
 
Current Methodological Concerns and Constraints 
 Convincing evidence of allelopathy in marine systems will require improvements 
in methodology at all levels. First, researchers should focus on identifying allelopathic 
compounds that are naturally released or found at the surface of organisms. Second, 
researchers must consider the waterborne transport of allelopathic compounds, designing 
experiments that address the fluid dynamics of the specific system. Finally, researchers 
should consider the physiological effects of allelopathic compounds on competing 
species. Here, we discuss limitations of current methods used for researching allelopathic 
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interactions and suggest alternative methods that may provide more ecologically relevant 
results and their potential benefits.  
 
Production and release of allelopathic compounds 
Identification of allelopathic compounds 
 Few studies have successfully led to identification of allelopathic compound(s). 
Instead, researchers have typically utilized mixtures of compounds exuded or extracted 
from allelopathic organisms to answer ecological questions. Both approaches have 
advantages. Because organisms may produce multiple compounds that both inhibit and 
stimulate competitors (e.g., Chapter 5 of this thesis) researchers must test the overall 
effects of one organism on another using whole extracts or exudates of a potentially 
allelopathic organism. Researchers can also assess whether total allelopathic potency 
changes with changing situations (e.g., in nutrient limiting conditions or the presence of 
specific community members). In contrast, conducting ecological tests with isolated, pure 
allelopathic compounds does not give researchers a complete picture of the allelopathic 
interactions between organisms.  
The isolation and identification of allelopathic compounds also had advantages, 
however. For example, if allelopathic compounds were successfully isolated and their 
structures elucidated, one could also test factors that influence the biosynthesis and 
exudation of allelopathic substances. Also, as with chemical defenses against consumers 
(Koricheva 2002), the use of allelopathic compounds may be costly. Because the cost of 
using chemical cues may be affected by the availability of specific nutrients (Bryant et al. 
1983), knowing the molecular structures of allelopathic compounds would enable 
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scientists to form and test hypotheses concerning the cost of producing compounds under 
specific nutrient regimes. In addition, many questions about the transport of waterborne 
allelopathic compounds through the environment could only be asked once molecular 
structures are known. The exudation rate, the solubility constant, and the diffusion rate of 
a pure compound can be measured or calculated (Cussler 1997), allowing researchers to 
assess natural localized concentrations of allelopathic compounds and thus to determine 
the active space of allelopathy.  Working with individual compounds, one could also 
determine whether allelopathic effects are general (i.e., inhibit all species) or if some 
organisms produce multiple compounds, each with species-specific allelopathic effects. 
In addition, if the molecular structure of an allelopathic compound is similar to that of 
other biologically active compounds with known modes of action, knowledge of its 
structure may provide insight into allelopathic mechanisms of action. 
To date, studies that aim to track allelopathy to its molecular source in a given 
benthic or pelagic marine system have primarily investigated the allelopathic effects of 
previously identified compounds. In pelagic systems, several species of marine 
dinoflagellates and haptophytes are known to produce compounds that are neurotoxic to 
vertebrates, but which have largely unknown ecological functions within plankton 
communities. Although these compounds can be responsible for mass mortalities of fish, 
birds, and marine mammals (Landsberg 2002), they have rarely been shown to be 
allelopathic to phytoplankton competitors. For example, Alexandrium spp. dinoflagellates 
produce saxitoxin and structurally related compounds whose neurotoxicity stems from 
their blockage of sodium channels (Baden et al. 1998). While filtrates of Alexandrium 
spp. are allelopathic to other dinoflagellates, diatoms, and chryptophytes, the effects seem 
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to be unrelated to saxitoxins (Tillmann & John 2002; Fistarol et al. 2004b). Similarly, the 
dinoflagellate Karenia brevis produces a group of neurotoxins called brevetoxins, which 
are largely not responsible for the allelopathic effects of K. brevis on competitors 
(Kubanek et al. 2005; Chapters 4 and 5 of this thesis). However, unidentified compounds 
isolated from exudates of the dinoflagellate Karlodinium micrum are icthyotoxic and 
hemolytic (Deeds et al. 2002), and were later also found to be allelopathic (Adolf et al. 
2006). In a few cases, allelopathy among phytoplankton has been linked to specific 
compounds; for example, several sequiterpene alcohols from the dinoflagellate 
Gymnodinium nagasakiense (Kajiwara et al. 1992) and fatty acid methyl esters produced 
by Nanochloris oculata were shown to inhibit the growth of competitors. However, in 
neither study were these compounds shown to be effective at natural waterborne 
concentrations. In contrast, allelopathic effects of benthic organisms have more often 
been explained by fully characterized compounds. Several sponges and macroalgae use 
compounds previously identified as feeding deterrents to overgrow competitors or avoid 
being overgrown by competitors (de Nys et al. 1991; Thacker et al. 1998; Kubanek et al. 
2002). 
 Although sometimes successful, currently available methods for testing 
allelopathic effects of known compounds have drawbacks. For example, (Windust et al. 
1996; Windust et al. 1997) found that okadaic acid, produced by the dinoflagellate 
Prorocentrum lima, suppressed the growth of several species of phytoplankton. However, 
when filtrates of P. lima were fractionated by high performance liquid chromatography 
(HPLC) and fractions tested at realistic waterborne concentrations (much lower than the 
concentrations used by Windust et al.), unidentified compound(s) were found to be 
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responsible for allelopathy rather than okadaic acid (Sugg & Van Dolah 1999). The 
results of this study suggest that bioassays must be carefully designed to mimic natural 
conditions, using realistic compound concentrations and ecologically relevant 
competitors. In addition, focusing only on previously identified compounds biases against 
the discovery of new allelopathic compounds and may prevent researchers from 
observing that multiple compounds (e.g., one previously identified and one unknown 
compound) act together to create allelopathic effects.  
Researchers may employ a variety of techniques to isolate allelopathic 
compounds, including bioassay-guided fractionation to narrow down the number of 
possible allelopathic compound from hundreds to only a few, within a manageable 
number of experimental steps. While bioassay-guided fractionation is ideal for exploring 
interactions involving a single, relatively stable compound, multiple fractionation steps 
can lead to loss of allelopathic compounds, and additive or synergistic effects of 
compounds can be difficult to test. While scientists have partially purified and 
characterized several novel allelopathic compounds by bioassay-guided fractionation 
(Suzuki et al. 1998; Sugg & Van Dolah 1999; Koh & Sweatman 2000; Deeds et al. 2002; 
Chapter 6), their molecular structures have not been fully determined.   
Alternatively, researchers can employ comparative approaches to discovering 
novel allelopathic compounds. In cases in which production of allelopathic compounds is 
variable (e.g., Prince et al. 2008; Prince et al. submitted), chemical profiles can be 
compared between allelopathic and non-allelopathic exudates or extracts. A 
metabolomics approach, allowing simultaneous comparison of the concentrations of 
hundreds of metabolites (Viant 2007), could be used to determine whether the presence 
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of certain metabolites correlates with allelopathic activity. However, a compound 
identified by this type of correlative approach may not be responsible for the overall 
allelopathic effect. In addition, chemical variability inherent in complex extracts and 
exudates may make the signal of allelopathy difficult to detect against background noise.  
Researchers may also investigate changes in gene expression when the production 
of allelopathic compounds is variable. Differential expression of genes related to the 
production of allelopathic compounds may be determined using expressed sequence tags 
(ESTs) from a cDNA library of an allelopathic organism or transcriptional changes of 
mRNA using microarrays (Dupont et al. 2007). If the differentially expressed genes code 
for enzymes known to be involved in the production of secondary metabolites (e.g., 
polyketide synthase genes Staunton & Weissman 2001), researchers might gain some 
insight into the class of molecules to which allelopathic compounds belong. This 
approach is complicated by the lack of well annotated genomes (Johnson & Browman 
2007) for most allelopathic organisms, making it possible that these methods will provide 
a sequence that does not correspond to a known gene. In addition, determining the 
structure of a molecule based on differentially expressed genes is not straightforward, and 
results may be difficult to interpret.  
 
Allelopathic interactions mediated by cell contact 
 Experimental demonstration of allelopathy requires the use of ecologically 
realistic bioassays, in which competitors are exposed only to compounds they would 
normally encounter in nature. For example, if allelopathic interactions are mediated by 
contact between competitors, only compounds present at the surface of an organism have 
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the potential to act as allelopathic agents. Yet, in some cases researchers have reported 
allelopathic effects using extracts of whole organisms (e.g., Thacker et al. 1998; Engel & 
Pawlik 2000), which could lead to an over-estimation of allelopathy if compounds 
extracted from deep within an organism suppress competitors, or an under-estimation if 
allelopathic surface compounds are tested at reduced, whole organism concentrations. A 
few studies have acknowledged this problem. For example, after determining that the 
sponge Ectyoplasia ferox produces  tritepene glycosides that prevent it from being 
overgrown by another sponge competitor, Kubanek et al. (2002) found that the 
concentration of these compounds was significantly higher in the outermost layer of the 
sponge than in inner portions, suggesting that observed allelopathic effects may have 
been conservative (however, outer layer concentrations may still have been artificially 
high compared to actual surface concentrations). One solution to this problem may be the 
method proposed by de Nys et al. (1998), in which organisms are dipped briefly in 
hexane to extract lipophilic compounds from the surface without lysing cells. Once 
collected, allelopathic effects of such compounds can be tested at approximately natural 
concentrations. In a subsequent test, Nylund et al. (2006) found that results from this 
method of collecting and testing surface compounds from macroalgae were more 
predictive of an organism’s ability to inhibit fouling than tests that utilized whole 
organism extracts. However, application of this surface extraction method is likely to be 
limited to highly lipophilic compounds and organisms whose cells are resistant to brief 
solvent exposure.  
  In contrast to benthic systems, no study of planktonic interactions has established 
that allelopathy occurs through cell contact. However, a few studies have shown that 
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competition can be mediated by cell contact (e.g., Uchida et al. 1995; Yamasaki et al. 
2007b). For example, Uchida et al. (1995) reported that contact with the red tide 
dinoflagellate Heterocapsa sp. caused cells of competitors to lose motility and eventually 
lyse. Similarly, contact with the dinoflagellate Cochlodinium polykrikoides caused the 
cells of one dinoflagellate competitor to develop an abnormal shape (Yamasaki et al. 
2007b). However, neither study demonstrated conclusively that these effects were 
chemically mediated. 
 
Allelopathic interactions mediated by waterborne compounds 
Demonstration of allelopathy via waterborne compounds requires experiments 
that use only naturally exuded materials, rather than whole cell extracts which contain 
compounds not normally encountered by competitors (e.g., Freeburg et al. 1979; Wu et 
al. 1998; Koh & Sweatman 2000). One solution is to expose competitors to filtrates of 
potentially allelopathic phytoplankton (e.g., Arzul et al. 1999; Kubanek et al. 2005; 
Tillmann et al. 2007). However, when using filtrates, one must ensure that allelopathic 
filtrates are not nutrient limited compared to controls. Because cultured organisms 
deplete nutrients as they grow, filtrates of these cultures have lower nutrient 
concentrations than fresh media.  Thus, in many cases, researchers have added nutrients 
to filtrates (e.g., Arzul et al. 1999; Yamasaki et al. 2007a), but this approach can lead to 
experiments in which nutrient concentrations in filtrates are higher than that of control 
media, potentially stimulating competitor growth and decreasing the likelihood of 
detecting allelopathic effects. To reduce the problem of nutrient artifacts, Kubanek et al. 
(2005) diluted filtrates of the dinoflagellate Karenia brevis four-fold with culture media, 
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consequently testing potential allelopathic compounds at artificially low concentrations. 
Alternatively, the nutrient concentrations of filtrates can be measured directly, and 
nutrient concentrations of controls adjusted to match treatments (e.g., Fistarol et al. 
2004b). Recent studies have reported a method to extract waterborne (extracellular) 
organic compounds from cultures, in which Prince et al. (2006; 2008) added a mixture of 
polystyrene resins to live phytoplankton cultures. Adsorbed organic compounds were 
then eluted using organic solvents. Because only an insignificant fraction of inorganic 
nutrients were extracted (Prince et al. 2008), this method enables allelopathic compounds 
to be tested at realistic exuded concentrations without the confounding variable of 
unequal nutrient concentrations. 
In marine benthic systems, waterborne compounds may inhibit settlement and 
metamorphosis of competitor larvae, but few studies have tested this possibility using 
ecologically relevant assays. For example, Koh & Sweatman (2000) found that 
compounds extracted from whole tissues of the scleractinian Tubastrea faulkneri 
inhibited metamorphosis of larvae of coral competitors, but did not test whether these 
compounds were exuded by T. faulkneri in natural environments. Other studies have 
reported that coral larvae are unlikely to settle near some filamentous cyanobacteria and 
macroalgae, but this may or may not be explained by the exudation of compounds into 
the water column (Kuffner & Paul 2004; Kuffner et al. 2006). Maida et al. (1995) found 
that scleractinian coral settlement was lower around the soft corals Sinularia flexibilis and 
Sarcophyton glaucum than around scleractinian coral controls. In subsequent tests to 
determine whether this pattern was chemically mediated, Maida et al. (1995) observed 
reduced settlement of scleractinian coral larvae onto ceramic tiles impregnated with 
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whole soft coral extracts; however, the authors did not determine whether the tiles 
released compounds at realistic rates. When Kubanek et al. (2002) collected water 
surrounding the allelopathic sponge Ectyoplasia ferox, they found that compounds were 
not present at high enough waterborne concentrations to significantly inhibit competitors 
by this mechanism. However, Dobretsov et al. (2006) did find that compounds exuded by 
the macroalgae Caulerpa racemosa inhibited the settlement of bryozoan and polychaete 
foulers. 
Realistic allelopathy assays testing compounds at their natural waterborne 
concentrations are difficult to conduct because one cannot measure the concentration of 
an unknown compound and because extracting compounds directly from seawater has 
historically not been straightforward.  However, waterborne extractions are feasible for 
cultures and even for field samples using techniques such as the polystyrene resin method 
used by Prince et al. (2006; 2008), by collecting exudates of allelopathic organisms using 
gas permeable/water impermeable bags, or by pumping water surrounding organisms 
through a column that collects organic compounds (e.g., Kubanek et al. 2002; Selander et 
al. in prep). 
 
Transport of allelopathic compounds through the environment 
 Researchers studying allelopathy in marine environments should also consider the 
physical environment through which waterborne compounds travel. Within fluids, the 
relative importance of forces that govern the transport of molecules differs depending 
upon spatial scale. At small scales (i.e., that of individual phytoplankton cells), viscous 
forces dominate, and molecules move away from a source primarily by the relatively 
148 
slow process of diffusion (Purcell 1977). However, at larger scales (i.e., that of 
macroscopic benthic organisms), inertial forces dominate and compounds travel by the 
relatively rapid process of advection (Vogel 1994). Thus, the movement of compounds 
between single-celled planktonic organisms is fundamentally different than the transport 
of compounds among larger benthic organisms, which may affect allelopathic outcomes. 
Because diffusion is the dominant process moving allelopathic compounds away 
from phytoplankton cells, cells are expected to be surrounded by a halo of their exuded 
compounds. Much of the surrounding water and exudate should move with each cell as it 
swims (Purcell 1977; Dusenbery 1992) since phytoplankton are smaller than the smallest 
scale of turbulent mixing in the ocean (approximately one millimeter) (Fischer et al. 
1979). By working with filtrates or extracellular extracts of cultured phytoplankton, past 
experiments have been designed to test the average allelopathic effect of exuded 
phytoplankton compounds. However, on the scale of individual cells, it is likely that there 
exists a complex chemical landscape, with patches of high concentrations of allelopathic 
compounds surrounded by areas of comparatively low concentration. The implications of 
a varied allelopathic landscape are difficult to assess using current methods but could be 
tackled using a mixture of modeling and innovative experimentation. Although models 
have been constructed for allelopathy in the plankton (e.g., Sole et al. 2005; Chen et al. 
2007; Roy & Chattopadhyay 2007), none have modeled the diffusion of allelopathic 
compounds away from an individual cell in order to predict this complex landscape. 
Future models should aim to predict the concentration of compounds surrounding an 
allelopathic organism, specifically focusing on factors that influence local concentrations 
of compounds and the gradient and scale over which concentrations of allelopathic 
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compounds change with increasing distance from the producing organisms. Parameters 
such as cell size and shape, swimming or sinking speed, and compound exudation and 
diffusion rates should be included in models of local concentrations of allelopathic 
compounds. The concentration of compounds necessary to produce allelopathic effects 
cannot be predicted by modeling, Thus, researchers could also experimentally generate 
dose-response curves of the allelopathic effects of identified compounds. Experimental 
results can be paired with models to determine the inter-organism distance over which 
allelopathy is effective. 
Because benthic organisms such as corals, sponges, and seaweeds occupy a scale 
of centimeters to meters, allelopathic compounds are expected to move between 
organisms primarily by advection (Vogel 1994). At this scale, understanding current 
magnitude and direction, turbulent velocity fluctuations, and boundary layer dynamics is 
central to understanding the fate of exuded allelopathic compounds. The motion of water 
near the substratum in benthic systems is characterized not only by high turbulence and 
high instantaneous velocity, but also by slow horizontal movement of water, suggesting 
that the concentration of exuded compounds may be patchy and rapidly changing (Koehl 
et al. 2007). Few studies have considered how flow affects allelopathic interactions in 
benthic systems. Maida et al. (1995) found that coral larvae did not settle evenly around 
soft corals. Measurements of prevailing currents confirmed that coral larvae recruitment 
was substantially more inhibited downstream, rather than upstream, of the allelopathic 
soft coral. The results of this study suggest that understanding the flow in benthic systems 
is central to determining which organisms will be impacted by allelopathy and how 
allelopathy will affect species distribution. Future studies should consider experiments 
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like those conducted by Maida et al. (1995); however, a more detailed map of flow fields 
would enable scientists to better predict areas where concentrations of allelopathic 
compounds are sufficient to inhibit competitor settlement or growth.  Mixtures of 
modeling and experiments have been used to answer similar questions in other fields. For 
example, Koehl et al. (2007) found that compounds exuded by the coral Porites 
compressa are not distributed evenly around corals, but instead form filaments in the 
turbulent water. Larvae of the sea slug Phestilla sibogae may settle onto coral hosts by 
sinking once larvae have encountered a filament of settlement cues from P. compressa. 
Questions about the fate of allelopathic compounds exuded into the water column could 
be answered by a similar combination of models to predict the flow field around an 
organism and experiments designed to visualize flow in the field and to test allelopathic 
effects of realistic exposure to waterborne compounds present in moving fluids. 
 
Physiological effects of allelopathic compounds on competitors 
 Although previous research has provided insight into some potential mechanisms 
of action of allelopathic compounds, additional ecologically relevant experiments are 
needed to understand their effects in natural systems. Nevertheless, determining how 
allelopathic compounds affect some model organisms can suggest potential physiological 
targets of allelopathy. For example, the hemolytic effect of algal toxins and microalgal 
exudates is often reported. Prymnesins 1 and 2, produced by the haptophyte Prymnesium 
parvum, and maitotoxin, from the dinoflagellate Gambierdiscus toxicus, lyse red blood 
cells of mammals, birds, and fish, a process which may be caused by the formation of 
cation pores in red blood cell membranes (Igarashi 1998; Igarashi et al. 1999). Although 
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prymnesins have not been shown to be allelopathic, exudates of P. parvum (that may 
contain prymnesins, among other compounds) have been shown to inhibit the growth of 
competing phytoplankton (Fistarol et al. 2003). However, cell-free filtrates of P. parvum 
did not possess hemolytic activity (Uronen et al. 2005), suggesting that prymnesins were 
not exuded from cells at high concentrations.  Thus, while the formation of membrane 
pores and subsequent cell lysis is likely the mode of action of prymnesins on mammalian 
red blood cells, the presence of prymnesins appears not to account for allelopathy, 
emphasizing the importance of relying on ecologically relevant experiments to determine 
the mode of action of allelopathic compounds. 
 Recent studies have reported specific allelopathic mechanisms of action (Prince et 
al. 2008). However, so far researchers have investigated the effects of allelopathic 
compounds on only a few cellular processes, focusing on those areas that are easy to test 
or have previously been shown to be a target of allelopathy. While this is an obvious 
place to start, researchers have no way of knowing whether a process identified in this 
way is the only target of allelopathic compounds or may be part of a more complex 
physiological outcome. In addition, it can be difficult to distinguish between a direct 
target of allelopathy versus a symptom of general cell stress. For example, the 
photosynthetic efficiency of competitors often decreases in response to allelopathic 
compounds (e.g., Pawlik et al. 2007; Raniello et al. 2007; Prince et al. 2008) but 
photosynthetic efficiency also decreases in response to nutrient stress (Parkhill et al. 
2001), temperature stress (Lesser & Gorbunov 2001), and metal toxicity (Miller-Morey 
& Van Dolah 2004). 
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 In order to better understand how allelopathy works in the context of organismal 
complexity, researchers could use “system”-based approaches that utilize whole genome, 
proteome, or metabolome profiling. One approach for determining how gene expression 
changes in response to allelopathic compounds could be to use expressed sequence tags 
(ESTs) from a cDNA library of a target organism susceptible to allelopathy (Dupont et al. 
2007). The specific ESTs that are differentially expressed for organisms exposed to 
allelopathic compounds versus controls may lead to identification of multiple sub-cellular 
targets, but to date no researchers have used this approach for allelopathic interactions. 
Similar studies have been used to determine the changes in gene expression of organisms 
exposed to other kinds of stresses. For example, Kore-eda et al. (2004) found that specific 
stress genes and a number of genes of unknown function were up-regulated in the ice 
plant Mesembryanthemum crystallinum in response to changes in salinity. Gene 
expression changes in response to allelopathy could also be determined by transcriptional 
changes of mRNA using microarrays (Dupont et al. 2007).  
Proteomics, the study of protein expression, could be a complementary tool for 
understanding modes of action of allelopathic compounds. Using 1D or 2D gel 
electrophoresis coupled with mass spectrometry, the differential expression of proteins in 
response to a stressor can be determined (Lopez 2007). Although this technique has not 
been employed for understanding protein responses to allelopathic compounds, 
differential protein expression has been observed in response to a variety of 
environmental conditions (e.g., Olsson et al. 2004; Barneah et al. 2006). However, one 
serious disadvantage of genomic and proteomic approaches described here is their 
reliance on well-annotated genomic and proteomic databases. For experiments using non-
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model organisms, researchers frequently discover differentially expressed genes or 
proteins with unknown sequences (e.g., Kore-eda et al. 2004; Olsson et al. 2004)), 
making the results of experiments difficult to interpret. While the genomes of some 
marine organisms have been sequenced, for example the diatom Thalassiosira 
pseudonana and the sea urchin Strongylocentrolus purpuratus, the current lack of 
genomic data for most marine organisms that are likely targets of allelopathy is a serious 
limitation (Johnson & Browman 2007). However, as genomes and cDNA libraries of 
additional organisms are sequenced and annotated, genomic and proteomic techniques 
will increasingly be appropriate for addressing the cellular processes affected by 
allelopathic compounds.  
The most recently developed “omics” technique, metabolomics, has been applied 
to only a small number of studies in marine ecology (e.g., Rosenblum et al. 2006; Viant 
et al. 2006). By using this technique that simultaneously measures hundreds of 
metabolites, researchers can assess rapid changes in the physiological state of organisms. 
One major drawback of metabolomic approaches is the difficulty of distinguishing 
treatment effects from normal background metabolic “noise”, thus requiring intensive 
replication of treatments and controls (Viant 2007). Despite current limitations, the future 
application of genomic, proteomic, and metabolomic techniques will provide researchers 
with an unbiased look at the physiological changes caused by allelopathic compounds, 




Determining Ecological and Evolutionary Implications 
of Allelopathic Interactions 
 The value of understanding mechanisms of allelopathic interactions is limited 
without an understanding of how allelopathy can influence community structure and how 
past evolutionary pressure and constraints have shaped the interactions that we see today. 
Research into allelopathy should incorporate more than pair-wise interactions. Instead, 
experiments should focus on how community composition changes the production and 
effects of allelopathic compounds and how allelopathic interactions change the 
composition of communities. Additionally, the evolutionary forces that shape allelopathic 
interactions should be considered and tested where possible – for example, regarding the 
issue of whether the production of allelopathic interaction is an evolutionary stable 
strategy, whether allelopathy can maintain biodiversity, and whether co-evolution shaped 
allelopathic interactions. 
 
The effects of allelopathic interactions on community structure 
Allelopathic interactions have the potential to both shape and be shaped by 
community composition. First, the production and effect of allelopathic compounds is not 
constant but likely changes in response to the presence of specific competitors and 
microbes. The microbial community can potentially produce or degrade allelopathic 
compounds (Hulot & Huisman 2004; Piel 2004) and play indirect roles in allelopathic 
interactions (Smith et al. 2006; Uronen et al. 2007). Second, studies of allelopathic 
interactions often consider only pair-wise interactions when, in fact, allelopathy has the 
potential to affect a wide array of competitors, especially in cases when compounds are 
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exuded into the water column. Changes in the composition of competitor species present 
in the community by allelopathy can influence the composition of higher trophic levels 
that prey on these species. Alternatively, higher trophic levels may influence the 
composition of competitors in a community, minimizing or enhancing allelopathic 
interactions. In order to get a more accurate picture of the complex web of implications of 
allelopathy, experiments should seek to understand the full extent of the interactions 
between production of allelopathic compounds and community structure. 
 
Effects of allelopathy on multiple competitors 
Despite the difficulty of working with complex ecological systems, several recent 
studies have provided insight into the effects of allelopathic compounds on natural 
plankton assemblages. For example, Fistarol et al. (2003; 2004b) found that while cell-
free filtrates of the cultured bloom-forming haptophyte Prymnesium parvum and 
dinoflagellates Alexandrium spp. inhibited natural phytoplankton assemblages, not all 
community members were equally affected. Thus, allelopathy may also change the 
species composition in a bloom community. In contrast, while some species of Baltic Sea 
cyanobacteria were found to inhibit the growth of a cryptophyte and a diatom in 
laboratory experiments (Suikkanen et al. 2004), compounds exuded by the 
cyanobacterium did not decrease the total density of photosynthetic organisms in a 
natural plankton community. In fact, filtrates actually stimulated many species of 
cyanobacteria, as well as some eukaryotic phytoplankton (Suikkanen et al. 2005). Similar 
experiments have been performed in benthic systems. For example, by measuring coral 
spat recruitment, Maida et al. (2001) found that the diversity and composition of coral 
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recruits was significantly different around two potentially allelopathic soft corals and a 
non-allelopathic control. These examples demonstrate that the knowledge gained from 
working with natural community assemblages can provide more insight into how 
allelopathic compounds affect communities than experiments that focus simply on pair-
wise species interactions. 
Studies that consider the effects of allelopathic compounds on natural 
assemblages of competitors still face the limitation that small collections or clonal 
cultures of allelopathic organisms rarely represent the full range of genetic diversity of 
natural populations. In fact, when assessing the allelopathic effects of phytoplankton, 
researchers often use a single, genetically identical strain in experiments, despite the fact 
that a number of recent studies have indicated a surprisingly high degree of genetic 
diversity present during phytoplankton blooms (e.g., Evans et al. 2004; Gribble & 
Anderson 2007). One way to overcome this problem is to use field collections as sources 
of allelopathic substances, which is possible for species that form nearly monospecific 
blooms, e.g., the dinoflagellate Karenia brevis (Steidinger & Haddad 1981). Prince et al. 
(2008) found that extracellular compounds collected from exudates of a natural K. brevis 
bloom strongly suppressed the growth of three of five competitor species tested in pair-
wise lab experiments. However, the allelopathic effects of K. brevis blooms varied 
dramatically over temporal and spatial scales, and bloom intensity was not a good 
predictor of allelopathic potency (Prince et al. submitted). Researchers assessing 
allelopathic effects of benthic organisms usually collect multiple organisms for 
experiments (e.g., de Nys et al. 1991; Thacker et al. 1998), although the genetic 
relatedness of these individuals is unknown. Secondary metabolite profiles are known to 
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vary at the individual and population levels for benthic invertebrates (Pettit 1991) and 
macroalgae (Kubanek et al. 2006; Lane et al. 2007), suggesting that the production of 
allelopathic compounds could also vary across and within populations. However, 
population-level variability has not been directly assessed in any studies of benthic 
allelopathy. While some researchers have collected allelopathic organisms from different 
populations (e.g., Kubanek et al. 2002), only the average allelopathic effect was reported. 
Future studies should attempt to understand the role genetic diversity plays in the 
production of allelopathic compounds, which could also have implication for evolution of 
allelopathy.  
Species composition within marine communities may also influence allelopathic 
outcomes, for example by altering the waterborne concentration of compounds produced 
by some phytoplankton. Two studies have demonstrated increased production of 
anatoxins and microcystins by freshwater cyanobacteria in response to the presence of 
dinoflagellate or green algal competitors (Kearns & Hunter 2000; Vardi et al. 2002). In 
contrast, Myers et al. (submitted) found that the presence of phytoplankton competitors 
led to decreased concentrations of brevetoxins exuded from the dinoflagellate Karenia 
brevis. However, neither anatoxins nor microcystins have been shown to have 
allelopathic roles, and brevetoxins were rarely responsible for the allelopathic effects of 
K. brevis. In a recent study, Prince et al. (submitted) found that blooms of K. brevis were 
less allelopathic during a year in which the diatom Skeletonema costatum was part of the 
bloom community compared with a year when S. costatum was absent. Lab experiments 
revealed that adding live S. costatum cells to live bloom samples significantly reduced the 
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allelopathic effects of blooms, suggesting that S. costatum is able to undermine K. brevis 
allelopathy.  
Few studies have investigated how allelopathic interactions change with the 
presence of specific competitors in benthic systems, although Thacker et al. (1998) 
determined that the presence of a competitor sponge Cacospongia sp. did not induce 
production of the allelopathic compound 7-deacetoxyolepupuane in the sponge Dysidea. 
Curiously, Thacker et al. (1998) found that sections of live Cacospongia sp. exposed to 
7-deacetoxyolepupuane contained higher concentrations of organic compounds, although 
the identity of these compounds and their ecological roles were not determined. The  
variable nature of allelopathic interactions may be better understood as studies shift away 
from consideration of competitors as passive targets of allelopathic compounds and 
toward the view that allelopathy is a dynamic and interactive process. 
 
Influence of bacterial community on allelopathic interactions 
 The role that bacteria play in allelopathic interactions remains unclear. Although 
evidence is accumulating that microbial symbionts are responsible for production of 
many natural products isolated from eukaryotic organisms (Piel 2004), no studies have 
conclusively demonstrated the role of associated microbes in the production of 
allelopathic compounds. For example, sponges are believed to use allelopathic 
compounds to compete for space with corals (Porter & Targett 1988), as well as to defend 
against overgrowth from (Engel & Pawlik 2000) and to overgrow (Thacker et al. 1998) 
other sponges. However, nearly 40% of sponge biomass may be made up of associated 
microbes (Taylor et al. 2007), which have been demonstrated as the source of some 
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sponge metabolites (Bewley & Faulkner 1998; Piel 2004), making symbiotic bacteria a 
possible source for sponge allelopathic compounds.  
As with benthic macroorganisms, allelopathic phytoplankton are also known to 
associate with bacteria which have been implicated in the production of natural products 
(Doucette 1995). Most tests of allelopathy among planktonic organisms have involved 
use of non-axenic (i.e., bacteria-containing) phytoplankton strains, making it difficult to 
determine whether observed allelopathic effects were caused by phytoplankton or 
associated bacteria (e.g., Tillmann & John 2002; Kubanek et al. 2005; Uronen et al. 
2007). However, other studies have shown filtrates of axenic phytoplankton to be 
allelopathic (e.g., Yamasaki et al. 2007a), indicating that at least in some cases eukaryotic 
plankton are responsible for the production of allelopathic compounds. The potential for 
a symbiotic microbe to act as producer of allelopathic compounds benefiting its 
eukaryotic host raises the important question of whether the production of natural 
products can drive the evolution of symbiosis. Thus, future studies should attempt to 
determine whether allelopathic compounds are produced by associated bacteria. 
In addition to being possible sources of allelopathic compounds, bacteria may 
play indirect roles in allelopathic interactions. First, heterotrophic bacteria have been 
hypothesized to degrade allelopathic compounds exuded into the water column, which 
models predict should limit the effects of allelopathy (Hulot & Huisman 2004). Second, 
pathogenic effects of some bacteria may lead to a mistaken interpretation of allelopathy 
being important. For example, Smith et al. (2006) found that macroalgae stimulated the 
growth of bacteria, which resulted in coral mortality. Had researchers not directly tested 
whether the proximity of algae to corals stimulated bacterial growth, the results could 
160 
have been misinterpreted as an allelopathic interaction between macroalgae and corals. 
Finally, the microbial community can also benefit directly from allelopathy. The 
haptophyte Prymnesium parvum was shown to cause cell lysis of the competing 
phytoplankter Rhodomonas salina, resulting in an increase of dissolved nutrients, which 
was shown to boost bacterial biomass (Uronen et al. 2007). Thus, allelopathy may 
influence marine communities by providing food for mixotrophic and heterotrophic 
plankton or by increasing the concentration of pathogenic bacteria.  However, Uronen et 
al. (2007) used microbes associated with P. parvum and R. salina cultures rather than the 
bacteria that naturally occur during P. parvum blooms, making community consequences 
unclear. Additionally, Uronen et al. (2007) did not consider how bacterial species 
composition associated with phytoplankton changed due to compounds released from 
lysed cells. Clearly microbial communities may play complex roles in allelopathic 
interactions: bacteria have the potential to produce or degrade allelopathic compounds, 
mediate apparent allelopathic effects, and may be stimulated by allelopathic interactions. 
The complexity of these interactions begs further investigation into the role of specific 
microbes involved and the mechanisms mediating interactions using ecologically relevant 
species and experiments. 
 
Influence of allelopathic interactions on multiple trophic levels 
By definition, allelopathic interactions occur between competitors, but allelopathy 
may indirectly affect higher trophic levels. Because, as primary producers, phytoplankton 
and some benthic algae form the base of the marine food chain in photic zones, changes 
in their species composition or abundance caused by allelopathy are likely to impact 
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consumers.  For example, the dinoflagellate Karenia brevis and macroalga Caulerpa 
racemosa may use allelopathy to exclude many competitors (Steidinger & Haddad 1981; 
Piazzi et al. 2001; Kubanek et al. 2005; Raniello et al. 2007), which is likely to impact 
grazers of benthic and pelagic communities. K. brevis has been shown to be nutritionally 
inadequate to some copepods (Prince et al. 2006) and to cause physiological distress in 
others (Sykes & Huntley 1987). The effects of Caulerpa racemosa on grazers is less 
clear, but if C. racemosa dominates the community, even a small change in grazing 
patterns could have a dramatic effect on consumers. Although several studies have 
established that allelopathic compounds released by phytoplankton change the relative 
abundance of other phytoplankton taxa (Fistarol et al. 2003; Fistarol et al. 2004b; 
Suikkanen et al. 2004), the effect the altered phytoplankton assemblage on zooplankton 
grazers is yet unknown. If toxic or unpalatable phytoplankters are less susceptible to 
allelopathy than palatable species, then consumers could decrease in abundance, which 
has the potential to affect higher trophic levels and could eventually damage 
commercially important fisheries. However, no study has tested this hypothesis. Simple 
experiments that assess the fitness of grazer species on a control phytoplankton 
assemblage and a phytoplankton assemblage which has been exposed to allelopathic 
compounds could begin to resolve the indirect effects of allelopathy on consumers. 
In some cases, clear distinctions between competition and predation cannot be 
made. Because mixotrophic algae are able to phytosynthesize as well as use organic 
carbon sources, they may simultaneously compete with and prey upon other microalgal 
species. Therefore, allelopathic compounds may enable mixotrophs both to kill 
competitors that limit their access to resources as well as to ingest prey. For example, the 
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mixotrophic dinoflagellate Karlodinium micrum has been found to produce allelopathic 
compounds of yet-unidentified molecular structure called karlotoxins, which inhibit the 
growth of the cryptophyte competitor Storeatula major. However, the presence of 
karlotoxins also increased ingestion of S. major by K. micrum, indicating that karlotoxins 
play more than one role (Adolf et al. 2006). Similarly, the mixotrophic haptophyte 
Prymnesium parvum inhibits the growth of competing phytoplankton by the exudation of 
allelopathic compounds, which may also help P. parvum ingest algal prey under nutrient 
limited conditions (Graneli & Johansson 2003; Graneli 2006). The multiple strategies of 
mixotrophic algae, which change with different resource availability and community 
composition, underscore the complexity of allelopathic interactions. 
 
Understanding the evolutionary context of allelopathy 
 Once allelopathic interactions are placed in the context of ecological 
communities, the evolutionary pressures that select for or constrain the production of 
allelopathic compounds can be better understood. To establish why allelopathic 
interactions between organisms persist over time, it is important to consider the fitness 
benefit to producing allelopathic compounds. However, because the producer of 
allelopathic compounds is expected to bear costs, implications of the cost-to-benefit ratio 
must be explored, focusing on the strategies used by allelopathic organisms to minimize 
this ratio. Scientists should also consider how co-evolution between competitor species 
may influence allelopathy and its outcomes, in addition to the patterns in the production 




Fitness benefits of allelopathy 
 In order for allelopathy to be an evolutionarily stable strategy, the production of 
allelopathic compounds must provide a fitness benefit to allelopathic organisms. While 
the benefits of killing competitors may seem obvious in some systems, the effects of 
allelopathy on the fitness of producers have not been tested. For example, if space is 
limited in benthic systems, the ability of a sponge to overgrow a competitor (Thacker et 
al. 1998) or keep from being overgrown (Engel & Pawlik 2000; Kubanek et al. 2002) 
may allow the allelopathic sponge to survive and reproduce better than those that are 
overgrown or have no space to settle. However, no studies have clearly linked the 
production of an allelopathic compound to increased survival, growth, or reproduction. In 
contrast, the production of compounds that defend against predation have been directly 
linked to fitness benefits to the producing organism (e.g., Baldwin 1998), and future 
studies of the benefits of allelopathy should attempt to establish a similar pattern. 
 In cases where allelopathic compounds are waterborne, the potential benefit to 
the producer is less obvious than for organisms using surface-mediated allelopathy. In 
fact, (Lewis 1986) proposed a major theoretical challenge to allelopathy, which he refers 
to as “the problem of distributed benefits.” He argued that because the planktonic 
environment is not spatially segregated, organisms producing an allelopathic compound 
should incur the entire cost of this production, while the benefit of allelopathic 
compounds could be shared by all organisms resistant to allelopathy. If an organism 
“cheats” by benefiting from allelopathy without paying the cost of production, it will 
presumably be more fit and eventually outcompete organisms that do produce 
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allelopathic compounds. What Lewis failed to note, however, is the scale of allelopathic 
interactions in the plankton. As we mentioned previously, because an individual 
phytoplankton cell is smaller than the scale of turbulent mixing in the ocean (Fischer et 
al. 1979), compounds exuded into the water will move away from producers primarily by 
the relatively slow process of diffusion (Purcell 1977). Thus, it is likely that that in the 
complex allelopathic landscape of the plankton, benefits are not distributed, but rather 
remain mostly associated with producers rather than cheaters. The role of spatial 
segregation in allelopathic interactions among bacteria has been explored in detail, both 
through models (e.g., Durrett 1997) and experiments (e.g., Kerr et al. 2002). Researchers 
have found that spatial segregation promotes the persistence of the allelopathic phenotype 
(Kerr et al. 2002). Similar outcomes have been predicted by models of allelopathic 
interactions among phytoplankton; lower mixing intensity should also favor plankton that 
produce allelopathic compounds (Hulot & Huisman 2004). Although we predict that the 
theoretical challenges to allelopathy in the phytoplankton can be addressed by 
considering the scale at which interactions occur, the actual benefit to the producing 
organism has not been conclusively demonstrated.  
 
Role of allelopathy in maintaining biodiversity 
Allelopathic interactions may play a role in maintaining biodiversity. Czaran et al. 
(2002) modeled three phenotypes: one allelopathic, one susceptible to allelopathy but not 
allelopathic, and one resistant to allelopathy but not allelopathic. In this scenario, 
susceptible organisms were superior exploitation competitors because they incurred 
neither the costs of producing nor resisting allelopathic compounds. Resistant organisms 
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were intermediate exploitation competitors because they incurred the cost of resistance 
but not production. Allelopathic organisms were the worst exploitation competitors 
because they carried the cost of production and resistance to allelopathic compounds. In 
the proposed model, all three phenotypes can persist because although an obvious winner 
would emerge in any pair-wise interaction, when all three phenotypes are present a rock-
paper-scissors situation emerges where no phenotype can out-compete the other two. 
Such a system has been demonstrated experimentally using three strains of Escherichia 
coli. However, biodiversity was only maintained in a spatially segregated system, 
because, in well-mixed systems, the susceptible strain was killed by the allelopathic 
strain, which was then out-competed by the resistant strain (Kerr et al. 2002). While three 
is the minimum number of phenotypes necessary for biodiversity to be maintained by 
such a non-hierarchical system, Czaran et al. (2002) predicted through modeling that a 
stable equilibrium of hundreds of phenotypes with varying degrees of allelopathy and 
resistance is possible. Because the different phenotypes could be different species or 
different strains of the same species, Czaran et al. (2002) proposes this situation as one 
factor that may explain why so many species can exist using the same resources – a 
dilemma originally termed the “paradox of the plankton” (Hutchinson 1961).  
 
The costs of allelopathy  
Attempts to understand the costs of producing allelopathic compounds may 
benefit from the extensive theoretical consideration of this subject from the chemical 
defense literature (e.g., Feeny 1976; Rhodes 1979; Coley 1985; Herms & Mattson 1992). 
Chemical defense theories attempt to explain under which circumstances the benefits of 
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producing defensive compounds outweigh the costs and how defenses should be 
allocated in time and space. Much of the discussion is also relevant to the production of 
allelopathic compounds. Natural selection should favor production or release of 
allelopathic compounds only when benefits outweigh the costs, and organisms may 
develop strategies to minimize these costs. The costs of defense can be divided into 
several categories, including allocation costs (i.e., costs incurred from allocating 
resources to production of compounds), opportunity costs (i.e., costs associated with loss 
of competitive ability due to allocating resources to defense rather than growth) and 
ecological costs (i.e., costs incurred when compounds disadvantage the producer in some 
other ecological interaction, such as making the producer more vulnerable to pathogens) 
(Koricheva 2002). While costs of defense against herbivores and predators have been 
demonstrated (e.g., Baldwin 1998; Mutikainen et al. 2002; Puustinen et al. 2004), few 
studies have shown that the production of allelopathic compounds are similarly costly. 
However, in one of very few examples of the ecological costs of allelopathy, the 
mixotrophic dinoflagellate Karlodinium micrum was found to inhibit the growth of 
competitors (Adolf et al. 2006), but more highly allelopathic strains of K. micrum were 
also more susceptible to infection by the parasitic dinoflagellate Amoebophrya sp. (Bai et 
al. 2007).  
  When multiple competitors, predators, and pathogens are present, it may benefit 
an allelopathic organism to use a single compound against several competitors or as a 
way to inhibit both competitors and to serve additional ecological functions (e.g., as a 
defense against predation). Multiple functions of allelopathic compounds may minimize 
the allocation costs, but may also constrain potential co-evolution between an allelopathic 
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organism and a competitor (cf., Schmitt et al. 1995). Clear examples of compounds that 
are used for both defense against predation and for allelopathy exist for a handful of 
marine sponges (Thacker et al. 1998; Kubanek et al. 2002). However, because 
allelopathic compounds produced by phytoplankton have rarely been identified, it is 
difficult to determine whether similar situations occur in pelagic systems. Exudates from 
cultures and blooms of phytoplankton have been shown to suppress laboratory 
monocultures of multiple competitors (e.g., Kubanek et al. 2005; Tillmann et al. 2007; 
Prince et al. 2008) as well as multiple species within natural phytoplankton assemblages 
(e.g., Fistarol et al. 2003; Fistarol et al. 2004b). If multiple species are inhibited by a 
single allelopathic compound, the allocation cost allelopathy would be reduced, but co-
evolution between a single competitor species and the allelopathic species would be 
constrained. Alternatively, multiple allelopathic compounds with species-specific effects 
may be produced by organisms. Although maintaining production of multiple compounds 
is likely to be more energetically costly than producing a single compound for multiple 
uses, it is possible that the benefits from the resulting evolutionary flexibility outweigh 
the costs. Questions about the cost-to-benefit ratio of compound production will be 
difficult to answer without identification of more allelopathic compounds. 
Producing or releasing allelopathic compounds only when necessary, such as in 
the presence of a susceptible competitor or when resources are especially limiting, might 
minimize both allocation and ecological costs of allelopathy. Studies have documented 
variability in the allelopathic potency of filtrates or extracellular extracts (e.g., Prince et 
al. submitted), which may result from such minimization of costs. However, these authors 
did not find that the presence of susceptible competitors consistently induced production 
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of allelopathic compounds by K. brevis. In contrast, Uronen et al. (2005) found that 
filtrates of the haptophyte Prymnesium parvum are more allelopathic under nitrate and 
phosphate limited conditions, suggesting that allelopathic compounds may be produced 
when the benefits likely to be gained from them is greatest (i.e., when nutrients are 
limited). More research is needed before the costs of allelopathy are understood. If the 
structures of allelopathic compounds were known, the energy (i.e., ATP used to assemble 
compounds) and other resources (e.g., nitrogen incorporated into compounds) required to 
produce allelopathic compounds could be assessed, facilitating efforts to understand 
allocation costs.  
 
Conclusions 
 Recent studies have provided several strong examples of pair-wise competitive 
outcomes mediated by allelopathy within marine systems. Future studies should focus on 
overcoming the limitations of current methodology as well as incorporating broader and 
contextual questions of how allelopathic interactions change community structure, and 
how allelopathic interactions are shaped by evolution. Great strides could be made in 
understanding allelopathic interactions if methodological concerns were to be addressed. 
For example, the isolation and structure elucidation of compounds would enable 
researchers to more easily ask questions about the biosynthesis of allelopathic 
compounds, the species-specificity of allelopathy, the allocation costs of producing 
allelopathic compounds, and the rates and concentrations at which these compounds 
travel through the environment. Understanding the transport of allelopathic compounds 
through the environment will require a focus on issues of scale and flow but will provide 
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a more nuanced view of the variability of allelopathy and the conditions that favor it. 
Finally, genomic, proteomic, and metabolomic techniques should enable researchers to 
take an unbiased look at the physiological effects of allelopathic compounds on target 
competitors, providing a more accurate and complete picture of their modes of action. 
 Future studies should focus on how allelopathic interactions change community 
structure and are shaped by evolutionary forces in order to make the questions relevant to 
marine ecology. Recent studies in the plankton have provided evidence that allelopathic 
compounds can affect whole communities by reducing total phytoplankton biomass, 
changing relative species abundance, and increasing microbial biomass (Fistarol et al. 
2003; Fistarol et al. 2004b; Suikkanen et al. 2005; Uronen et al. 2007). However, 
questions remain about the roles of associated microbes in the production of allelopathic 
compounds and the effect of changing phytoplankton assemblages on higher trophic 
levels. Studies of allelopathy among benthic organisms can provide insights into 
community structure when the influence of allelopathic interactions on whole 
communities, rather than pair-wise interactions, are considered. Finally, the facts that 
allelopathic compounds vary in their production (e.g., Uronen et al. 2005; Prince et al. 
submitted), can be used for more than one function (e.g., Kubanek et al. 2002; Adolf et 
al. 2006), and have species-specific effects (e.g., Fistarol et al. 2003; Kubanek et al. 
2005), have implications for the evolutionary forces and constraints of allelopathic 
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